GT,Diagnosis 1
['Vitamin B12-unresponsive methylmalonic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Methylmalonic Acidemia: A rare inherited disorder characterized by the inability to properly metabolize certain proteins and fats, leading to a buildup of methylmalonic acid in the body. Symptoms in common: Metabolic acidosis, Decreased methylmalonyl-CoA mutase activity. Symptoms not in common: Death in infancy, Death in childhood (although these can occur in severe cases).

+2. Propionic Acidemia: Another inherited metabolic disorder that affects the breakdown of certain proteins and lipids, resulting in an accumulation of propionic acid and other harmful substances. Symptoms in common: Metabolic acidosis. Symptoms not in common: Decreased methylmalonyl-CoA mutase activity, Death in infancy, Death in childhood (although these can occur in severe cases).

+3. Maple Syrup Urine Disease: A rare genetic disorder that affects the body's ability to break down certain amino acids, leading to a buildup of toxic substances and a characteristic sweet, maple syrup-like odor in the urine. Symptoms in common: Metabolic acidosis. Symptoms not in common: Decreased methylmalonyl-CoA mutase activity, Death in infancy, Death in childhood (although these can occur in severe cases).

+4. Isovaleric Acidemia: An inherited metabolic disorder that affects the breakdown of the amino acid leucine, leading to an accumulation of isovaleric acid and other toxic substances. Symptoms in common: Metabolic acidosis. Symptoms not in common: Decreased methylmalonyl-CoA mutase activity, Death in infancy, Death in childhood (although these can occur in severe cases).

+5. Organic Acidemias: A group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to deficiencies in specific enzymes involved in the breakdown of proteins, fats, and carbohydrates. Symptoms in common: Metabolic acidosis. Symptoms not in common: Decreased methylmalonyl-CoA mutase activity, Death in infancy, Death in childhood (although these can occur in severe cases).

Please note that a proper diagnosis would require additional tests and a thorough evaluation by a medical professional."
['Succinic semialdehyde dehydrogenase deficiency'],"Based on the provided symptoms: ['Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Pneumonia', 'Elevated urinary carboxylic acid'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Leigh Syndrome:
Matching symptoms: Motor delay, Generalized hypotonia, Death in infancy
Non-matching symptoms: Pneumonia, Elevated urinary carboxylic acid

+2. Pompe Disease:
Matching symptoms: Motor delay, Generalized hypotonia, Pneumonia
Non-matching symptoms: Death in infancy, Elevated urinary carboxylic acid

+3. Propionic Acidemia:
Matching symptoms: Motor delay, Generalized hypotonia, Elevated urinary carboxylic acid
Non-matching symptoms: Death in infancy, Pneumonia

+4. Methylmalonic Acidemia:
Matching symptoms: Motor delay, Generalized hypotonia, Elevated urinary carboxylic acid
Non-matching symptoms: Death in infancy, Pneumonia

+5. Spinal Muscular Atrophy (SMA):
Matching symptoms: Motor delay, Generalized hypotonia
Non-matching symptoms: Death in infancy, Pneumonia, Elevated urinary carboxylic acid

+6. Congenital Myopathies:
Matching symptoms: Motor delay, Generalized hypotonia
Non-matching symptoms: Death in infancy, Pneumonia, Elevated urinary carboxylic acid

Please note that this is a preliminary analysis based on the provided symptoms, and further diagnostic tests and evaluations may be required to confirm or rule out these potential diseases."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has symptoms of 'Hyperphenylalaninemia' and 'Hypertyrosinemia,' which are common in PKU. However, the symptoms 'Abnormality of prenatal development or birth,' 'Death in infancy,' and 'Neonatal death' are not typically associated with PKU if it is diagnosed and treated early.

+2. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body cannot break down certain amino acids, including leucine, isoleucine, and valine. The patient does not have any symptoms specifically related to MSUD, such as maple syrup odor in urine, vomiting, and lethargy.

+3. Homocystinuria:
This is a genetic disorder characterized by the inability to metabolize the amino acid homocysteine, leading to its accumulation in the body. The patient does not have any symptoms specifically related to homocystinuria, such as developmental delays, osteoporosis, and thromboembolism.

+4. Tyrosinemia:
This is a group of inherited disorders characterized by the inability to metabolize the amino acid tyrosine, leading to its accumulation in the body. The patient has the symptom of 'Hypertyrosinemia,' which is common in tyrosinemia. However, other symptoms like liver disease, kidney disease, and neurological problems are not mentioned.

+5. Congenital Hypothyroidism:
This is a condition in which the thyroid gland does not produce enough thyroid hormones, which are essential for normal growth and development. The patient does not have any symptoms specifically related to congenital hypothyroidism, such as poor feeding, constipation, and prolonged jaundice.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a detailed medical history, by a qualified healthcare professional."
['PMM2-CDG'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Pontocerebellar Hypoplasia Type 1 (PCH1): A rare genetic disorder characterized by severe cerebellar hypoplasia or atrophy, leading to motor delays, failure to thrive, and often death in infancy. The patient has symptoms such as cerebellar atrophy, motor delay, and failure to thrive, which are consistent with this condition.

+2. Congenital Muscular Dystrophy (CMD): A group of inherited disorders affecting muscle development and function, often presenting with motor delays, abnormal muscle physiology, and failure to thrive. The patient has symptoms like motor delay and abnormal muscle physiology, which could be indicative of CMD.

+3. Congenital Diaphragmatic Hernia (CDH): A birth defect in which the diaphragm fails to form properly, allowing abdominal organs to protrude into the chest cavity. The patient has the symptom of congenital diaphragmatic hernia, which is a defining feature of this condition.

+4. Berardinelli-Seip Congenital Lipodystrophy: A rare genetic disorder characterized by a near-total lack of body fat (lipodystrophy) from birth, leading to abnormal fat distribution and metabolic complications. The patient has the symptom of lipodystrophy, which is a hallmark of this condition.

+5. Hiatus Hernia: A condition in which part of the stomach protrudes through the diaphragm into the chest cavity. The patient has the symptom of hiatus hernia, which is consistent with this condition.

It's important to note that a comprehensive medical evaluation, including physical examination, laboratory tests, and imaging studies, would be necessary to confirm or rule out any of these potential diagnoses."
['Maple syrup urine disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Maple Syrup Urine Disease (MSUD): A rare inherited disorder characterized by the inability to break down certain amino acids, leading to a buildup of toxic substances in the body. Symptoms include delayed development, intellectual disability, hypotonia, athetosis, and a distinctive maple syrup odor in urine and sweat.

+2. Cerebral Palsy: A group of disorders affecting movement, muscle tone, and posture, often caused by brain damage before, during, or shortly after birth. Symptoms may include motor delays, abnormal muscle tone, feeding difficulties, and intellectual disabilities.

+3. Meningitis: An inflammation of the protective membranes covering the brain and spinal cord, often caused by viral or bacterial infections. Symptoms can include fever, opisthotonus (abnormal posturing), and intellectual disabilities in severe cases.

+4. Spinal Muscular Atrophy (SMA): A genetic disorder characterized by progressive muscle weakness and atrophy, leading to motor delays, hypotonia, feeding difficulties, and respiratory complications.

+5. Congenital Metabolic Disorders: A group of inherited disorders affecting the body's ability to metabolize specific substances, such as amino acids or organic acids. Symptoms may include developmental delays, intellectual disabilities, feeding difficulties, and elevated levels of specific metabolites in urine or blood.

+6. Congenital Anomalies: Birth defects or structural abnormalities present at birth, which can affect various organ systems and lead to a range of symptoms, including developmental delays, intellectual disabilities, and physical abnormalities.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided symptoms may overlap with multiple conditions, and further investigation would be necessary to determine the underlying cause."
['Phenylketonuria'],"Based on the provided symptoms: ['Skin rash', 'Abnormality of prenatal development or birth', 'Obesity', 'Death in infancy', 'Diarrhea', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Recurrent viral infections', 'Hyperphenylalaninemia', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule', 'Hernia'], here are some potential diseases with their descriptions:

+1. Phenylketonuria (PKU):
This disease is characterized by hyperphenylalaninemia, which is present in the given symptoms. It is a genetic disorder that causes an inability to break down the amino acid phenylalanine, leading to its accumulation in the body. Symptoms common with PKU include hypertyrosinemia and abnormalities of prenatal development or birth.

+2. Inflammatory Bowel Disease (IBD):
IBD encompasses conditions like Crohn's disease and ulcerative colitis, which can cause gastrointestinal inflammation, diarrhea, and skin rashes like erythematous plaques, macules, and papules, as mentioned in the symptoms.

+3. Primary Immunodeficiency Disorders:
These disorders, such as severe combined immunodeficiency (SCID), can lead to recurrent viral infections, as indicated in the symptoms. Some forms may also be associated with abnormalities of prenatal development or birth.

+4. Congenital Diaphragmatic Hernia:
This birth defect involves a hernia, which is one of the listed symptoms. It can also lead to neonatal death or death in infancy, as mentioned in the symptoms.

+5. Prader-Willi Syndrome:
This genetic disorder is characterized by obesity, which is one of the provided symptoms. It can also be associated with abnormalities of prenatal development or birth.

It's important to note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and potentially additional tests or investigations. The provided symptoms may overlap with multiple conditions, and further assessment by a healthcare professional is necessary to determine the most accurate diagnosis."
['Biotinidase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Leiner's Disease: A rare inherited metabolic disorder characterized by severe skin rashes, alopecia (hair loss), and increased lactate levels in the blood and cerebrospinal fluid. The patient has the following symptoms in common: Skin rash, Alopecia, Increased circulating lactate concentration, Increased CSF lactate. The patient does not have the symptom ""Death in infancy"" mentioned.

+2. Biotinidase Deficiency: A genetic disorder that affects the body's ability to recycle and reuse the vitamin biotin, leading to various symptoms, including skin rashes, alopecia, and neurological problems. The patient has the following symptoms in common: Skin rash, Alopecia. The patient does not have the symptoms ""Death in infancy,"" ""Increased circulating lactate concentration,"" or ""Increased CSF lactate"" mentioned.

+3. Omenn Syndrome: A rare inherited immune disorder characterized by severe skin rashes, alopecia, and increased susceptibility to infections. The patient has the following symptoms in common: Skin rash, Alopecia. The patient does not have the symptoms ""Death in infancy,"" ""Increased circulating lactate concentration,"" or ""Increased CSF lactate"" mentioned.

+4. Propionic Acidemia: A rare inherited metabolic disorder that causes the body to accumulate propionic acid, leading to various symptoms, including skin rashes, developmental delays, and increased lactate levels in the blood and cerebrospinal fluid. The patient has the following symptoms in common: Skin rash, Increased circulating lactate concentration, Increased CSF lactate. The patient does not have the symptoms ""Death in infancy"" or ""Alopecia"" mentioned.

+5. Netherton Syndrome: A rare inherited skin disorder characterized by severe skin rashes, alopecia, and increased susceptibility to infections. The patient has the following symptoms in common: Skin rash, Alopecia. The patient does not have the symptoms ""Death in infancy,"" ""Increased circulating lactate concentration,"" or ""Increased CSF lactate"" mentioned.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided information is for educational purposes only and should not be considered a substitute for professional medical advice."
['PMM2-CDG'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Niemann-Pick Disease Type C:
This is a rare inherited disorder characterized by abnormal cholesterol accumulation in various tissues, including the brain, liver, and spleen. It can cause neurological problems, intellectual disability, and organ dysfunction.
Common Symptoms: Intellectual disability, Abnormal facial shape
Uncommon Symptoms: Rod-cone dystrophy, Cerebellar atrophy, Death in infancy, Thromboembolism, Abnormal calvaria morphology, Lipodystrophy, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis

+2. Ataxia-Telangiectasia:
A rare neurodegenerative disorder that affects the brain and other body systems. It can cause progressive cerebellar atrophy, leading to problems with movement, balance, and coordination.
Common Symptoms: Cerebellar atrophy, Abnormal facial shape
Uncommon Symptoms: Rod-cone dystrophy, Intellectual disability, Death in infancy, Thromboembolism, Abnormal calvaria morphology, Lipodystrophy, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis

+3. Joubert Syndrome:
A rare genetic disorder characterized by abnormal brain development, particularly in the cerebellar region. It can cause intellectual disability, abnormal breathing patterns, and abnormal eye movements.
Common Symptoms: Intellectual disability, Cerebellar agenesis
Uncommon Symptoms: Rod-cone dystrophy, Death in infancy, Thromboembolism, Abnormal facial shape, Abnormal calvaria morphology, Lipodystrophy, Acute hepatitis, Chronic hepatitis

+4. Hepatitis C:
A viral infection that primarily affects the liver and can lead to chronic liver disease, including hepatitis and cirrhosis.
Common Symptoms: Acute hepatitis, Chronic hepatitis
Uncommon Symptoms: Rod-cone dystrophy, Intellectual disability, Cerebellar atrophy, Death in infancy, Thromboembolism, Abnormal facial shape, Abnormal calvaria morphology, Lipodystrophy, Cerebellar agenesis

+5. Antiphospholipid Syndrome:
An autoimmune disorder characterized by the presence of antiphospholipid antibodies, which can increase the risk of blood clots and thromboembolism.
Common Symptoms: Thromboembolism
Uncommon Symptoms: Rod-cone dystrophy, Intellectual disability, Cerebellar atrophy, Death in infancy, Abnormal facial shape, Abnormal calvaria morphology, Lipodystrophy, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis

Please note that this is a hypothetical analysis based on the provided symptoms, and a proper diagnosis would require a comprehensive medical evaluation by a qualified healthcare professional."
['Glutaryl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Glutaric Aciduria Type 1: This is a rare inherited disorder that affects the body's ability to break down certain proteins and fats. Symptoms include macrocephaly, lethargy, generalized hypotonia, dystonia, fever, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, glutaric aciduria, neonatal death, decreased plasma free carnitine, and dyskinesia.

+2. Zellweger Syndrome: This is a rare inherited disorder that affects the body's ability to metabolize certain fats and lipids. Symptoms include macrocephaly, cystic hygroma, lethargy, generalized hypotonia, dystonia, death in infancy, and neonatal death.

+3. Leigh Syndrome: This is a rare inherited neurometabolic disorder that affects the central nervous system. Symptoms include macrocephaly, lethargy, generalized hypotonia, dystonia, dyspnea, drowsiness, sleep abnormality, and dyskinesia.

+4. Niemann-Pick Disease Type C: This is a rare inherited disorder that affects the body's ability to metabolize cholesterol and other lipids. Symptoms include macrocephaly, lethargy, generalized hypotonia, dystonia, dyspnea, drowsiness, sleep abnormality, and dyskinesia.

+5. Mitochondrial Encephalomyopathy: This is a group of disorders that affect the mitochondria, which are the powerhouses of cells. Symptoms include macrocephaly, lethargy, generalized hypotonia, dystonia, dyspnea, drowsiness, sleep abnormality, and dyskinesia.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and imaging studies, by a qualified healthcare professional."
['Isovaleric acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Glycine Encephalopathy (Non-Ketotic Hyperglycinemia): A rare inherited metabolic disorder characterized by abnormally high levels of glycine in the body, leading to neurological problems. The patient has symptoms such as lethargy, drowsiness, sleep abnormality, and abnormal circulating glycine concentration, which are consistent with this disease. However, the patient does not seem to exhibit symptoms like seizures or intellectual disability, which are also common in this condition.

+2. Carnitine Deficiency: A metabolic disorder caused by a deficiency of carnitine, a compound essential for the transport of fatty acids into the mitochondria for energy production. The patient has symptoms like lethargy, feeding difficulties, and abnormal circulating carnitine concentration, which align with this condition. However, there is no information provided about other common symptoms like muscle weakness, low blood sugar, or heart problems.

+3. Inborn Errors of Metabolism: A group of genetic disorders that affect the body's ability to metabolize specific nutrients, leading to a buildup of toxic substances or a deficiency of essential compounds. The patient has symptoms like lethargy, drowsiness, hyperammonemia (elevated ammonia levels), and abnormal circulating glycine and carnitine concentrations, which could be indicative of various inborn errors of metabolism. However, more specific information about the patient's medical history and laboratory tests would be needed for a more accurate diagnosis.

+4. Congenital Abnormalities: A broad category that includes various birth defects or developmental abnormalities present at birth. The patient has symptoms like abnormality of prenatal development or birth, which could suggest a congenital abnormality. However, without more specific details about the nature of the abnormality, it is difficult to narrow down the diagnosis further.

+5. Neonatal or Childhood Diseases: This category encompasses a wide range of conditions that can affect infants or children, leading to symptoms like neonatal death, death in infancy, or death in childhood. The patient has these symptoms, but more information is needed to determine the specific underlying cause or condition.

It's important to note that a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests, would be necessary to arrive at an accurate diagnosis and provide appropriate treatment recommendations."
['PMM2-CDG'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Pontocerebellar Hypoplasia Type 1 (PCH1): A rare genetic disorder characterized by severe hypoplasia or atrophy of the cerebellum and brainstem. Symptoms include: Intellectual disability, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia, Encephalopathy, Growth delay. The patient does not have Microcephaly, Strabismus, Nystagmus, or Death in infancy listed as symptoms.

+2. Joubert Syndrome: A rare genetic disorder characterized by abnormalities in the brain, specifically the cerebellar vermis. Symptoms include: Intellectual disability, Ataxia, Hypotonia, Cerebellar agenesis or hypoplasia. The patient does not have Strabismus, Nystagmus, Hyporeflexia, Motor delay, Encephalopathy, Growth delay, or Death in infancy listed as symptoms.

+3. Lissencephaly: A rare genetic brain malformation characterized by the absence of normal convolutions in the cerebral cortex. Symptoms include: Intellectual disability, Hypotonia, Seizures, Microcephaly. The patient does not have Strabismus, Nystagmus, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Encephalopathy, Growth delay, or Death in infancy listed as symptoms.

+4. Zellweger Spectrum Disorder: A group of rare genetic disorders characterized by a lack of functional peroxisomes in cells. Symptoms include: Intellectual disability, Hypotonia, Seizures, Growth delay, Liver dysfunction, Hearing and vision problems. The patient does not have Microcephaly, Strabismus, Nystagmus, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Encephalopathy, or Death in infancy listed as symptoms.

+5. Infantile Neuroaxonal Dystrophy: A rare genetic disorder characterized by the accumulation of abnormal proteins in the nerve cells of the brain and other tissues. Symptoms include: Intellectual disability, Hypotonia, Ataxia, Nystagmus, Optic atrophy, Seizures. The patient does not have Microcephaly, Strabismus, Hyporeflexia, Motor delay, Cerebellar atrophy, Encephalopathy, Growth delay, or Death in infancy listed as symptoms.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including genetic testing and imaging studies, by a qualified healthcare professional."
"['Methylmalonic acidemia with homocystinuria, type cblC']","Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Methylmalonic Acidemia: A rare inherited disorder characterized by the inability to properly metabolize certain proteins and fats, leading to a buildup of methylmalonic acid in the body. Symptoms in common: Methylmalonic aciduria, Abnormal circulating carnitine concentration, Hyperammonemia, Hyperhomocystinemia, Hyperalaninemia, Neonatal death, Death in infancy, Death in childhood. Symptoms not in common: Strabismus, Nystagmus, Optic atrophy, Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Ventricular septal defect.

+2. Propionic Acidemia: Another inherited disorder involving the breakdown of certain proteins and fats, resulting in an accumulation of propionic acid and other harmful substances. Symptoms in common: Hyperammonemia, Hyperhomocystinemia, Hyperalaninemia, Neonatal death, Death in infancy, Death in childhood, Abnormal circulating carnitine concentration, Elevated urinary carboxylic acid. Symptoms not in common: Strabismus, Nystagmus, Optic atrophy, Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Ventricular septal defect.

+3. Mitochondrial Encephalomyopathy: A group of disorders caused by dysfunctional mitochondria, which are the powerhouses of cells. Symptoms in common: Optic atrophy, Motor delay, Generalized hypotonia, Death in infancy, Death in childhood. Symptoms not in common: Strabismus, Nystagmus, Abnormality of prenatal development or birth, Ventricular septal defect, Hyperammonemia, Hyperhomocystinemia, Hyperalaninemia, Neonatal death, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Elevated urinary carboxylic acid.

+4. Congenital Disorders of Glycosylation: A group of rare inherited metabolic disorders affecting the glycosylation process, which is crucial for the proper functioning of proteins and lipids. Symptoms in common: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Neonatal death, Death in infancy, Death in childhood. Symptoms not in common: Strabismus, Nystagmus, Optic atrophy, Ventricular septal defect, Hyperammonemia, Hyperhomocystinemia, Hyperalaninemia, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Elevated urinary carboxylic acid.

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be necessary to confirm the actual diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body is unable to break down certain amino acids properly. Symptoms include vomiting, poor appetite, lethargy, and a distinctive maple syrup odor in urine and earwax. The patient has vomiting in common with MSUD, but there is no information about the characteristic odor or other symptoms.

+2. Galactosemia:
This is an inherited disorder in which the body is unable to metabolize galactose, a sugar found in milk and dairy products. Symptoms include vomiting, diarrhea, jaundice, and failure to thrive. The patient has vomiting and diarrhea in common with galactosemia, but there is no information about jaundice or failure to thrive.

+3. Hereditary Fructose Intolerance (HFI):
This is a rare genetic disorder in which the body is unable to break down fructose, a sugar found in fruits, honey, and some vegetables. Symptoms include vomiting, abdominal pain, hypoglycemia, and failure to thrive. The patient has hypoglycemia and vomiting in common with HFI, but there is no information about abdominal pain or failure to thrive.

+4. Organic Acidemias:
These are a group of inherited disorders that affect the body's ability to break down certain amino acids and fatty acids. Symptoms can include vomiting, lethargy, developmental delays, and elevated levels of specific organic acids in the blood and urine. The patient has vomiting and elevated circulating hepatic transaminase concentration in common with organic acidemias, but there is no information about developmental delays or specific organic acid levels.

+5. Fatty Acid Oxidation Disorders:
These are a group of inherited disorders that affect the body's ability to break down fatty acids for energy. Symptoms can include hypoglycemia, lethargy, vomiting, and abnormal circulating carnitine concentration. The patient has hypoglycemia, vomiting, and abnormal circulating carnitine concentration in common with fatty acid oxidation disorders.

Please note that a proper diagnosis would require additional tests and a thorough evaluation by a medical professional."
['Succinic semialdehyde dehydrogenase deficiency'],"Based on the provided symptoms: ['Coma', 'Death in infancy', 'Hyperkalemia', 'Hyponatremia', 'Neonatal death', 'Respiratory acidosis', 'Elevated urinary carboxylic acid'], here are some potential diseases with their descriptions:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder caused by a deficiency in the enzyme responsible for breaking down certain amino acids. Symptoms include elevated urinary carboxylic acid, neonatal death, coma, and respiratory acidosis. The patient exhibits these symptoms.

+2. Organic Acidemias:
These are a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms can include neonatal death, coma, respiratory acidosis, and elevated urinary carboxylic acid. The patient exhibits these symptoms.

+3. Urea Cycle Disorders:
These are genetic disorders that affect the body's ability to remove ammonia from the bloodstream. Symptoms can include hyperammonemia, respiratory alkalosis, lethargy, and coma. The patient exhibits coma, but not the other symptoms mentioned.

+4. Adrenal Insufficiency (Addison's Disease):
This is a condition where the adrenal glands do not produce enough hormones, leading to an imbalance of electrolytes like hyperkalemia and hyponatremia. The patient exhibits hyperkalemia and hyponatremia, but not the other symptoms mentioned.

+5. Severe Dehydration:
Severe dehydration can lead to electrolyte imbalances like hyperkalemia and hyponatremia, as well as coma in extreme cases. The patient exhibits hyperkalemia, hyponatremia, and coma, but not the other symptoms mentioned.

It's important to note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided symptoms may not be sufficient for a definitive diagnosis, and further investigation may be necessary."
['Classic homocystinuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Marfan Syndrome: A genetic disorder affecting the connective tissues, characterized by tall stature, long limbs, and potential cardiovascular complications.
Symptoms in common: Long foot, Large hands
Symptoms not in common: Ptosis, Ectopia lentis, Intellectual disability, Motor delay, Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

+2. Homocystinuria: A rare inherited metabolic disorder characterized by an inability to metabolize the amino acid homocysteine, leading to its accumulation in the body.
Symptoms in common: Hyperhomocystinemia, Intellectual disability, Motor delay, Ectopia lentis
Symptoms not in common: Ptosis, Large hands, Long foot, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

+3. Cystathionine Beta-Synthase Deficiency: A rare inherited disorder of amino acid metabolism, leading to elevated levels of homocysteine and methionine in the body.
Symptoms in common: Hyperhomocystinemia, Hypermethioninemia, Intellectual disability, Motor delay, Ectopia lentis
Symptoms not in common: Ptosis, Large hands, Long foot, Death in childhood, Death in adolescence, Fatigue

+4. Sotos Syndrome: A rare genetic disorder characterized by excessive growth during childhood, distinctive facial features, and developmental delays.
Symptoms in common: Large hands, Intellectual disability, Motor delay
Symptoms not in common: Ptosis, Ectopia lentis, Long foot, Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

+5. Progeria: A rare genetic disorder that causes premature aging, characterized by growth delays, loss of body fat and hair, and an increased risk of cardiovascular complications.
Symptoms in common: None
Symptoms not in common: Ptosis, Ectopia lentis, Large hands, Intellectual disability, Motor delay, Long foot, Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's medical history, physical examination, and additional tests as necessary."
[],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Down Syndrome: A genetic disorder caused by the presence of an extra copy of chromosome 21, characterized by intellectual disability, distinctive facial features (wide mouth, epicanthus), and an increased risk of certain medical conditions.
Symptoms in common: Wide mouth, Epicanthus
Symptoms not in common: Carious teeth, Hyperinsulinemia, Sparse hair, Seizure, Death in infancy, Hypoglycemia, Neonatal death, Death in childhood, Abnormal hemoglobin, Feeding difficulties

+2. Diabetes Mellitus: A chronic metabolic disorder characterized by high blood sugar levels due to the body's inability to produce or use insulin effectively.
Symptoms in common: Hyperinsulinemia, Hypoglycemia
Symptoms not in common: Wide mouth, Epicanthus, Carious teeth, Sparse hair, Seizure, Death in infancy, Neonatal death, Death in childhood, Abnormal hemoglobin, Feeding difficulties

+3. Sickle Cell Anemia: A genetic disorder in which the body produces abnormal hemoglobin, leading to sickle-shaped red blood cells that can cause various complications.
Symptoms in common: Abnormal hemoglobin
Symptoms not in common: Wide mouth, Epicanthus, Carious teeth, Hyperinsulinemia, Sparse hair, Seizure, Death in infancy, Hypoglycemia, Neonatal death, Death in childhood, Feeding difficulties

+4. Epilepsy: A neurological disorder characterized by recurrent seizures, which can vary in severity and cause various symptoms.
Symptoms in common: Seizure
Symptoms not in common: Wide mouth, Epicanthus, Carious teeth, Hyperinsulinemia, Sparse hair, Death in infancy, Hypoglycemia, Neonatal death, Death in childhood, Abnormal hemoglobin, Feeding difficulties

+5. Failure to Thrive: A condition in which a child fails to gain weight and grow as expected, often due to underlying medical or environmental factors.
Symptoms in common: Feeding difficulties
Symptoms not in common: Wide mouth, Epicanthus, Carious teeth, Hyperinsulinemia, Sparse hair, Seizure, Death in infancy, Hypoglycemia, Neonatal death, Death in childhood, Abnormal hemoglobin

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be necessary to confirm the actual diagnosis."
['Propionic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Nonketotic Hyperglycinemia (NKH):
This is a rare inherited metabolic disorder characterized by abnormally high levels of glycine in the body. Symptoms the patient has in common: Intellectual disability, Seizure, Hyperglycinemia. Symptoms the patient does not have in common: Anemia, Hyperammonemia, Hepatomegaly.

+2. Maple Syrup Urine Disease (MSUD):
A rare inherited disorder in which the body is unable to break down certain amino acids properly, leading to a buildup of toxic substances. Symptoms the patient has in common: Intellectual disability, Seizure, Hyperammonemia. Symptoms the patient does not have in common: Hyperglycinemia, Hypoglycinemia, Anemia.

+3. Carnitine Deficiency:
A condition in which the body lacks sufficient levels of carnitine, a nutrient that plays a crucial role in energy production. Symptoms the patient has in common: Intellectual disability, Seizure, Abnormal circulating carnitine concentration. Symptoms the patient does not have in common: Hyperammonemia, Hyperglycinemia, Hypoglycinemia.

+4. Organic Acidemias:
A group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms the patient has in common: Intellectual disability, Seizure, Hyperammonemia. Symptoms the patient does not have in common: Hyperglycinemia, Hypoglycinemia, Anemia.

+5. Urea Cycle Disorders:
A group of inherited metabolic disorders that affect the body's ability to remove ammonia from the bloodstream. Symptoms the patient has in common: Intellectual disability, Seizure, Hyperammonemia. Symptoms the patient does not have in common: Hyperglycinemia, Hypoglycinemia, Anemia.

Please note that a proper diagnosis would require additional tests and a thorough evaluation by a medical professional."
['Vitamin B12-unresponsive methylmalonic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Methylmalonic Acidemia (MMA):
The patient exhibits several symptoms consistent with MMA, including methylmalonic aciduria, decreased methylmalonyl-CoA mutase activity, metabolic acidosis, and feeding difficulties. However, some symptoms like thrombocytopenia, leukopenia, and neonatal death are not typically associated with MMA.

+2. Leigh Syndrome:
The patient's symptoms of generalized hypotonia, apnea, and abnormal nervous system physiology could be indicative of Leigh Syndrome. However, the patient does not exhibit other common symptoms of Leigh Syndrome, such as seizures, developmental delays, and vision problems.

+3. Severe Combined Immunodeficiency (SCID):
The patient's symptoms of thrombocytopenia and leukopenia could suggest a form of SCID. However, the patient does not exhibit other common symptoms of SCID, such as recurrent infections, failure to thrive, and chronic diarrhea.

+4. Mitochondrial Disorders:
The patient's symptoms of metabolic acidosis, apnea, and abnormal nervous system physiology could be indicative of a mitochondrial disorder. However, the patient does not exhibit other common symptoms of mitochondrial disorders, such as muscle weakness, vision problems, and hearing loss.

+5. Congenital Disorders of Glycosylation (CDG):
The patient's symptoms of generalized hypotonia, thrombocytopenia, and feeding difficulties could be consistent with certain types of CDG. However, the patient does not exhibit other common symptoms of CDG, such as developmental delays, seizures, and liver dysfunction.

It's important to note that this is a preliminary analysis based on the provided symptoms, and further diagnostic tests and evaluations would be necessary to confirm or rule out any specific disease."
['Systemic primary carnitine deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Leigh Syndrome:
This is a rare inherited neurometabolic disorder that affects the central nervous system. It is characterized by progressive loss of mental and movement abilities.
Common Symptoms: Coma, Hypoglycemia, Vomiting, Elevated circulating alkaline phosphatase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration.
Uncommon Symptoms: Death in infancy, Sudden death, Decreased plasma free carnitine.

+2. Carnitine Palmitoyltransferase II Deficiency:
This is a rare inherited disorder that affects the body's ability to use long-chain fatty acids for energy production.
Common Symptoms: Coma, Hypoglycemia, Vomiting, Decreased plasma free carnitine, Increased circulating lactate dehydrogenase concentration.
Uncommon Symptoms: Death in infancy, Sudden death, Elevated circulating alkaline phosphatase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+3. Maple Syrup Urine Disease:
This is a rare inherited disorder that affects the body's ability to break down certain amino acids, leading to a buildup of these substances in the blood and urine.
Common Symptoms: Coma, Vomiting, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.
Uncommon Symptoms: Death in infancy, Sudden death, Hypoglycemia, Elevated circulating alkaline phosphatase concentration, Decreased plasma free carnitine, Increased circulating lactate dehydrogenase concentration.

+4. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS):
This is a rare inherited disorder that affects the mitochondria, the energy-producing structures within cells.
Common Symptoms: Coma, Increased circulating lactate dehydrogenase concentration.
Uncommon Symptoms: Death in infancy, Sudden death, Hypoglycemia, Vomiting, Elevated circulating alkaline phosphatase concentration, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and imaging studies, by a qualified healthcare professional."
['3-methylcrotonyl-CoA carboxylase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive loss of mental and movement abilities. It is characterized by degeneration of the brain stem, a part of the brain that is crucial for controlling respiratory functions and movement.
Symptoms in common: Lethargy, Clumsiness, Drowsiness, Poor coordination, Feeding difficulties
Symptoms not in common: Death in infancy, Neonatal death, Death in childhood, Decreased plasma free carnitine

+2. Carnitine Deficiency: A condition characterized by a lack of carnitine, a nutrient that plays a crucial role in energy production. It can be caused by genetic factors or acquired due to certain medical conditions or medications.
Symptoms in common: Lethargy, Clumsiness, Poor coordination, Decreased plasma free carnitine
Symptoms not in common: Death in infancy, Drowsiness, Sleep abnormality, Neonatal death, Death in childhood, Feeding difficulties

+3. Niemann-Pick Disease Type C: A rare inherited metabolic disorder that affects the ability of the body to transport cholesterol and other lipids within cells. It can cause progressive neurological deterioration and other complications.
Symptoms in common: Lethargy, Clumsiness, Drowsiness, Poor coordination, Sleep abnormality
Symptoms not in common: Death in infancy, Neonatal death, Death in childhood, Decreased plasma free carnitine, Feeding difficulties

+4. Mitochondrial Encephalomyopathy: A group of disorders caused by mutations in the mitochondrial DNA or nuclear genes that affect mitochondrial function. These disorders can affect various organs, including the brain, muscles, and nerves.
Symptoms in common: Lethargy, Clumsiness, Drowsiness, Poor coordination, Feeding difficulties
Symptoms not in common: Death in infancy, Sleep abnormality, Neonatal death, Death in childhood, Decreased plasma free carnitine

+5. Infantile Neuroaxonal Dystrophy: A rare inherited disorder that affects the nervous system, causing progressive neurological deterioration and impaired motor skills.
Symptoms in common: Lethargy, Clumsiness, Drowsiness, Poor coordination, Feeding difficulties
Symptoms not in common: Death in infancy, Sleep abnormality, Neonatal death, Death in childhood, Decreased plasma free carnitine

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided information is for educational purposes only and should not be considered a substitute for professional medical advice."
[],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, particularly the brain stem, and is characterized by progressive loss of mental and movement abilities. Common symptoms include delayed speech and language development, encephalopathy, hypotonia, and respiratory issues.

+2. Mitochondrial Encephalomyopathy: A group of disorders caused by dysfunctional mitochondria, which are the energy-producing structures within cells. Symptoms may include muscle weakness, exercise intolerance, seizures, vision and hearing problems, and developmental delays.

+3. Glycine Encephalopathy: A rare inherited disorder caused by a deficiency of the glycine cleavage enzyme system, leading to an accumulation of glycine in the body. Symptoms may include developmental delays, seizures, hypotonia, and respiratory issues.

+4. Leukodystrophy: A group of genetic disorders that affect the growth and development of the myelin sheath, which insulates nerve fibers in the brain and spinal cord. Symptoms may include progressive loss of motor and cognitive functions, seizures, and vision and hearing problems.

+5. Cerebral Palsy: A group of disorders that affect movement, muscle tone, and posture, caused by damage to the developing brain. Symptoms may include spastic diplegia, spastic tetraplegia, dysarthria, and developmental delays.

For each potential disease, I have indicated which symptoms the patient has in common and which symptoms the patient does not have in common with the proposed disease."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Carnitine Deficiency Disorders:
Common Symptoms: Abnormal circulating carnitine concentration
Uncommon Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death

+2. Inborn Errors of Metabolism:
Common Symptoms: Abnormality of prenatal development or birth, Neonatal death
Uncommon Symptoms: Death in infancy, Abnormal circulating carnitine concentration

+3. Congenital Anomalies:
Common Symptoms: Abnormality of prenatal development or birth
Uncommon Symptoms: Death in infancy, Neonatal death, Abnormal circulating carnitine concentration

+4. Neonatal Disorders:
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Uncommon Symptoms: Abnormal circulating carnitine concentration

+5. Metabolic Disorders:
Common Symptoms: Abnormal circulating carnitine concentration
Uncommon Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death

Please note that these are general potential diagnoses based on the provided symptoms, and further evaluation and testing would be required to confirm the specific condition."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric aciduria type 1:
Symptoms in common: Macrocephaly, Lethargy, Generalized hypotonia, Metabolic acidosis, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine.
Symptoms not in common: Cystic hygroma, Hyperhidrosis, Dystonia, Death in infancy, Fever, Vomiting, Diarrhea, Dyspnea, Drowsiness, Sleep abnormality, Neonatal death, Death in childhood, Dyskinesia.

+2. Canavan disease:
Symptoms in common: Macrocephaly, Lethargy, Generalized hypotonia, Hyperhidrosis.
Symptoms not in common: Cystic hygroma, Dystonia, Death in infancy, Metabolic acidosis, Fever, Vomiting, Diarrhea, Dyspnea, Drowsiness, Sleep abnormality, Glutaric aciduria, Elevated circulating glutaric acid concentration, Neonatal death, Death in childhood, Decreased plasma free carnitine, Dyskinesia.

+3. Leigh syndrome:
Symptoms in common: Lethargy, Generalized hypotonia, Dystonia, Metabolic acidosis, Vomiting, Dyspnea, Drowsiness, Sleep abnormality, Neonatal death, Death in childhood.
Symptoms not in common: Macrocephaly, Cystic hygroma, Hyperhidrosis, Death in infancy, Fever, Diarrhea, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Dyskinesia.

+4. Maple syrup urine disease:
Symptoms in common: Lethargy, Generalized hypotonia, Metabolic acidosis, Vomiting, Drowsiness, Sleep abnormality, Neonatal death, Death in childhood.
Symptoms not in common: Macrocephaly, Cystic hygroma, Hyperhidrosis, Dystonia, Death in infancy, Fever, Diarrhea, Dyspnea, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Dyskinesia.

+5. Propionic acidemia:
Symptoms in common: Lethargy, Generalized hypotonia, Metabolic acidosis, Vomiting, Dyspnea, Drowsiness, Sleep abnormality, Neonatal death, Death in childhood.
Symptoms not in common: Macrocephaly, Cystic hygroma, Hyperhidrosis, Dystonia, Death in infancy, Fever, Diarrhea, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Dyskinesia."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia
Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Death in adolescence

+2. Tyrosinemia type I:
Symptoms in common: Hypertyrosinemia
Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Hyperphenylalaninemia, Neonatal death, Death in childhood, Death in adolescence

+3. Congenital disorders of glycosylation:
Symptoms in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence

+4. Severe combined immunodeficiency (SCID):
Symptoms in common: Death in infancy, Neonatal death, Death in childhood
Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence

+5. Cystic fibrosis:
Symptoms in common: Death in childhood, Death in adolescence
Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required for an accurate diagnosis."
['L-2-hydroxyglutaric aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Leukodystrophy: A group of rare, inherited metabolic disorders that affect the brain, spinal cord, and peripheral nerves. The patient shares symptoms such as delayed speech and language development, intellectual disability, difficulty walking, difficulty climbing stairs, and difficulty running. However, the symptoms of hyperreflexia, death in infancy, death in childhood, and abnormal cerebral white matter morphology are not explicitly mentioned for this disease.

+2. Pelizaeus-Merzbacher Disease: A rare, inherited disorder that affects the central nervous system and causes progressive neurological deterioration. The patient shares symptoms such as delayed speech and language development, intellectual disability, difficulty walking, difficulty climbing stairs, and difficulty running. The symptoms of hyperreflexia and abnormal cerebral white matter morphology are also consistent with this disease. However, death in infancy and death in childhood are not typical symptoms.

+3. Adrenoleukodystrophy: A rare, inherited disorder that affects the nervous system and adrenal glands. The patient shares symptoms such as delayed speech and language development, intellectual disability, difficulty walking, difficulty climbing stairs, and difficulty running. The symptom of abnormal cerebral white matter morphology is also consistent with this disease. However, hyperreflexia, death in infancy, and death in childhood are not typical symptoms.

+4. Metachromatic Leukodystrophy: A rare, inherited disorder that affects the nervous system and causes progressive neurological deterioration. The patient shares symptoms such as delayed speech and language development, intellectual disability, difficulty walking, difficulty climbing stairs, and difficulty running. The symptom of abnormal cerebral white matter morphology is also consistent with this disease. However, hyperreflexia, death in infancy, and death in childhood are not typical symptoms.

+5. Krabbe Disease: A rare, inherited disorder that affects the nervous system and causes progressive neurological deterioration. The patient shares symptoms such as delayed speech and language development, intellectual disability, difficulty walking, difficulty climbing stairs, and difficulty running. The symptoms of hyperreflexia and abnormal cerebral white matter morphology are also consistent with this disease. However, death in infancy and death in childhood are more common in severe cases of Krabbe disease.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate diagnostic tests. The provided symptoms may overlap with multiple disorders, and further investigation is necessary to determine the underlying cause."
['Maple syrup urine disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Hyperleucinemia, Hyperisoleucinemia, Hypervalinemia, Neonatal death
Symptoms not in common: Apathy, Spasticity, Generalized hypotonia, Obesity, Death in infancy, Hypoglycemia, Death in early adulthood

+2. Leigh Syndrome:
Symptoms in common: Apathy, Generalized hypotonia, Death in infancy, Neonatal death
Symptoms not in common: Spasticity, Obesity, Hypoglycemia, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Death in early adulthood

+3. Prader-Willi Syndrome:
Symptoms in common: Obesity, Hypotonia (generalized hypotonia)
Symptoms not in common: Apathy, Spasticity, Death in infancy, Hypoglycemia, Neonatal death, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Death in early adulthood

+4. Niemann-Pick Disease Type C:
Symptoms in common: Apathy, Hypotonia (generalized hypotonia)
Symptoms not in common: Spasticity, Obesity, Death in infancy, Hypoglycemia, Neonatal death, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Death in early adulthood

+5. Glycogen Storage Disease Type I (Von Gierke Disease):
Symptoms in common: Hypoglycemia
Symptoms not in common: Apathy, Spasticity, Generalized hypotonia, Obesity, Death in infancy, Neonatal death, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Death in early adulthood

Please note that a proper diagnosis would require additional tests and a comprehensive evaluation by a medical professional."
['Classic galactosemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Galactosemia:
Symptoms in common: Delayed speech and language development, Obesity, Death in infancy, Hyperalaninemia, Aminoaciduria, Increased total bilirubin, Abnormality of galactoside metabolism, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating tyrosine concentration, Hypergalactosemia.
Symptoms not in common: Death in adolescence.

+2. Phenylketonuria (PKU):
Symptoms in common: Delayed speech and language development, Hyperalaninemia, Aminoaciduria, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating tyrosine concentration.
Symptoms not in common: Obesity, Death in infancy, Increased total bilirubin, Abnormality of galactoside metabolism, Death in adolescence, Hypergalactosemia.

+3. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Delayed speech and language development, Death in infancy, Aminoaciduria, Abnormal circulating aspartate family amino acid concentration.
Symptoms not in common: Obesity, Hyperalaninemia, Increased total bilirubin, Abnormality of galactoside metabolism, Abnormal circulating tyrosine concentration, Death in adolescence, Hypergalactosemia.

+4. Crigler-Najjar Syndrome:
Symptoms in common: Increased total bilirubin.
Symptoms not in common: Delayed speech and language development, Obesity, Death in infancy, Hyperalaninemia, Aminoaciduria, Abnormality of galactoside metabolism, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating tyrosine concentration, Death in adolescence, Hypergalactosemia.

+5. Hereditary Fructose Intolerance:
Symptoms in common: Abnormality of galactoside metabolism.
Symptoms not in common: Delayed speech and language development, Obesity, Death in infancy, Hyperalaninemia, Aminoaciduria, Increased total bilirubin, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating tyrosine concentration, Death in adolescence, Hypergalactosemia.

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required for an accurate diagnosis."
['3-hydroxy-3-methylglutaric aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Methylmalonic Acidemia (MMA):
This is a genetic disorder caused by a deficiency in the enzyme methylmalonyl-CoA mutase, which is involved in the breakdown of certain amino acids and fatty acids. Symptoms include metabolic acidosis, hyperammonemia, vomiting, and elevated levels of methylmalonic acid in the urine and blood. The patient has metabolic acidosis, hyperammonemia, and vomiting in common with this disease, but the other symptoms are not specifically mentioned.

+2. Propionic Acidemia:
This is another genetic disorder caused by a deficiency in the enzyme propionyl-CoA carboxylase, which is involved in the breakdown of certain amino acids and fatty acids. Symptoms include metabolic acidosis, hyperammonemia, vomiting, and elevated levels of propionic acid and other organic acids in the urine and blood. The patient has metabolic acidosis, hyperammonemia, and vomiting in common with this disease, but the other symptoms are not specifically mentioned.

+3. Isovaleric Acidemia:
This is a genetic disorder caused by a deficiency in the enzyme isovaleryl-CoA dehydrogenase, which is involved in the breakdown of the amino acid leucine. Symptoms include metabolic acidosis, vomiting, and elevated levels of isovaleric acid and other organic acids in the urine and blood. The patient has metabolic acidosis and vomiting in common with this disease, but the other symptoms are not specifically mentioned.

+4. Glutaric Acidemia Type I:
This is a genetic disorder caused by a deficiency in the enzyme glutaryl-CoA dehydrogenase, which is involved in the breakdown of certain amino acids and fatty acids. Symptoms include metabolic acidosis, hyperammonemia, vomiting, and elevated levels of glutaric acid and other organic acids in the urine and blood. The patient has metabolic acidosis, hyperammonemia, and vomiting in common with this disease, but the other symptoms are not specifically mentioned.

+5. Maple Syrup Urine Disease (MSUD):
This is a genetic disorder caused by a deficiency in the enzyme complex that breaks down the branched-chain amino acids leucine, isoleucine, and valine. Symptoms include metabolic acidosis, hyperammonemia, vomiting, and elevated levels of these amino acids and their byproducts in the urine and blood, which can give a distinctive maple syrup odor. The patient has metabolic acidosis, hyperammonemia, and vomiting in common with this disease, but the other symptoms are not specifically mentioned.

Please note that a definitive diagnosis would require additional testing and evaluation by a medical professional."
['Classic homocystinuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Acute Intermittent Porphyria:
This is a rare inherited disorder characterized by abnormal production of porphyrins, which are compounds involved in the production of heme. Symptoms include abdominal pain, vomiting, constipation, and neurological symptoms like seizures and paralysis. The patient has the symptom 'Abnormal circulating porphyrin concentration' in common with this disease, but does not seem to exhibit other typical symptoms like abdominal pain or seizures.

+2. Homocystinuria:
This is a rare inherited metabolic disorder caused by a deficiency of the enzyme cystathionine beta-synthase, which leads to an accumulation of homocysteine in the blood and urine. Symptoms include developmental delays, intellectual disability, skeletal abnormalities, and an increased risk of blood clots. The patient has the symptoms 'Hyperhomocystinemia' and 'Generalized hypotonia' in common with this disease, but does not seem to exhibit skeletal abnormalities or blood clotting issues.

+3. Methylmalonic Acidemia:
This is a rare inherited disorder characterized by a deficiency of the enzyme methylmalonyl-CoA mutase, which is involved in the metabolism of certain amino acids. Symptoms include lethargy, vomiting, dehydration, developmental delays, and neurological problems. The patient has the symptom 'Hypomethioninemia' in common with this disease, but does not seem to exhibit other typical symptoms like lethargy or vomiting.

+4. Lesch-Nyhan Syndrome:
This is a rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT), which leads to an accumulation of uric acid in the body. Symptoms include intellectual disability, self-mutilating behavior, gout, and kidney stones. The patient does not seem to exhibit any of the typical symptoms associated with this disease.

+5. Folic Acid Deficiency Anemia:
This is a type of anemia caused by a lack of folic acid, a B vitamin essential for the production of red blood cells. Symptoms include fatigue, weakness, shortness of breath, and pale skin. The patient has the symptoms 'Anemia' and 'Abnormality of folate metabolism' in common with this condition, but does not seem to exhibit other typical symptoms like fatigue or shortness of breath."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. Symptoms include hyperphenylalaninemia, intellectual disability, seizures, and behavioral problems.
Common symptoms: Hyperphenylalaninemia
Uncommon symptoms: Abnormality of prenatal development or birth, Death in infancy, Upper airway obstruction, Hypertyrosinemia, Neonatal death, Death in childhood, Chronic pulmonary obstruction, Death in adolescence, Death in early adulthood

+2. Congenital Hypothyroidism:
This condition is caused by a deficiency of thyroid hormones present at birth, leading to impaired growth and development. Symptoms include intellectual disability, growth retardation, and lethargy.
Common symptoms: Abnormality of prenatal development or birth
Uncommon symptoms: Death in infancy, Upper airway obstruction, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in childhood, Chronic pulmonary obstruction, Death in adolescence, Death in early adulthood

+3. Cystic Fibrosis:
This is a genetic disorder that affects the lungs, digestive system, and other organs. Symptoms include chronic respiratory infections, poor growth, and digestive problems.
Common symptoms: Chronic pulmonary obstruction
Uncommon symptoms: Abnormality of prenatal development or birth, Death in infancy, Upper airway obstruction, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in childhood, Death in adolescence, Death in early adulthood

+4. Severe Combined Immunodeficiency (SCID):
This is a group of rare genetic disorders characterized by a deficient immune system, making individuals highly susceptible to infections. Symptoms include recurrent infections, failure to thrive, and potentially life-threatening complications.
Common symptoms: Death in infancy, Death in childhood, Death in adolescence, Death in early adulthood
Uncommon symptoms: Abnormality of prenatal development or birth, Upper airway obstruction, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Chronic pulmonary obstruction

It's important to note that this is a preliminary assessment based on the provided symptoms, and further diagnostic tests and evaluations would be necessary to confirm or rule out any specific condition."
['Biotinidase deficiency'],"+1. Leigh Syndrome:
Common Symptoms: Seizure, Fatigue
Uncommon Symptoms: Apathy, Spasticity, Death in infancy, Alopecia, Dyspnea, Elevated urinary carboxylic acid

+2. Adrenoleukodystrophy:
Common Symptoms: Fatigue, Seizure, Spasticity
Uncommon Symptoms: Apathy, Death in infancy, Alopecia, Dyspnea, Elevated urinary carboxylic acid

+3. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS):
Common Symptoms: Seizure, Fatigue, Dyspnea
Uncommon Symptoms: Apathy, Spasticity, Death in infancy, Alopecia, Elevated urinary carboxylic acid

+4. Niemann-Pick Disease Type C:
Common Symptoms: Seizure, Spasticity, Fatigue
Uncommon Symptoms: Apathy, Death in infancy, Alopecia, Dyspnea, Elevated urinary carboxylic acid

+5. Glutaric Aciduria Type 1:
Common Symptoms: Seizure, Elevated urinary carboxylic acid
Uncommon Symptoms: Apathy, Spasticity, Death in infancy, Alopecia, Dyspnea, Fatigue

+6. Alpers-Huttenlocher Syndrome:
Common Symptoms: Seizure, Fatigue, Alopecia
Uncommon Symptoms: Apathy, Spasticity, Death in infancy, Dyspnea, Elevated urinary carboxylic acid"
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Tyrosinemia type I: A rare inherited disorder characterized by the accumulation of toxic metabolites due to a deficiency in the enzyme fumarylacetoacetate hydrolase (FAH). Symptoms include liver disease, kidney disease, neurological problems, and an increased risk of liver cancer.
Common symptoms: Hypertyrosinemia
Uncommon symptoms: Obesity, Death in infancy, Fever, Vomiting, Neonatal death, Death in childhood, Gastrointestinal inflammation, Hyperphenylalaninemia, Death in adolescence

+2. Phenylketonuria (PKU): An inherited metabolic disorder characterized by the inability to break down the amino acid phenylalanine, leading to its accumulation in the body and potential brain damage.
Common symptoms: Hyperphenylalaninemia
Uncommon symptoms: Obesity, Death in infancy, Fever, Vomiting, Hypertyrosinemia, Neonatal death, Death in childhood, Gastrointestinal inflammation, Death in adolescence

+3. Crohn's Disease: A chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract, causing abdominal pain, diarrhea, weight loss, and malnutrition.
Common symptoms: Gastrointestinal inflammation
Uncommon symptoms: Obesity, Death in infancy, Fever, Vomiting, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Death in adolescence

+4. Severe Acute Malnutrition: A life-threatening condition caused by a lack of nutrients, often seen in areas with food insecurity or during famines, leading to wasting, stunting, and increased susceptibility to infections.
Common symptoms: None
Uncommon symptoms: Obesity, Death in infancy, Fever, Vomiting, Hypertyrosinemia, Neonatal death, Death in childhood, Gastrointestinal inflammation, Hyperphenylalaninemia, Death in adolescence

+5. Congenital Disorders of Glycosylation (CDG): A group of rare inherited metabolic disorders that affect the glycosylation process, leading to various symptoms depending on the specific type and severity, including developmental delays, neurological problems, and multi-organ dysfunction.
Common symptoms: None
Uncommon symptoms: Obesity, Death in infancy, Fever, Vomiting, Hypertyrosinemia, Neonatal death, Death in childhood, Gastrointestinal inflammation, Hyperphenylalaninemia, Death in adolescence

Please note that this is a hypothetical scenario, and a proper diagnosis should be made by a qualified medical professional after a thorough examination and appropriate tests."
['Biotinidase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Phenylketonuria (PKU):
Phenylketonuria is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. Symptoms include intellectual disability, seizures, and behavioral problems if left untreated.
Common symptoms: Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration
Uncommon symptoms: Skin rash, Death in infancy, Alopecia, Metabolic acidosis, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid

+2. Maple Syrup Urine Disease (MSUD):
MSUD is a rare inherited disorder that affects the body's ability to break down certain amino acids, leading to a buildup of toxic substances. Symptoms include a distinctive sweet odor, poor feeding, lethargy, and developmental delays.
Common symptoms: Aminoaciduria, Abnormal circulating glycine concentration
Uncommon symptoms: Skin rash, Death in infancy, Alopecia, Metabolic acidosis, Increased CSF lactate, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid

+3. Isovaleric Acidemia:
Isovaleric acidemia is a rare genetic disorder that affects the metabolism of the amino acid leucine. Symptoms include vomiting, lethargy, developmental delays, and a distinctive sweaty foot odor.
Common symptoms: Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid
Uncommon symptoms: Skin rash, Death in infancy, Alopecia, Metabolic acidosis, Increased CSF lactate, Erythematous plaque, Erythematous macule, Erythematous papule

+4. Psoriasis:
Psoriasis is an autoimmune disorder that causes the rapid buildup of skin cells, resulting in red, scaly patches on the skin. Symptoms include itchy, red, and scaly patches on the skin, nail changes, and joint pain.
Common symptoms: Erythematous plaque, Erythematous macule, Erythematous papule
Uncommon symptoms: Skin rash, Death in infancy, Alopecia, Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid

+5. Alopecia Areata:
Alopecia areata is an autoimmune disorder that causes hair loss on the scalp, face, and other areas of the body. Symptoms include patchy hair loss, nail changes, and, in some cases, complete hair loss.
Common symptoms: Alopecia
Uncommon symptoms: Skin rash, Death in infancy, Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required for an accurate diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Methylmalonic acidemia:
Symptoms in common: Decreased methylmalonyl-CoA mutase activity, Feeding difficulties, Dehydration
Symptoms not in common: Death in infancy, Neonatal death

+2. Propionic acidemia:
Symptoms in common: Decreased methylmalonyl-CoA mutase activity, Feeding difficulties, Dehydration
Symptoms not in common: Death in infancy, Neonatal death

+3. Maple syrup urine disease:
Symptoms in common: Feeding difficulties, Dehydration
Symptoms not in common: Death in infancy, Neonatal death, Decreased methylmalonyl-CoA mutase activity

+4. Organic acidemias:
Symptoms in common: Decreased methylmalonyl-CoA mutase activity, Feeding difficulties, Dehydration
Symptoms not in common: Death in infancy, Neonatal death

+5. Inborn errors of metabolism:
Symptoms in common: Feeding difficulties, Dehydration
Symptoms not in common: Death in infancy, Neonatal death, Decreased methylmalonyl-CoA mutase activity

Based on the provided symptoms, the most likely diagnosis appears to be methylmalonic acidemia or propionic acidemia, as the patient exhibits decreased methylmalonyl-CoA mutase activity, feeding difficulties, and dehydration, which are common symptoms of these disorders."
['Biotinidase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive loss of mental and movement abilities. Symptoms in common: Lethargy, generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, drowsiness, sleep abnormality. Symptoms not in common: Death in infancy, fever, decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, aminoaciduria, stomatitis, stridor, abnormal circulating glycine concentration, fatigue, elevated urinary carboxylic acid, gangrene.

+2. Propionic Acidemia: A rare inherited disorder in which the body is unable to process certain proteins and lipids properly, leading to a buildup of propionic acid. Symptoms in common: Lethargy, metabolic acidosis, increased circulating lactate concentration, drowsiness, propionyl-CoA carboxylase deficiency, aminoaciduria, fatigue, elevated urinary carboxylic acid. Symptoms not in common: Generalized hypotonia, death in infancy, fever, sleep abnormality, decreased pyruvate carboxylase activity, stomatitis, stridor, abnormal circulating glycine concentration, gangrene.

+3. Glycine Encephalopathy: A rare inherited disorder characterized by an accumulation of glycine in the body, leading to neurological problems. Symptoms in common: Lethargy, generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, drowsiness, sleep abnormality, abnormal circulating glycine concentration. Symptoms not in common: Death in infancy, fever, decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, aminoaciduria, stomatitis, stridor, fatigue, elevated urinary carboxylic acid, gangrene.

+4. Pyruvate Carboxylase Deficiency: A rare inherited metabolic disorder that affects the body's ability to metabolize certain amino acids and lipids, leading to a buildup of lactic acid. Symptoms in common: Lethargy, generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, drowsiness, decreased pyruvate carboxylase activity, fatigue. Symptoms not in common: Death in infancy, fever, propionyl-CoA carboxylase deficiency, aminoaciduria, stomatitis, stridor, abnormal circulating glycine concentration, elevated urinary carboxylic acid, gangrene.

+5. Neonatal Herpes Simplex Virus Infection: A viral infection that can cause severe complications in newborns, including encephalitis and disseminated disease. Symptoms in common: Lethargy, fever, stomatitis, stridor. Symptoms not in common: Generalized hypotonia, death in infancy, metabolic acidosis, increased circulating lactate concentration, drowsiness, sleep abnormality, decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, aminoaciduria, abnormal circulating glycine concentration, fatigue, elevated urinary carboxylic acid, gangrene."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia,' which are common in PKU. However, the symptoms of 'Abnormality of prenatal development or birth,' 'Death in infancy,' 'Neonatal death,' and 'Death in childhood' are not typically associated with PKU if it is diagnosed and treated early.

+2. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body cannot break down certain amino acids, leading to their accumulation in the blood and urine. The patient does not have any symptoms specifically related to MSUD, such as the characteristic sweet, maple syrup-like odor in urine and sweat.

+3. Tyrosinemia:
This is a group of inherited disorders characterized by the inability to metabolize the amino acid tyrosine, leading to its accumulation in the body. The patient has the symptom of 'Hypertyrosinemia,' which is common in tyrosinemia. However, other symptoms like liver and kidney problems, neurological issues, and developmental delays are not mentioned.

+4. Homocystinuria:
This is a rare inherited disorder in which the body cannot properly metabolize the amino acid homocysteine, leading to its accumulation in the blood and tissues. The patient does not have any symptoms specifically related to homocystinuria, such as developmental delays, osteoporosis, or thrombosis.

+5. Urea Cycle Disorders:
These are a group of inherited disorders that affect the body's ability to remove ammonia from the bloodstream, leading to its accumulation in the body. The patient does not have any symptoms specifically related to urea cycle disorders, such as lethargy, vomiting, or respiratory distress.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a detailed medical history, which cannot be provided based solely on the given symptoms."
['3-hydroxy-3-methylglutaric aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Methylmalonic Acidemia: This is a rare inherited disorder characterized by the inability to properly metabolize certain proteins and fats. Symptoms in common: 'Dicarboxylic aciduria', '3-Methylglutaric aciduria', 'Elevated urinary carboxylic acid'. Symptoms not in common: 'Death in infancy'.

+2. Propionic Acidemia: Another inherited metabolic disorder that affects the breakdown of certain proteins and lipids. Symptoms in common: 'Dicarboxylic aciduria', '3-Methylglutaric aciduria', 'Elevated urinary carboxylic acid'. Symptoms not in common: 'Death in infancy'.

+3. Isovaleric Acidemia: A rare genetic disorder that disrupts the metabolism of the amino acid leucine. Symptoms in common: 'Dicarboxylic aciduria', '3-Methylglutaric aciduria', 'Elevated urinary carboxylic acid'. Symptoms not in common: 'Death in infancy'.

+4. Glutaric Acidemia Type I: An inherited disorder that affects the metabolism of certain amino acids and leads to the accumulation of glutaric acid. Symptoms in common: 'Dicarboxylic aciduria', '3-Methylglutaric aciduria', 'Elevated urinary carboxylic acid'. Symptoms not in common: 'Death in infancy'.

+5. Multiple Carboxylase Deficiency: A rare metabolic disorder that affects the metabolism of various enzymes involved in the breakdown of proteins, fats, and carbohydrates. Symptoms in common: 'Dicarboxylic aciduria', '3-Methylglutaric aciduria', 'Elevated urinary carboxylic acid'. Symptoms not in common: 'Death in infancy'.

Please note that a proper diagnosis would require additional tests and a thorough evaluation by a medical professional."
['Wilson disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Wilson's disease: A rare inherited disorder that causes excessive accumulation of copper in the body, particularly in the liver, brain, and other vital organs. Symptoms in common: Elevated circulating hepatic transaminase concentration, Abnormal circulating porphyrin concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Decreased circulating copper concentration.

+2. Hemochromatosis: A genetic disorder characterized by excessive absorption and accumulation of iron in the body. Symptoms in common: Elevated circulating hepatic transaminase concentration, Decreased serum iron. Symptoms not in common: Carious teeth, Obesity, Death in childhood, Abnormal circulating porphyrin concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Decreased circulating copper concentration.

+3. Maple syrup urine disease: A rare inherited disorder in which the body is unable to break down certain amino acids properly, leading to a buildup of these substances in the blood and urine. Symptoms in common: Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. Symptoms not in common: Carious teeth, Obesity, Elevated circulating hepatic transaminase concentration, Death in childhood, Abnormal circulating porphyrin concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Decreased circulating copper concentration, Decreased serum iron.

+4. Dental caries: A bacterial infection that causes demineralization and destruction of the hard tissues of the teeth. Symptoms in common: Carious teeth. Symptoms not in common: Obesity, Elevated circulating hepatic transaminase concentration, Death in childhood, Abnormal circulating porphyrin concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Decreased circulating copper concentration, Decreased serum iron.

Please note that a proper diagnosis requires a comprehensive evaluation by a qualified medical professional, considering all relevant factors and test results."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Carnitine Deficiency Disorders: These are a group of inherited metabolic disorders characterized by the body's inability to transport fatty acids into the mitochondria for energy production. Symptoms in common: Abnormal circulating carnitine concentration. Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.

+2. Inborn Errors of Metabolism: A broad category of genetic disorders that affect the body's ability to metabolize proteins, carbohydrates, or fats. Symptoms in common: Abnormality of prenatal development or birth, Abnormal circulating carnitine concentration. Symptoms not in common: Death in infancy, Neonatal death.

+3. Congenital Anomalies: Birth defects that occur during prenatal development and can affect various organs or systems. Symptoms in common: Abnormality of prenatal development or birth. Symptoms not in common: Death in infancy, Neonatal death, Abnormal circulating carnitine concentration.

+4. Neonatal Disorders: A range of conditions that affect newborns, including genetic disorders, infections, and birth injuries. Symptoms in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Abnormal circulating carnitine concentration.

+5. Fatty Acid Oxidation Disorders: A group of inherited metabolic disorders that affect the body's ability to break down fatty acids for energy. Symptoms in common: Abnormal circulating carnitine concentration. Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's medical history, physical examination, and additional tests as necessary."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Phenylketonuria (PKU):
Common Symptoms: Hyperphenylalaninemia
Uncommon Symptoms: Death in infancy, Death in childhood, Recurrent viral infections, Hypertyrosinemia

+2. Tyrosinemia Type I:
Common Symptoms: Hypertyrosinemia
Uncommon Symptoms: Death in infancy, Death in childhood, Recurrent viral infections, Hyperphenylalaninemia

+3. Severe Combined Immunodeficiency (SCID):
Common Symptoms: Recurrent viral infections, Death in infancy (if untreated)
Uncommon Symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Death in childhood

+4. Leukocyte Adhesion Deficiency (LAD):
Common Symptoms: Recurrent viral infections
Uncommon Symptoms: Death in infancy, Death in childhood, Hypertyrosinemia, Hyperphenylalaninemia

+5. Maple Syrup Urine Disease (MSUD):
Common Symptoms: None
Uncommon Symptoms: Death in infancy, Death in childhood, Recurrent viral infections, Hypertyrosinemia, Hyperphenylalaninemia

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required for an accurate diagnosis."
['3-methylcrotonyl-CoA carboxylase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Isovaleric Acidemia:
Symptoms in common: Elevated urinary carboxylic acid, Abnormal circulating glycine concentration
Symptoms not in common: Aminoaciduria, Abnormal circulating carnitine concentration

+2. Methylmalonic Acidemia:
Symptoms in common: Elevated urinary carboxylic acid, Abnormal circulating carnitine concentration
Symptoms not in common: Aminoaciduria, Abnormal circulating glycine concentration

+3. Propionic Acidemia:
Symptoms in common: Elevated urinary carboxylic acid, Abnormal circulating carnitine concentration
Symptoms not in common: Aminoaciduria, Abnormal circulating glycine concentration

+4. Glutaric Acidemia Type I:
Symptoms in common: Elevated urinary carboxylic acid
Symptoms not in common: Aminoaciduria, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration

+5. Maple Syrup Urine Disease:
Symptoms in common: Aminoaciduria
Symptoms not in common: Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration, Elevated urinary carboxylic acid

The provided symptoms suggest a potential organic acidemia, which is a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. The elevated urinary carboxylic acid and abnormal circulating glycine/carnitine concentrations are common findings in these disorders."
['Carbamoyl-phosphate synthetase 1 deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder characterized by progressive loss of mental and movement abilities. The patient has symptoms in common with Leigh Syndrome, such as generalized hypotonia, feeding difficulties, and neonatal death. However, the patient does not seem to exhibit neurological symptoms typically associated with Leigh Syndrome.

+2. Mitochondrial DNA Depletion Syndrome: A group of disorders caused by a severe decrease in the number of mitochondrial DNA molecules within cells. The patient shares symptoms like generalized hypotonia, hepatomegaly, and feeding difficulties with this syndrome. However, the presence of 3-methylglutaconic aciduria is not a typical feature of mitochondrial DNA depletion syndrome.

+3. Methylmalonic Acidemia: An inherited disorder in which the body is unable to properly process certain proteins and fats. The patient exhibits symptoms like tachypnea, feeding difficulties, and neonatal death, which can be seen in methylmalonic acidemia. However, the presence of 3-methylglutaconic aciduria and hepatomegaly are not typical features of this disorder.

+4. 3-Methylglutaconic Aciduria: A group of rare inherited metabolic disorders characterized by the accumulation of 3-methylglutaconic acid in the body. The patient has the defining symptom of 3-methylglutaconic aciduria, as well as other common symptoms like generalized hypotonia, hepatomegaly, and feeding difficulties.

+5. Zellweger Spectrum Disorder: A group of inherited metabolic disorders caused by a dysfunction in the peroxisomes within cells. The patient shares symptoms like generalized hypotonia, hepatomegaly, and feeding difficulties with this disorder. However, the presence of 3-methylglutaconic aciduria is not a typical feature of Zellweger spectrum disorder.

It's important to note that a definitive diagnosis would require further testing and evaluation by a medical professional, as some of these disorders share overlapping symptoms."
['Citrullinemia type I'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Ornithine Transcarbamylase Deficiency (OTC Deficiency): A rare inherited disorder characterized by the accumulation of ammonia in the blood due to a deficiency of the enzyme ornithine transcarbamylase. Symptoms in common: Hyperammonemia, lethargy, respiratory alkalosis, hypoglycemia, hypothermia, drowsiness, neonatal death, death in childhood, acute hepatitis, chronic hepatitis. Symptoms not in common: Delayed speech and language development, hyperhidrosis, abnormality of prenatal development or birth, motor delay, obesity, sleep abnormality, tachypnea, oroticaciduria, pustule, elevated plasma citrulline.

+2. Citrullinemia: A rare inherited disorder caused by a deficiency of the enzyme argininosuccinate synthetase, leading to the accumulation of citrulline and ammonia in the blood. Symptoms in common: Hyperammonemia, lethargy, respiratory alkalosis, hypoglycemia, hypothermia, drowsiness, neonatal death, death in childhood, acute hepatitis, chronic hepatitis, elevated plasma citrulline. Symptoms not in common: Delayed speech and language development, hyperhidrosis, abnormality of prenatal development or birth, motor delay, obesity, sleep abnormality, tachypnea, oroticaciduria, pustule.

+3. Congenital Disorders of Glycosylation (CDG): A group of rare inherited metabolic disorders affecting the glycosylation process, which is the attachment of sugar molecules to proteins and lipids. Symptoms in common: Delayed speech and language development, hyperhidrosis, abnormality of prenatal development or birth, lethargy, motor delay, obesity, death in infancy, death in childhood. Symptoms not in common: Hypoglycemia, respiratory alkalosis, hyperammonemia, hypothermia, drowsiness, sleep abnormality, tachypnea, oroticaciduria, neonatal death, elevated plasma citrulline, pustule, acute hepatitis, chronic hepatitis.

+4. Prader-Willi Syndrome: A rare genetic disorder characterized by a chronic feeling of hunger, obesity, and developmental delays. Symptoms in common: Delayed speech and language development, hyperhidrosis, abnormality of prenatal development or birth, lethargy, motor delay, obesity, sleep abnormality. Symptoms not in common: Death in infancy, hypoglycemia, respiratory alkalosis, hyperammonemia, hypothermia, drowsiness, tachypnea, oroticaciduria, neonatal death, death in childhood, elevated plasma citrulline, pustule, acute hepatitis, chronic hepatitis."
['Glutaryl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Glutaric Aciduria Type 1:
Symptoms in common: Macrocephaly, Irritability, Seizure, Generalized hypotonia, Athetosis, Glutaric aciduria
Symptoms not in common: Abnormality of visual evoked potentials, Death in infancy, Neonatal death

+2. Canavan Disease:
Symptoms in common: Macrocephaly, Irritability, Seizure, Generalized hypotonia, Abnormality of visual evoked potentials
Symptoms not in common: Athetosis, Glutaric aciduria, Death in infancy, Neonatal death

+3. Leukodystrophy, Hypomyelinating, 5:
Symptoms in common: Macrocephaly, Seizure, Generalized hypotonia, Abnormality of visual evoked potentials
Symptoms not in common: Irritability, Athetosis, Glutaric aciduria, Death in infancy, Neonatal death

+4. Lissencephaly Syndrome, Norman-Roberts Type:
Symptoms in common: Macrocephaly, Seizure, Generalized hypotonia, Abnormality of visual evoked potentials
Symptoms not in common: Irritability, Athetosis, Glutaric aciduria, Death in infancy, Neonatal death

+5. Leukodystrophy, Hypomyelinating, 2:
Symptoms in common: Macrocephaly, Seizure, Generalized hypotonia, Abnormality of visual evoked potentials
Symptoms not in common: Irritability, Athetosis, Glutaric aciduria, Death in infancy, Neonatal death

Please note that this is a preliminary analysis based on the provided symptoms, and further diagnostic tests and evaluations may be required to confirm the diagnosis."
['Tyrosinemia type 1'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Phenylketonuria (PKU):
Symptoms in common: 'Abnormal circulating phenylalanine concentration', 'Delayed speech and language development'.
Symptoms not in common: '4-Hydroxyphenylpyruvic aciduria', 'Elevated urinary delta-aminolevulinic acid', 'Hypertyrosinemia', 'Death in childhood'.

+2. Tyrosinemia type I:
Symptoms in common: 'Hypertyrosinemia', 'Elevated urinary delta-aminolevulinic acid', 'Death in childhood'.
Symptoms not in common: 'Delayed speech and language development', '4-Hydroxyphenylpyruvic aciduria', 'Abnormal circulating phenylalanine concentration'.

+3. Hawkinsinuria:
Symptoms in common: '4-Hydroxyphenylpyruvic aciduria', 'Delayed speech and language development'.
Symptoms not in common: 'Elevated urinary delta-aminolevulinic acid', 'Hypertyrosinemia', 'Death in childhood', 'Abnormal circulating phenylalanine concentration'.

+4. Acute Intermittent Porphyria (AIP):
Symptoms in common: 'Elevated urinary delta-aminolevulinic acid'.
Symptoms not in common: 'Delayed speech and language development', '4-Hydroxyphenylpyruvic aciduria', 'Hypertyrosinemia', 'Death in childhood', 'Abnormal circulating phenylalanine concentration'.

+5. Hereditary Tyrosinemia type III:
Symptoms in common: 'Hypertyrosinemia', 'Delayed speech and language development'.
Symptoms not in common: '4-Hydroxyphenylpyruvic aciduria', 'Elevated urinary delta-aminolevulinic acid', 'Death in childhood', 'Abnormal circulating phenylalanine concentration'.

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required to confirm the actual diagnosis."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia, Elevated urinary carboxylic acid
Symptoms not in common: Abnormality of prenatal development or birth, Obesity, Death in infancy, Neonatal death, Death in childhood, Hypertyrosinemia

+2. Tyrosinemia Type I:
Symptoms in common: Hypertyrosinemia, Elevated urinary carboxylic acid
Symptoms not in common: Abnormality of prenatal development or birth, Obesity, Death in infancy, Neonatal death, Death in childhood, Hyperphenylalaninemia

+3. Congenital Hypothyroidism:
Symptoms in common: Abnormality of prenatal development or birth, Obesity
Symptoms not in common: Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Elevated urinary carboxylic acid

+4. Prader-Willi Syndrome:
Symptoms in common: Abnormality of prenatal development or birth, Obesity
Symptoms not in common: Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Elevated urinary carboxylic acid

+5. Inborn Errors of Metabolism:
Symptoms in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Elevated urinary carboxylic acid
Symptoms not in common: Obesity, Hypertyrosinemia, Hyperphenylalaninemia

Please note that a proper diagnosis would require additional tests and a comprehensive evaluation by a medical professional."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. Symptoms include intellectual disability, seizures, and hyperphenylalaninemia. The patient has intellectual disability, seizures, and hyperphenylalaninemia in common with PKU.

+2. Maple Syrup Urine Disease (MSUD):
A rare inherited disorder where the body cannot break down certain amino acids, leading to the accumulation of toxic substances. Symptoms may include intellectual disability, seizures, and elevated urinary carboxylic acid. The patient has intellectual disability, seizures, and elevated urinary carboxylic acid in common with MSUD.

+3. Prader-Willi Syndrome:
A genetic disorder characterized by obesity, intellectual disability, short stature, and hyperphagia (excessive hunger). The patient has obesity, intellectual disability, and severe short stature in common with Prader-Willi Syndrome.

+4. Lesch-Nyhan Syndrome:
A rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). Symptoms include intellectual disability, hyperactivity, self-mutilating behavior, and elevated levels of uric acid. The patient has hyperactivity and intellectual disability in common with Lesch-Nyhan Syndrome.

+5. Tyrosinemia Type I:
A rare inherited disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase (FAH), leading to the accumulation of toxic metabolites. Symptoms include liver disease, kidney disease, neurological problems, and hypertyrosinemia. The patient has hypertyrosinemia in common with Tyrosinemia Type I.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a detailed medical history, by a qualified healthcare professional."
['Vitamin B12-unresponsive methylmalonic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Methylmalonic Acidemia: A rare inherited disorder characterized by the inability to properly metabolize certain proteins and fats, leading to the accumulation of methylmalonic acid in the body. The patient has symptoms such as methylmalonic acidemia, methylmalonic aciduria, vomiting, and potentially metabolic acidosis, which are consistent with this condition. However, the patient does not seem to exhibit symptoms like seizures, generalized hypotonia, thrombocytopenia, leukopenia, or neonatal death.

+2. Organic Acidemias: A group of inherited metabolic disorders that involve the abnormal accumulation of organic acids in the body due to enzyme deficiencies. The patient's symptoms of metabolic acidosis, hyperammonemia, and vomiting could be indicative of an organic acidemia. However, the specific symptoms of methylmalonic acidemia and methylmalonic aciduria suggest a more specific diagnosis.

+3. Propionic Acidemia: Another inherited metabolic disorder characterized by the accumulation of propionic acid and other related compounds in the body. The patient's symptoms of metabolic acidosis, hyperammonemia, and vomiting could be consistent with propionic acidemia. However, the presence of methylmalonic acidemia and methylmalonic aciduria points more towards methylmalonic acidemia as the likely diagnosis.

+4. Inherited Bone Marrow Failure Syndromes: A group of rare genetic disorders that affect the production of blood cells in the bone marrow. The patient's symptoms of thrombocytopenia (low platelet count) and leukopenia (low white blood cell count) could be indicative of an inherited bone marrow failure syndrome. However, the other metabolic symptoms suggest a different underlying condition.

+5. Neonatal Sepsis: A potentially life-threatening condition in newborns caused by a bacterial or viral infection. The patient's symptoms of seizures, generalized hypotonia, and neonatal death could be consistent with severe neonatal sepsis. However, the metabolic abnormalities and specific symptoms like methylmalonic acidemia and aciduria are not typically associated with sepsis.

It's important to note that a comprehensive medical evaluation, including laboratory tests and genetic analysis, would be necessary to confirm the specific diagnosis and provide appropriate treatment."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Carnitine Deficiency Disorders:
Common Symptoms: Abnormal circulating carnitine concentration
Uncommon Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death

+2. Inborn Errors of Metabolism:
Common Symptoms: Abnormality of prenatal development or birth, Neonatal death
Uncommon Symptoms: Death in infancy, Abnormal circulating carnitine concentration

+3. Congenital Anomalies:
Common Symptoms: Abnormality of prenatal development or birth
Uncommon Symptoms: Death in infancy, Neonatal death, Abnormal circulating carnitine concentration

+4. Neonatal Disorders:
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Uncommon Symptoms: Abnormal circulating carnitine concentration

+5. Metabolic Disorders:
Common Symptoms: Abnormal circulating carnitine concentration
Uncommon Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death

Please note that these are general potential diagnoses based on the provided symptoms, and further evaluation and testing would be required to confirm the specific condition."
['Vitamin B12-unresponsive methylmalonic acidemia'],"Based on the provided symptoms: ['Death in infancy', 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting', 'Methylmalonic aciduria'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Methylmalonic acidemia:
Matching symptoms: 'Death in infancy', 'Metabolic acidosis', 'Hyperammonemia', 'Methylmalonic aciduria'
Non-matching symptoms: 'Vomiting'

+2. Propionic acidemia:
Matching symptoms: 'Death in infancy', 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting'
Non-matching symptoms: 'Methylmalonic aciduria'

+3. Isovaleric acidemia:
Matching symptoms: 'Death in infancy', 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting'
Non-matching symptoms: 'Methylmalonic aciduria'

+4. Maple syrup urine disease:
Matching symptoms: 'Death in infancy', 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting'
Non-matching symptoms: 'Methylmalonic aciduria'

+5. Urea cycle disorders:
Matching symptoms: 'Death in infancy', 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting'
Non-matching symptoms: 'Methylmalonic aciduria'

The presence of 'Methylmalonic aciduria' strongly suggests Methylmalonic acidemia as the potential diagnosis. However, other organic acidemias and urea cycle disorders cannot be completely ruled out based on the provided symptoms."
['Ornithine transcarbamylase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Ornithine Transcarbamylase Deficiency (OTC Deficiency): A rare inherited disorder characterized by the accumulation of ammonia in the blood (hyperammonemia), which can lead to seizures, cerebral edema (brain swelling), and potentially death in infancy or the neonatal period. The patient has symptoms of seizures, hyperammonemia, and cerebral edema, which are consistent with OTC Deficiency. However, the symptoms of oroticaciduria and neonatal death are not specifically mentioned for this condition.

+2. Urea Cycle Disorders: A group of inherited metabolic disorders that affect the body's ability to remove ammonia from the bloodstream, leading to hyperammonemia. Symptoms can include seizures, lethargy, vomiting, and in severe cases, coma and death. The patient has symptoms of seizures and hyperammonemia, which are consistent with urea cycle disorders. However, the other listed symptoms are not specifically mentioned for this group of disorders.

+3. Maple Syrup Urine Disease (MSUD): A rare inherited disorder characterized by the inability to break down certain amino acids, leading to the accumulation of toxic substances in the body. Symptoms can include seizures, lethargy, poor feeding, and a distinctive maple syrup odor in urine and cerumen (earwax). The patient has symptoms of seizures, which are consistent with MSUD. However, the other listed symptoms are not specifically mentioned for this condition.

+4. Nonketotic Hyperglycinemia: A rare inherited disorder characterized by an accumulation of glycine in the body, leading to seizures, developmental delays, and potentially death in infancy. The patient has symptoms of seizures and death in infancy, which are consistent with nonketotic hyperglycinemia. However, the other listed symptoms are not specifically mentioned for this condition.

It's important to note that a proper diagnosis should be made by a qualified medical professional after a thorough evaluation, including medical history, physical examination, and appropriate laboratory tests."
['Biotinidase deficiency'],"Based on the provided symptoms: ['Seizure', 'Generalized hypotonia', 'Growth delay', 'Death in infancy', 'Alopecia', 'Fasciculations', 'Elevated urinary carboxylic acid'], here are some potential diagnoses:

+1. Leigh Syndrome: This is a severe neurological disorder that primarily affects the central nervous system. It is characterized by degeneration of the brain's motor control areas, leading to symptoms such as seizures, hypotonia (decreased muscle tone), growth delay, and potentially death in infancy. The patient exhibits seizures, generalized hypotonia, growth delay, and the possibility of death in infancy, which are consistent with Leigh Syndrome. However, alopecia (hair loss), fasciculations (muscle twitching), and elevated urinary carboxylic acid are not typical symptoms of this condition.

+2. Menkes Disease: This is a rare inherited disorder that affects copper metabolism in the body. Symptoms may include seizures, hypotonia, growth delay, alopecia (hair loss), and elevated urinary carboxylic acid levels. The patient exhibits seizures, generalized hypotonia, growth delay, alopecia, and elevated urinary carboxylic acid, which are consistent with Menkes Disease. However, death in infancy and fasciculations are not typical symptoms of this condition.

+3. Mitochondrial Disorders: These are a group of disorders caused by dysfunctional mitochondria, the energy-producing structures within cells. Symptoms can vary widely but may include seizures, hypotonia, growth delay, alopecia, fasciculations, and elevated urinary carboxylic acid levels. The patient exhibits seizures, generalized hypotonia, growth delay, alopecia, fasciculations, and elevated urinary carboxylic acid, which are consistent with various mitochondrial disorders. However, death in infancy is not a common symptom in all cases.

+4. Organic Acidemias: These are a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms may include seizures, hypotonia, growth delay, alopecia, and elevated urinary carboxylic acid levels. The patient exhibits seizures, generalized hypotonia, growth delay, alopecia, and elevated urinary carboxylic acid, which are consistent with organic acidemias. However, death in infancy and fasciculations are not typical symptoms of these disorders.

It's important to note that a comprehensive medical evaluation, including laboratory tests and imaging studies, would be necessary to confirm or rule out these potential diagnoses accurately."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia
Symptoms not in common: Obesity, Hypercholesterolemia, Hypertyrosinemia, Death in early adulthood

+2. Tyrosinemia Type I:
Symptoms in common: Hypertyrosinemia
Symptoms not in common: Obesity, Hypercholesterolemia, Hyperphenylalaninemia, Death in early adulthood

+3. Familial Hypercholesterolemia:
Symptoms in common: Hypercholesterolemia
Symptoms not in common: Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood

+4. Obesity-related Metabolic Disorders:
Symptoms in common: Obesity, Hypercholesterolemia
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood

+5. Inborn Errors of Metabolism:
Symptoms in common: Hypertyrosinemia, Hyperphenylalaninemia
Symptoms not in common: Obesity, Hypercholesterolemia, Death in early adulthood

Please note that a proper diagnosis would require additional information, such as medical history, physical examination, and laboratory tests. The provided symptoms may not be sufficient to make a definitive diagnosis."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia
Symptoms not in common: Hypospadias, Death in infancy, Premature birth, Hypertyrosinemia, Severe short stature, Neonatal death, Hernia

+2. Tyrosinemia Type I:
Symptoms in common: Hypertyrosinemia
Symptoms not in common: Hypospadias, Death in infancy, Premature birth, Severe short stature, Neonatal death, Hyperphenylalaninemia, Hernia

+3. Congenital Adrenal Hyperplasia (CAH):
Symptoms in common: Hypospadias (in males)
Symptoms not in common: Death in infancy, Premature birth, Hypertyrosinemia, Severe short stature, Neonatal death, Hyperphenylalaninemia, Hernia

+4. Prader-Willi Syndrome:
Symptoms in common: Severe short stature
Symptoms not in common: Hypospadias, Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Hernia

+5. Inguinal Hernia:
Symptoms in common: Hernia
Symptoms not in common: Hypospadias, Death in infancy, Premature birth, Hypertyrosinemia, Severe short stature, Neonatal death, Hyperphenylalaninemia

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required to confirm the actual diagnosis."
['Smith-Lemli-Opitz syndrome'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Smith-Lemli-Opitz Syndrome (SLOS):
Symptoms in common: Microcephaly, Low-set ears, Wide nasal bridge, Strabismus, Delayed speech and language development, Syndactyly, Intellectual disability, Motor delay, Severe short stature, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration.
Symptoms not in common: Death in infancy, Difficulty walking, Difficulty climbing stairs, Neonatal death, Death in childhood, Difficulty running, Severe hearing impairment.

+2. Down Syndrome:
Symptoms in common: Microcephaly, Low-set ears, Wide nasal bridge, Strabismus, Delayed speech and language development, Intellectual disability, Motor delay, Severe short stature, Difficulty walking, Difficulty climbing stairs, Difficulty running.
Symptoms not in common: Syndactyly, Death in infancy, Neonatal death, Death in childhood, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Severe hearing impairment.

+3. Congenital Rubella Syndrome:
Symptoms in common: Microcephaly, Low-set ears, Wide nasal bridge, Strabismus, Delayed speech and language development, Intellectual disability, Motor delay, Severe short stature, Severe hearing impairment.
Symptoms not in common: Syndactyly, Death in infancy, Difficulty walking, Elevated 8-dehydrocholesterol, Difficulty climbing stairs, Neonatal death, Death in childhood, Difficulty running, Elevated circulating 7-dehydrocholesterol concentration.

+4. Fetal Alcohol Spectrum Disorders (FASD):
Symptoms in common: Microcephaly, Low-set ears, Wide nasal bridge, Strabismus, Delayed speech and language development, Intellectual disability, Motor delay, Severe short stature.
Symptoms not in common: Syndactyly, Death in infancy, Difficulty walking, Elevated 8-dehydrocholesterol, Difficulty climbing stairs, Neonatal death, Death in childhood, Difficulty running, Elevated circulating 7-dehydrocholesterol concentration, Severe hearing impairment."
['Glutaryl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Glutaric Aciduria Type 1 (GA1):
This is a rare inherited metabolic disorder characterized by an inability to break down certain amino acids, leading to the accumulation of glutaric acid in the body. The patient has the following symptoms in common with GA1: 'Ataxia', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Progressive neurologic deterioration', 'Decreased plasma free carnitine', and 'Abnormal circulating acylcarnitine concentration'. However, the patient does not seem to exhibit 'Death in infancy' or 'Death in childhood', which are common in severe cases of GA1.

+2. Meningitis:
This is an inflammation of the membranes (meninges) surrounding the brain and spinal cord, often caused by viral or bacterial infections. The patient has the following symptoms in common with meningitis: 'Fever', 'Opisthotonus' (neck stiffness), and potentially 'Athetosis' (involuntary movements). However, the patient does not seem to exhibit other common symptoms of meningitis, such as headache, photophobia, or altered mental status.

+3. Gastroenteritis:
This is an inflammation of the gastrointestinal tract, often caused by viral or bacterial infections. The patient has the following symptoms in common with gastroenteritis: 'Diarrhea', 'Dehydration', and potentially 'Fever'. However, the patient does not seem to exhibit other common symptoms of gastroenteritis, such as abdominal pain, nausea, or vomiting.

+4. Metabolic Disorder:
The presence of 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Decreased plasma free carnitine', and 'Abnormal circulating acylcarnitine concentration' may indicate an underlying metabolic disorder, potentially related to amino acid metabolism or fatty acid oxidation. However, without additional information, it is difficult to pinpoint a specific metabolic disorder.

It's important to note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation, including laboratory tests and imaging studies, would be necessary to confirm or rule out any of these potential diseases."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia
Symptoms not in common: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Hip dysplasia, Death in infancy, Hypertyrosinemia, Neonatal death

+2. Tyrosinemia type I:
Symptoms in common: Hypertyrosinemia
Symptoms not in common: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Hip dysplasia, Death in infancy, Hyperphenylalaninemia, Neonatal death

+3. Congenital disorders of glycosylation (CDG):
Symptoms in common: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia
Symptoms not in common: Hip dysplasia, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia

+4. Prader-Willi syndrome:
Symptoms in common: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia
Symptoms not in common: Hip dysplasia, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia

+5. Zellweger syndrome:
Symptoms in common: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Neonatal death
Symptoms not in common: Hip dysplasia, Death in infancy, Hypertyrosinemia, Hyperphenylalaninemia

Please note that this is a preliminary assessment based on the provided symptoms, and further diagnostic tests and evaluations may be required to confirm or rule out these potential diseases."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has the symptoms of 'Hyperphenylalaninemia' in common with PKU. However, the other symptoms like 'Retrognathia,' 'Seizure,' 'Generalized hypotonia,' 'Death in infancy,' 'Apnea,' 'Opisthotonus,' and 'Neonatal death' are not typically associated with PKU.

+2. Tyrosinemia type I:
This is a rare inherited disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites. The patient has the symptom of 'Hypertyrosinemia' in common with Tyrosinemia type I. However, the other symptoms are not typically associated with this disorder.

+3. Congenital myotonic dystrophy:
This is a genetic disorder characterized by severe muscle weakness and respiratory problems. The patient has the symptoms of 'Generalized hypotonia,' 'Apnea,' and 'Death in infancy' in common with congenital myotonic dystrophy. However, the other symptoms like 'Retrognathia,' 'Seizure,' 'Opisthotonus,' 'Hypertyrosinemia,' 'Hyperphenylalaninemia,' and 'Death in childhood' are not typically associated with this disorder.

+4. Severe congenital neurodevelopmental disorder:
This is a broad category of disorders that affect brain development and function, leading to various neurological and developmental problems. The patient has the symptoms of 'Abnormality of prenatal development or birth,' 'Seizure,' 'Generalized hypotonia,' 'Death in infancy,' 'Apnea,' 'Opisthotonus,' and 'Death in childhood' in common with severe congenital neurodevelopmental disorders. However, the symptoms like 'Retrognathia,' 'Hypertyrosinemia,' and 'Hyperphenylalaninemia' are not typically associated with these disorders.

It's important to note that a comprehensive medical evaluation, including laboratory tests and imaging studies, would be necessary to arrive at an accurate diagnosis."
['Tyrosinemia type 1'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Phenylketonuria (PKU):
Symptoms in common: Intellectual disability, Seizure, Hyperphenylalaninemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.
Symptoms not in common: Autistic behavior, Self-mutilation, Hyperactivity, Motor delay, Obesity, Death in infancy, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Neonatal death, Death in childhood, Elevated circulating alpha-fetoprotein concentration, Decreased serum iron.

+2. Lesch-Nyhan Syndrome:
Symptoms in common: Self-mutilation, Intellectual disability, Hyperactivity, Elevated circulating alkaline phosphatase concentration.
Symptoms not in common: Autistic behavior, Seizure, Motor delay, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Decreased serum iron.

+3. Autism Spectrum Disorder (ASD):
Symptoms in common: Autistic behavior, Intellectual disability.
Symptoms not in common: Self-mutilation, Hyperactivity, Seizure, Motor delay, Obesity, Death in infancy, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Decreased serum iron.

+4. Rett Syndrome:
Symptoms in common: Autistic behavior, Self-mutilation, Intellectual disability, Motor delay, Obesity.
Symptoms not in common: Hyperactivity, Seizure, Death in infancy, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Decreased serum iron.

+5. Tyrosinemia Type I:
Symptoms in common: Intellectual disability, Seizure, Hypertyrosinemia, Elevated circulating alkaline phosphatase concentration, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating aspartate family amino acid concentration.
Symptoms not in common: Autistic behavior, Self-mutilation, Hyperactivity, Motor delay, Obesity, Death in infancy, Neonatal death, Death in childhood, Hyperphenylalaninemia, Abnormal circulating alanine concentration, Decreased serum iron."
['Classic galactosemia'],"Based on the provided symptoms: ['Death in infancy', 'Vomiting', 'Increased total bilirubin', 'Neonatal death', 'Hypergalactosemia'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Galactosemia: A rare genetic disorder in which the body is unable to metabolize galactose, a sugar found in lactose (milk sugar). Symptoms include vomiting, jaundice (increased total bilirubin), failure to thrive, and potentially life-threatening complications if left untreated.
Matching symptoms: Vomiting, Increased total bilirubin, Hypergalactosemia
Non-matching symptoms: Death in infancy, Neonatal death (although these can occur in severe cases)

+2. Crigler-Najjar syndrome: A rare inherited disorder characterized by an inability to metabolize bilirubin, leading to severe jaundice and potential brain damage.
Matching symptoms: Increased total bilirubin
Non-matching symptoms: Death in infancy, Vomiting, Neonatal death, Hypergalactosemia

+3. Biliary atresia: A rare disease of the liver and bile ducts that occurs in infants, causing bile to become trapped in the liver, leading to jaundice and liver damage.
Matching symptoms: Increased total bilirubin, Neonatal death (if left untreated)
Non-matching symptoms: Death in infancy, Vomiting, Hypergalactosemia

+4. Neonatal hemochromatosis: A rare disorder characterized by excessive iron deposition in the liver and other organs of a newborn, leading to liver failure and potentially life-threatening complications.
Matching symptoms: Neonatal death (if left untreated)
Non-matching symptoms: Death in infancy, Vomiting, Increased total bilirubin, Hypergalactosemia

+5. Inborn errors of metabolism: A group of rare genetic disorders that affect the body's ability to metabolize specific nutrients, such as amino acids, carbohydrates, or lipids. Some of these disorders can present with symptoms like vomiting, jaundice, and potentially life-threatening complications.
Matching symptoms: Vomiting, Increased total bilirubin
Non-matching symptoms: Death in infancy, Neonatal death, Hypergalactosemia

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and imaging studies, as well as a thorough review of the patient's medical history and physical examination findings."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to a buildup of phenylalanine and its byproducts in the body. The patient has the symptoms of 'Hyperphenylalaninemia' and 'Abnormal circulating tyrosine concentration,' which are common in PKU. However, the symptoms of 'Abnormality of prenatal development or birth,' 'Death in infancy,' and 'Neonatal death' are not typically associated with PKU if it is diagnosed and treated early.

+2. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body cannot break down certain amino acids, including leucine, isoleucine, and valine. The patient does not have any symptoms specifically related to MSUD, such as maple syrup odor in urine, vomiting, lethargy, and developmental delays.

+3. Homocystinuria:
This is an inherited metabolic disorder characterized by the inability to metabolize the amino acid homocysteine, leading to its accumulation in the body. The patient does not have any symptoms specifically related to homocystinuria, such as developmental delays, intellectual disability, skeletal abnormalities, and an increased risk of blood clots.

+4. Tyrosinemia:
This is a group of inherited metabolic disorders characterized by the inability to metabolize the amino acid tyrosine, leading to its accumulation in the body. The patient has the symptom of 'Abnormal circulating tyrosine concentration,' which is common in tyrosinemia. However, the other symptoms provided are not typically associated with tyrosinemia.

+5. Congenital Hypothyroidism:
This is a condition in which the thyroid gland does not produce enough thyroid hormones, which are essential for normal growth and development. The patient does not have any symptoms specifically related to congenital hypothyroidism, such as poor feeding, constipation, prolonged jaundice, and developmental delays.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and other diagnostic procedures, by a qualified healthcare professional."
['Biotinidase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Carnitine Deficiency Syndrome: This is a condition characterized by low levels of carnitine, a nutrient that plays a crucial role in energy production. Symptoms that match: Abnormal circulating carnitine concentration. Symptoms that do not match: Obesity, Death in childhood, Death in adolescence.

+2. Barth Syndrome: A rare genetic disorder that affects multiple organ systems, including the heart, muscles, and immune system. Symptoms that match: Abnormal circulating carnitine concentration. Symptoms that do not match: Obesity, Death in childhood, Death in adolescence.

+3. Obesity-related Complications: Obesity can lead to various health issues, such as cardiovascular diseases, type 2 diabetes, and certain types of cancer. Symptoms that match: Obesity. Symptoms that do not match: Death in childhood, Abnormal circulating carnitine concentration, Death in adolescence.

+4. Childhood Metabolic Disorders: A group of inherited conditions that affect the body's ability to break down and utilize certain nutrients or produce energy. Symptoms that match: Death in childhood, Abnormal circulating carnitine concentration. Symptoms that do not match: Obesity, Death in adolescence.

+5. Adolescent-onset Genetic Disorders: Some genetic disorders may not manifest symptoms until adolescence or later in life. Symptoms that match: Death in adolescence. Symptoms that do not match: Obesity, Death in childhood, Abnormal circulating carnitine concentration.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and potentially additional tests or investigations. The provided symptoms may not be sufficient for an accurate diagnosis."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. Symptoms the patient has in common: Intellectual disability, Hypertyrosinemia, Hyperphenylalaninemia. Symptoms the patient does not have in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in adolescence.

+2. Maple Syrup Urine Disease (MSUD):
A rare inherited disorder that affects the body's ability to break down certain amino acids, leading to a buildup of toxic substances. Symptoms the patient has in common: Intellectual disability, Neonatal death. Symptoms the patient does not have in common: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence.

+3. Trisomy 18 (Edwards Syndrome):
A chromosomal disorder caused by the presence of an extra copy of chromosome 18, leading to severe developmental abnormalities. Symptoms the patient has in common: Abnormality of prenatal development or birth, Intellectual disability, Death in infancy, Neonatal death. Symptoms the patient does not have in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence.

+4. Trisomy 13 (Patau Syndrome):
Another chromosomal disorder caused by an extra copy of chromosome 13, resulting in severe intellectual disability and physical abnormalities. Symptoms the patient has in common: Abnormality of prenatal development or birth, Intellectual disability, Death in infancy, Neonatal death. Symptoms the patient does not have in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence.

+5. Niemann-Pick Disease Type C:
A rare inherited metabolic disorder that affects the body's ability to transport cholesterol and other lipids within cells, leading to their accumulation. Symptoms the patient has in common: Intellectual disability, Death in adolescence. Symptoms the patient does not have in common: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death.

Please note that a proper diagnosis would require additional information, such as medical history, laboratory tests, and a physical examination by a qualified healthcare professional."
['Smith-Lemli-Opitz syndrome'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Smith-Lemli-Opitz Syndrome (SLOS): A rare genetic disorder caused by a deficiency in the enzyme responsible for cholesterol biosynthesis, leading to elevated levels of 7-dehydrocholesterol and 8-dehydrocholesterol. Symptoms in common: Microcephaly, low-set ears, strabismus, ptosis, hypermetropia, syndactyly, intellectual disability, lethargy, motor delay, generalized hypotonia, feeding difficulties, hypocholesterolemia, elevated 8-dehydrocholesterol, neonatal death, death in childhood. Symptoms not in common: Cryptorchidism, hypospadias, obsolete eczematoid dermatitis, skin rash, dystonia, death in infancy, vomiting, constipation, drowsiness, sleep abnormality, recurrent viral infections, elevated circulating 7-dehydrocholesterol concentration, hypoxemia, severe hearing impairment.

+2. Congenital Disorders of Glycosylation (CDG): A group of inherited metabolic disorders affecting the glycosylation process, which is essential for proper protein function. Symptoms in common: Intellectual disability, lethargy, motor delay, generalized hypotonia, feeding difficulties, recurrent viral infections. Symptoms not in common: Cryptorchidism, hypospadias, microcephaly, low-set ears, strabismus, ptosis, hypermetropia, obsolete eczematoid dermatitis, skin rash, syndactyly, dystonia, death in infancy, vomiting, constipation, drowsiness, sleep abnormality, hypocholesterolemia, elevated 8-dehydrocholesterol, neonatal death, death in childhood, elevated circulating 7-dehydrocholesterol concentration, hypoxemia, severe hearing impairment.

+3. Zellweger Spectrum Disorder (ZSD): A group of genetic disorders characterized by a defect in the biogenesis of peroxisomes, which are cellular organelles involved in various metabolic processes. Symptoms in common: Intellectual disability, lethargy, motor delay, generalized hypotonia, feeding difficulties, hypotonia, neonatal death, death in childhood. Symptoms not in common: Cryptorchidism, hypospadias, microcephaly, low-set ears, strabismus, ptosis, hypermetropia, obsolete eczematoid dermatitis, skin rash, syndactyly, dystonia, death in infancy, vomiting, constipation, drowsiness, sleep abnormality, hypocholesterolemia, elevated 8-dehydrocholesterol, recurrent viral infections, elevated circulating 7-dehydrocholesterol concentration, hypoxemia, severe hearing impairment.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided list is based solely on the given symptoms and should not be considered a definitive diagnosis."
['Canavan disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder characterized by progressive loss of mental and movement abilities. It is caused by mutations in mitochondrial DNA or nuclear genes involved in energy production.
Symptoms in common: Hypotonia, Cerebral atrophy
Symptoms not in common: Strabismus, Obesity, Death in infancy, Fever, Abnormal circulating aspartate family amino acid concentration

+2. Pompe Disease: A rare inherited disorder caused by a deficiency of the enzyme acid alpha-glucosidase, which leads to the accumulation of glycogen in various tissues, particularly skeletal muscles.
Symptoms in common: Generalized hypotonia, Hyporeflexia
Symptoms not in common: Strabismus, Obesity, Death in infancy, Fever, Cerebral atrophy, Abnormal circulating aspartate family amino acid concentration

+3. Prader-Willi Syndrome: A rare genetic disorder caused by an abnormality in the 15th chromosome, characterized by intellectual disability, low muscle tone, and an insatiable appetite leading to obesity.
Symptoms in common: Hypotonia, Obesity
Symptoms not in common: Strabismus, Death in infancy, Fever, Cerebral atrophy, Abnormal circulating aspartate family amino acid concentration

+4. Niemann-Pick Disease Type C: A rare inherited lipid storage disorder characterized by the accumulation of cholesterol and other lipids in various tissues, including the brain, liver, and spleen.
Symptoms in common: Hypotonia, Cerebral atrophy
Symptoms not in common: Strabismus, Obesity, Death in infancy, Fever, Abnormal circulating aspartate family amino acid concentration

+5. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS): A rare inherited mitochondrial disorder characterized by stroke-like episodes, seizures, and progressive neurological and muscular impairment.
Symptoms in common: Hypotonia, Cerebral atrophy
Symptoms not in common: Strabismus, Obesity, Death in infancy, Fever, Abnormal circulating aspartate family amino acid concentration

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided list of potential diseases is based solely on the given symptoms and should not be considered a definitive diagnosis."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has the symptom 'Hyperphenylalaninemia' in common with PKU, which is a hallmark of the disease. However, the other symptoms listed are not typically associated with PKU.

+2. Tyrosinemia Type I:
This is a rare inherited disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites. The patient has the symptom 'Hypertyrosinemia' in common with this disease, which is a characteristic feature. However, the other symptoms listed are not typically associated with Tyrosinemia Type I.

+3. Coarctation of the Aorta:
This is a congenital heart defect where the aorta is narrowed, obstructing blood flow. The patient has the symptom 'Coarctation of aorta' in common with this condition. However, the other symptoms listed are not typically associated with Coarctation of the Aorta.

+4. Pneumonia:
This is an inflammatory condition of the lungs caused by various infectious agents, such as bacteria, viruses, or fungi. The patient has the symptom 'Pneumonia' in common with this condition. However, the other symptoms listed are not typically associated with Pneumonia.

+5. Obesity:
This is a medical condition characterized by excessive accumulation of body fat, which can lead to various health problems. The patient has the symptom 'Obesity' in common with this condition. However, the other symptoms listed are not typically associated with Obesity alone.

It's important to note that a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate diagnostic tests, would be necessary to accurately diagnose the patient's condition."
['Classic homocystinuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Homocystinuria: A rare inherited metabolic disorder characterized by the accumulation of homocysteine and methionine in the body. The patient has symptoms such as hyperhomocystinemia, hypermethioninemia, and aminoaciduria, which are common in homocystinuria. However, the patient does not seem to exhibit other common symptoms like developmental delays, intellectual disability, or skeletal abnormalities.

+2. Maple Syrup Urine Disease (MSUD): A rare inherited disorder in which the body is unable to break down certain amino acids properly, leading to a buildup of toxic substances. The patient has symptoms like aminoaciduria, which is common in MSUD. However, the patient does not seem to exhibit other common symptoms like a distinctive maple syrup odor in urine, poor feeding, and lethargy.

+3. Methylmalonic Acidemia: A rare inherited metabolic disorder characterized by the accumulation of methylmalonic acid in the body. The patient has symptoms like aminoaciduria, which is common in methylmalonic acidemia. However, the patient does not seem to exhibit other common symptoms like vomiting, dehydration, and lethargy.

+4. Nonketotic Hyperglycinemia: A rare inherited metabolic disorder characterized by an accumulation of glycine in the body. The patient has symptoms like aminoaciduria, which is common in nonketotic hyperglycinemia. However, the patient does not seem to exhibit other common symptoms like seizures, developmental delays, and intellectual disability.

+5. Phenylketonuria (PKU): A rare inherited metabolic disorder in which the body is unable to break down the amino acid phenylalanine properly. The patient has symptoms like aminoaciduria, which is common in PKU. However, the patient does not seem to exhibit other common symptoms like developmental delays, intellectual disability, and a musty odor.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a detailed medical history, which cannot be provided based solely on the given information."
[],"Based on the provided symptoms: ['Ataxia', 'Generalized hypotonia', 'Death in childhood', 'Abnormal circulating pyrimidine concentration', 'Uraciluria'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Lesch-Nyhan Syndrome:
Matching Symptoms: Ataxia, Generalized hypotonia
Non-Matching Symptoms: Death in childhood, Abnormal circulating pyrimidine concentration, Uraciluria

+2. Dihydropyrimidine Dehydrogenase Deficiency:
Matching Symptoms: Abnormal circulating pyrimidine concentration, Uraciluria
Non-Matching Symptoms: Ataxia, Generalized hypotonia, Death in childhood

+3. Ataxia-Telangiectasia:
Matching Symptoms: Ataxia
Non-Matching Symptoms: Generalized hypotonia, Death in childhood, Abnormal circulating pyrimidine concentration, Uraciluria

+4. Spinal Muscular Atrophy:
Matching Symptoms: Generalized hypotonia
Non-Matching Symptoms: Ataxia, Death in childhood, Abnormal circulating pyrimidine concentration, Uraciluria

+5. Leigh Syndrome:
Matching Symptoms: Ataxia, Generalized hypotonia, Death in childhood
Non-Matching Symptoms: Abnormal circulating pyrimidine concentration, Uraciluria

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required to confirm the actual diagnosis."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a rare inherited disorder that causes an abnormal buildup of the amino acid phenylalanine in the body due to a deficiency of the enzyme needed to break it down. The symptom 'Hyperphenylalaninemia' (high levels of phenylalanine in the blood) is consistent with PKU. However, the symptoms 'Hypertyrosinemia' (high levels of tyrosine) and 'Death in early adulthood' are not typically associated with PKU if it is well-managed through dietary restrictions.

+2. Tyrosinemia Type I:
This is a rare inherited disorder that causes an abnormal buildup of the amino acid tyrosine in the body due to a deficiency of the enzyme needed to break it down. The symptom 'Hypertyrosinemia' (high levels of tyrosine in the blood) is consistent with Tyrosinemia Type I. However, the symptoms 'Hyperphenylalaninemia' (high levels of phenylalanine) and 'Death in early adulthood' are not typically associated with this condition if it is well-managed through dietary restrictions and medication.

+3. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder that affects the body's ability to break down certain amino acids, including leucine, isoleucine, and valine. While MSUD can cause elevated levels of tyrosine and phenylalanine in the blood, it is not directly associated with the symptoms 'Hypertyrosinemia' or 'Hyperphenylalaninemia.' However, if left untreated, MSUD can lead to severe complications and potentially 'Death in early adulthood.'

It's important to note that a proper diagnosis would require additional clinical evaluation, laboratory tests, and a thorough medical history to determine the underlying cause of the reported symptoms accurately."
[],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Dihydropyrimidine Dehydrogenase Deficiency: This is a rare inherited disorder that affects the breakdown of pyrimidines, which are building blocks of DNA and RNA. Symptoms in common: Abnormal circulating pyrimidine concentration, Uraciluria. Symptoms not in common: Death in infancy, Respiratory insufficiency, Neonatal death.

+2. Ornithine Transcarbamylase Deficiency: This is a genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the body. Symptoms in common: Neonatal death, Respiratory insufficiency. Symptoms not in common: Death in infancy, Abnormal circulating pyrimidine concentration, Uraciluria.

+3. Severe Combined Immunodeficiency: This is a group of rare, life-threatening disorders characterized by a lack of immune system function. Symptoms in common: Death in infancy, Respiratory insufficiency. Symptoms not in common: Neonatal death, Abnormal circulating pyrimidine concentration, Uraciluria.

+4. Lesch-Nyhan Syndrome: This is a rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). Symptoms in common: Abnormal circulating pyrimidine concentration, Uraciluria. Symptoms not in common: Death in infancy, Respiratory insufficiency, Neonatal death.

+5. Congenital Disorders of Glycosylation: These are a group of inherited metabolic disorders that affect the glycosylation process, which is the attachment of sugar molecules to proteins and lipids. Symptoms in common: Death in infancy, Respiratory insufficiency. Symptoms not in common: Neonatal death, Abnormal circulating pyrimidine concentration, Uraciluria.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's complete medical history, physical examination, and relevant laboratory tests."
['Tyrosinemia type 1'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Tyrosinemia type I: A rare inherited disorder characterized by the inability to break down the amino acid tyrosine, leading to elevated levels of tyrosine and its byproducts in the body. Symptoms in common: Hypertyrosinemia, aminoaciduria, elevated circulating alpha-fetoprotein concentration, abnormal circulating porphyrin concentration. Symptoms not in common: Pallor, death in infancy, ascites, thrombocytosis, anemia, hypoalbuminemia, hypoproteinemia, elevated circulating alkaline phosphatase concentration, hernia.

+2. Crigler-Najjar syndrome: A rare inherited disorder characterized by the inability to metabolize bilirubin, leading to severe jaundice and elevated levels of bilirubin in the blood. Symptoms in common: Pallor, elevated circulating alkaline phosphatase concentration. Symptoms not in common: Death in infancy, ascites, thrombocytosis, anemia, hypoalbuminemia, hypoproteinemia, hypertyrosinemia, aminoaciduria, elevated circulating alpha-fetoprotein concentration, abnormal circulating porphyrin concentration, hernia.

+3. Glycogen storage disease type IV: A rare inherited disorder characterized by the inability to break down glycogen, leading to the accumulation of abnormal glycogen molecules in various tissues, particularly the liver and muscles. Symptoms in common: Ascites, elevated circulating alkaline phosphatase concentration. Symptoms not in common: Pallor, death in infancy, thrombocytosis, anemia, hypoalbuminemia, hypoproteinemia, hypertyrosinemia, aminoaciduria, elevated circulating alpha-fetoprotein concentration, abnormal circulating porphyrin concentration, hernia.

+4. Hereditary fructose intolerance: A rare inherited disorder characterized by the inability to metabolize fructose, leading to the accumulation of fructose and its byproducts in the body. Symptoms in common: Ascites, hypoalbuminemia, hypoproteinemia. Symptoms not in common: Pallor, death in infancy, thrombocytosis, anemia, elevated circulating alkaline phosphatase concentration, hypertyrosinemia, aminoaciduria, elevated circulating alpha-fetoprotein concentration, abnormal circulating porphyrin concentration, hernia.

+5. Congenital hepatic fibrosis: A rare inherited disorder characterized by the abnormal development of the liver's bile ducts, leading to progressive liver damage and scarring. Symptoms in common: Ascites, hypoalbuminemia, hypoproteinemia. Symptoms not in common: Pallor, death in infancy, thrombocytosis, anemia, elevated circulating alkaline phosphatase concentration, hypertyrosinemia, aminoaciduria, elevated circulating alpha-fetoprotein concentration, abnormal circulating porphyrin concentration, hernia."
['Canavan disease'],"Based on the provided symptoms: ['Seizure', 'Motor delay', 'Death in infancy', 'Abnormal circulating aspartate family amino acid concentration'], here are some potential diseases with their descriptions:

+1. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Seizure, Motor delay, Abnormal circulating aspartate family amino acid concentration
Symptoms not in common: Death in infancy (if treated early)

+2. Phenylketonuria (PKU):
Symptoms in common: Seizure, Motor delay, Abnormal circulating aspartate family amino acid concentration
Symptoms not in common: Death in infancy (if treated early)

+3. Nonketotic Hyperglycinemia:
Symptoms in common: Seizure, Motor delay, Abnormal circulating aspartate family amino acid concentration
Symptoms not in common: Death in infancy (if treated early)

+4. Glutaric Aciduria Type 1:
Symptoms in common: Seizure, Motor delay, Abnormal circulating aspartate family amino acid concentration
Symptoms not in common: Death in infancy (if treated early)

+5. Methylmalonic Acidemia:
Symptoms in common: Seizure, Motor delay, Abnormal circulating aspartate family amino acid concentration
Symptoms not in common: Death in infancy (if treated early)

Please note that these are just potential diagnoses based on the provided symptoms, and further testing and evaluation would be required to confirm the specific condition."
['Isovaleric acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Glycine Encephalopathy (NKH/GLDC): This is a rare inherited disorder that affects the metabolism of glycine, leading to an accumulation of the amino acid in the body. Symptoms include neonatal death, developmental delay, seizures, and abnormal circulating glycine concentration.
Symptoms in common: Abnormal circulating glycine concentration, Neonatal death, Death in infancy, Death in childhood.
Symptoms not in common: Fever, Vomiting, Diarrhea, Abdominal pain, Gastrointestinal inflammation, Recurrent viral infections, Abnormal circulating carnitine concentration, Death in adolescence, Body odor.

+2. Primary Carnitine Deficiency: This is a rare genetic disorder that affects the body's ability to transport and use carnitine, a nutrient essential for energy production. Symptoms include low carnitine levels, weakness, hypoglycemia, and cardiomyopathy.
Symptoms in common: Abnormal circulating carnitine concentration.
Symptoms not in common: Death in infancy, Fever, Vomiting, Diarrhea, Abdominal pain, Neonatal death, Death in childhood, Gastrointestinal inflammation, Recurrent viral infections, Abnormal circulating glycine concentration, Death in adolescence, Body odor.

+3. Severe Combined Immunodeficiency (SCID): This is a group of rare genetic disorders characterized by a deficiency in the immune system, making individuals highly susceptible to infections. Symptoms include recurrent viral, bacterial, and fungal infections, failure to thrive, and chronic diarrhea.
Symptoms in common: Recurrent viral infections, Diarrhea.
Symptoms not in common: Death in infancy, Fever, Vomiting, Abdominal pain, Neonatal death, Death in childhood, Gastrointestinal inflammation, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration, Death in adolescence, Body odor.

+4. Inflammatory Bowel Disease (IBD): This is a group of chronic inflammatory disorders that affect the gastrointestinal tract, including Crohn's disease and ulcerative colitis. Symptoms include abdominal pain, diarrhea, gastrointestinal inflammation, and recurrent infections.
Symptoms in common: Diarrhea, Abdominal pain, Gastrointestinal inflammation, Recurrent viral infections.
Symptoms not in common: Death in infancy, Fever, Vomiting, Neonatal death, Death in childhood, Abnormal circulating glycine concentration, Abnormal circulating carnitine concentration, Death in adolescence, Body odor.

Please note that this is a preliminary assessment based on the provided symptoms, and further diagnostic tests and evaluations may be necessary to confirm or rule out any specific condition."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a rare inherited disorder characterized by the inability to break down the amino acid phenylalanine. Symptoms the patient has in common: Intellectual disability, Hypertyrosinemia, Hyperphenylalaninemia. Symptoms the patient does not have: Hypertension, Obesity, Death in adolescence, Elevated urinary carboxylic acid, Death in early adulthood.

+2. Maple Syrup Urine Disease (MSUD):
A rare inherited disorder that affects the body's ability to break down certain amino acids, leading to a buildup of toxic substances. Symptoms the patient has in common: Intellectual disability, Elevated urinary carboxylic acid. Symptoms the patient does not have: Hypertension, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+3. Prader-Willi Syndrome:
A rare genetic disorder characterized by intellectual disability, insatiable appetite leading to obesity, and other physical and behavioral problems. Symptoms the patient has in common: Intellectual disability, Obesity. Symptoms the patient does not have: Hypertension, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Elevated urinary carboxylic acid, Death in early adulthood.

+4. Congenital Adrenal Hyperplasia (CAH):
A group of inherited disorders affecting the adrenal glands, leading to an imbalance of hormones. Symptoms the patient has in common: Hypertension, Obesity. Symptoms the patient does not have: Intellectual disability, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Elevated urinary carboxylic acid, Death in early adulthood.

+5. Organic Acidemias:
A group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms the patient has in common: Intellectual disability, Elevated urinary carboxylic acid. Symptoms the patient does not have: Hypertension, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

Please note that a proper diagnosis would require further medical evaluation, including laboratory tests and a comprehensive medical history."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder characterized by the body's inability to break down certain amino acids, including leucine, isoleucine, and valine. Symptoms the patient has in common: Hyperalaninemia (elevated levels of the amino acid alanine), small for gestational age, and potential neonatal or childhood death. Symptoms the patient does not have in common: Severe hearing impairment, abnormality of prenatal development or birth.

+2. Carnitine Deficiency:
This condition is caused by a deficiency in the production or transportation of carnitine, a compound essential for energy production in cells. Symptoms the patient has in common: Abnormal circulating carnitine concentration, potential neonatal or childhood death. Symptoms the patient does not have in common: Hyperalaninemia, severe hearing impairment, abnormality of prenatal development or birth, small for gestational age.

+3. Congenital Hearing Loss:
This refers to hearing loss present at birth or shortly after birth, which can be caused by genetic or environmental factors. Symptoms the patient has in common: Severe hearing impairment. Symptoms the patient does not have in common: Hyperalaninemia, abnormal circulating carnitine concentration, abnormality of prenatal development or birth, small for gestational age, neonatal or childhood death.

+4. Intrauterine Growth Restriction (IUGR):
This condition occurs when a baby does not grow to its normal potential size during pregnancy, often due to genetic or environmental factors. Symptoms the patient has in common: Small for gestational age, potential abnormality of prenatal development or birth. Symptoms the patient does not have in common: Hyperalaninemia, abnormal circulating carnitine concentration, severe hearing impairment, neonatal or childhood death.

Please note that a proper diagnosis would require additional information, such as medical history, laboratory tests, and a physical examination. This list is based solely on the provided symptoms and is not a definitive diagnosis."
['Ornithine transcarbamylase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Ornithine Transcarbamylase Deficiency (OTC Deficiency): A rare genetic disorder characterized by the accumulation of ammonia in the blood due to a deficiency of the enzyme ornithine transcarbamylase. Symptoms in common: Lethargy, Drowsiness, Abnormal circulating ornithine concentration. Symptoms not in common: Death in infancy, Sleep abnormality, Oroticaciduria.

+2. Urea Cycle Disorders: A group of inherited metabolic disorders that affect the body's ability to remove ammonia from the bloodstream. Symptoms in common: Lethargy, Drowsiness, Abnormal circulating ornithine concentration. Symptoms not in common: Death in infancy, Sleep abnormality, Oroticaciduria.

+3. Citrullinemia: A rare inherited disorder caused by a deficiency of the enzyme argininosuccinate synthetase, which is involved in the urea cycle. Symptoms in common: Lethargy, Drowsiness, Abnormal circulating ornithine concentration, Oroticaciduria. Symptoms not in common: Death in infancy, Sleep abnormality.

+4. Hyperammonemia: A metabolic disorder characterized by an excess of ammonia in the blood. Symptoms in common: Lethargy, Drowsiness. Symptoms not in common: Death in infancy, Sleep abnormality, Oroticaciduria, Abnormal circulating ornithine concentration.

+5. Inborn Errors of Metabolism: A group of genetic disorders that affect the body's ability to metabolize proteins, carbohydrates, or fats. Symptoms in common: Lethargy, Drowsiness, Abnormal circulating ornithine concentration, Oroticaciduria. Symptoms not in common: Death in infancy, Sleep abnormality.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, including a detailed medical history, physical examination, and appropriate laboratory tests."
['Glutaryl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Glutaric Aciduria Type 1: A rare inherited disorder characterized by an abnormal buildup of glutaric acid in the body. Symptoms in common: Ataxia, Dystonia, Abnormal cerebral morphology, Glutaric aciduria. Symptoms not in common: Death in childhood, Decreased plasma free carnitine, Abnormal myelination.

+2. Leukodystrophy: A group of rare, inherited disorders that affect the brain, spinal cord, and peripheral nerves. Symptoms in common: Ataxia, Dystonia, Abnormal cerebral morphology, Abnormal myelination. Symptoms not in common: Glutaric aciduria, Death in childhood, Decreased plasma free carnitine.

+3. Mitochondrial Encephalomyopathy: A group of disorders caused by mutations in the mitochondrial genome or nuclear genes that affect mitochondrial function. Symptoms in common: Ataxia, Dystonia, Abnormal cerebral morphology, Decreased plasma free carnitine. Symptoms not in common: Glutaric aciduria, Death in childhood, Abnormal myelination.

+4. Organic Acidemia: A group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms in common: Ataxia, Dystonia, Abnormal cerebral morphology, Glutaric aciduria, Decreased plasma free carnitine. Symptoms not in common: Death in childhood, Abnormal myelination.

+5. Neuronal Ceroid Lipofuscinosis: A group of inherited neurodegenerative disorders characterized by the accumulation of lipopigments in various tissues, including the brain. Symptoms in common: Ataxia, Dystonia, Abnormal cerebral morphology, Death in childhood. Symptoms not in common: Glutaric aciduria, Decreased plasma free carnitine, Abnormal myelination.

Please note that a definitive diagnosis would require further testing and evaluation by a medical professional."
['Phenylketonuria'],"Based on the provided symptoms: ['Death in infancy', 'Neonatal death', 'Hyperphenylalaninemia'], here are some potential diseases with their descriptions:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia
Symptoms not in common: Death in infancy, Neonatal death (if treated early)

+2. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Neonatal death (if untreated)
Symptoms not in common: Death in infancy, Hyperphenylalaninemia

+3. Galactosemia:
Symptoms in common: Neonatal death (if untreated)
Symptoms not in common: Death in infancy, Hyperphenylalaninemia

+4. Congenital Disorders of Glycosylation (CDG):
Symptoms in common: Death in infancy (in severe cases)
Symptoms not in common: Neonatal death, Hyperphenylalaninemia

+5. Zellweger Syndrome:
Symptoms in common: Death in infancy (in severe cases)
Symptoms not in common: Neonatal death, Hyperphenylalaninemia

Please note that a proper diagnosis requires a comprehensive evaluation, including medical history, physical examination, and additional tests. The provided symptoms are not sufficient for a definitive diagnosis."
['Systemic primary carnitine deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive loss of mental and movement abilities. Symptoms in common: Irritability, Coma, Generalized hypotonia, Encephalopathy, Vomiting. Symptoms not in common: Cardiomyopathy, Anemia, Hypoglycemia, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Death in childhood, Decreased plasma free carnitine, Abnormal circulating porphyrin concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+2. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS): A rare inherited mitochondrial disorder that affects the brain, muscles, and nervous system. Symptoms in common: Irritability, Coma, Generalized hypotonia, Encephalopathy, Vomiting, Cardiomyopathy. Symptoms not in common: Anemia, Hypoglycemia, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Death in childhood, Decreased plasma free carnitine, Abnormal circulating porphyrin concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+3. Organic Acidemias: A group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms in common: Irritability, Coma, Generalized hypotonia, Encephalopathy, Vomiting, Hypoglycemia, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Death in childhood, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. Symptoms not in common: Cardiomyopathy, Anemia, Decreased plasma free carnitine, Abnormal circulating porphyrin concentration.

+4. Acute Intermittent Porphyria: A rare inherited metabolic disorder that affects the production of heme, a component of hemoglobin. Symptoms in common: Irritability, Coma, Generalized hypotonia, Encephalopathy, Vomiting, Abdominal pain, Abnormal circulating porphyrin concentration. Symptoms not in common: Cardiomyopathy, Anemia, Hypoglycemia, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Death in childhood, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration."
['PMM2-CDG'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Ataxia-Telangiectasia: This is a rare, neurodegenerative disorder characterized by progressive cerebellar ataxia, oculomotor apraxia, choreoathetosis, telangiectasias, immunodeficiency, and a predisposition to malignancies. Symptoms in common: Ataxia, Hyporeflexia, Cerebellar atrophy. Symptoms not in common: Strabismus, Nystagmus, Motor delay, Generalized hypotonia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+2. Joubert Syndrome: A rare genetic disorder characterized by abnormal brain development, hypotonia, ataxia, developmental delays, and a distinctive malformation of the cerebellar vermis. Symptoms in common: Ataxia, Hypotonia, Motor delay, Cerebellar agenesis. Symptoms not in common: Strabismus, Nystagmus, Hyporeflexia, Encephalopathy, Growth delay, Death in infancy.

+3. Spinocerebellar Ataxia: A group of inherited disorders characterized by progressive ataxia, dysarthria, and other neurological symptoms due to degeneration of the cerebellum and its connections. Symptoms in common: Ataxia, Hyporeflexia, Cerebellar atrophy. Symptoms not in common: Strabismus, Nystagmus, Motor delay, Generalized hypotonia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+4. Leukodystrophy: A group of genetic disorders that affect the growth and development of the myelin sheath that insulates nerve fibers in the brain and spinal cord. Symptoms in common: Ataxia, Hyporeflexia, Motor delay, Encephalopathy, Growth delay. Symptoms not in common: Strabismus, Nystagmus, Generalized hypotonia, Cerebellar atrophy, Death in infancy, Cerebellar agenesis.

+5. Congenital Muscular Dystrophy: A group of inherited disorders characterized by muscle weakness and hypotonia present at birth or early infancy, often with associated brain and eye abnormalities. Symptoms in common: Hypotonia, Motor delay, Encephalopathy, Growth delay. Symptoms not in common: Strabismus, Nystagmus, Ataxia, Hyporeflexia, Cerebellar atrophy, Death in infancy, Cerebellar agenesis.

Please note that a proper diagnosis would require a comprehensive medical evaluation, including a detailed medical history, physical examination, and potentially additional tests or imaging studies."
['Classic homocystinuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Marfan Syndrome: A genetic disorder that affects the body's connective tissues, leading to abnormalities in the skeletal system, cardiovascular system, and eyes. The patient has the symptom 'Ectopia lentis' (dislocation of the eye lens) in common with this condition, but does not exhibit other common symptoms like tall stature, arachnodactyly (long, slender fingers), or cardiovascular complications.

+2. Homocystinuria: A rare inherited metabolic disorder characterized by the accumulation of homocysteine in the blood and urine. The patient has symptoms like 'Hyperhomocystinemia' (elevated homocysteine levels), 'Hypermethioninemia' (elevated methionine levels), and 'Aminoaciduria' (presence of amino acids in urine) in common with this condition. However, other symptoms like developmental delays, intellectual disability, and skeletal abnormalities are not specified.

+3. Phenylketonuria (PKU): An inherited metabolic disorder in which the body cannot break down the amino acid phenylalanine. The patient does not exhibit the characteristic symptoms of PKU, such as fair skin, blue eyes, musty odor, and developmental delays.

+4. Maple Syrup Urine Disease (MSUD): A rare inherited metabolic disorder characterized by the inability to break down certain amino acids. The patient does not exhibit the characteristic symptoms of MSUD, such as a maple syrup-like odor in urine, poor feeding, lethargy, and developmental delays.

+5. Lesch-Nyhan Syndrome: A rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). The patient does not exhibit the characteristic symptoms of Lesch-Nyhan Syndrome, such as self-mutilating behavior, gout, and neurological abnormalities.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided information is limited, and further investigation may be necessary to determine the underlying condition accurately."
['Ornithine transcarbamylase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Ornithine Transcarbamylase Deficiency (OTC Deficiency): A rare inherited disorder characterized by the accumulation of ammonia in the blood (hyperammonemia), which can lead to neurological symptoms such as seizures, lethargy, ataxia, and coma. Symptoms in common: Seizure, Ataxia, Lethargy, Hyperammonemia. Symptoms not in common: Metabolic acidosis, Fever, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence.

+2. Leigh Syndrome: A severe neurological disorder caused by genetic mutations that affect the body's ability to produce energy. Symptoms may include seizures, ataxia, lethargy, hyperreflexia, metabolic acidosis, and respiratory difficulties. Symptoms in common: Seizure, Ataxia, Lethargy, Hyperreflexia, Metabolic acidosis. Symptoms not in common: Fever, Hyperammonemia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence.

+3. Urea Cycle Disorders: A group of inherited metabolic disorders characterized by the inability to break down and remove ammonia from the body, leading to hyperammonemia and neurological symptoms such as seizures, lethargy, and coma. Symptoms in common: Seizure, Lethargy, Hyperammonemia. Symptoms not in common: Ataxia, Hyperreflexia, Metabolic acidosis, Fever, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence.

+4. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS): A rare inherited mitochondrial disorder that affects the body's ability to produce energy, leading to various symptoms such as seizures, ataxia, lethargy, metabolic acidosis, and stroke-like episodes. Symptoms in common: Seizure, Ataxia, Lethargy, Metabolic acidosis. Symptoms not in common: Hyperreflexia, Fever, Hyperammonemia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence.

+5. Spinal Muscular Atrophy (SMA): A genetic disorder characterized by progressive muscle weakness and atrophy, which can lead to respiratory difficulties, fasciculations, and in severe cases, death in childhood or adolescence. Symptoms in common: Fasciculations, Death in childhood, Death in adolescence. Symptoms not in common: Seizure, Ataxia, Lethargy, Hyperreflexia, Metabolic acidosis, Fever, Hyperammonemia, Diarrhea, Drowsiness, Sleep abnormality, Oroticaciduria.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided information is for educational purposes only and should not be considered a substitute for professional medical advice."
['Smith-Lemli-Opitz syndrome'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Smith-Lemli-Opitz Syndrome (SLOS): A rare genetic disorder characterized by intellectual disability, microcephaly, syndactyly, and distinctive facial features such as a small chin and ptosis. Symptoms in common: Microcephaly, pointed chin, short chin, strabismus, ptosis, syndactyly, intellectual disability, failure to thrive, hypocholesterolemia, elevated 8-dehydrocholesterol, feeding difficulties. Symptoms not in common: Hyperactivity, ataxia, generalized hypotonia, hyperreflexia, death in infancy, death in childhood, elevated circulating 7-dehydrocholesterol concentration, fatigue.

+2. Down Syndrome: A genetic disorder caused by the presence of an extra copy of chromosome 21, leading to intellectual disability, distinctive facial features, and various medical complications. Symptoms in common: Intellectual disability, strabismus, hypotonia, hyperreflexia, failure to thrive, feeding difficulties. Symptoms not in common: Microcephaly, pointed chin, short chin, ptosis, hyperactivity, syndactyly, ataxia, death in infancy, hypocholesterolemia, elevated 8-dehydrocholesterol, death in childhood, elevated circulating 7-dehydrocholesterol concentration, fatigue.

+3. Angelman Syndrome: A rare genetic disorder characterized by intellectual disability, ataxic movements, speech impairment, and a happy demeanor with frequent laughter. Symptoms in common: Intellectual disability, ataxia, hyperactivity. Symptoms not in common: Microcephaly, pointed chin, short chin, strabismus, ptosis, syndactyly, generalized hypotonia, hyperreflexia, failure to thrive, death in infancy, hypocholesterolemia, elevated 8-dehydrocholesterol, death in childhood, elevated circulating 7-dehydrocholesterol concentration, feeding difficulties, fatigue.

+4. Prader-Willi Syndrome: A rare genetic disorder characterized by hypotonia, intellectual disability, short stature, and an insatiable appetite leading to obesity. Symptoms in common: Intellectual disability, generalized hypotonia, failure to thrive, feeding difficulties. Symptoms not in common: Microcephaly, pointed chin, short chin, strabismus, ptosis, hyperactivity, syndactyly, ataxia, hyperreflexia, death in infancy, hypocholesterolemia, elevated 8-dehydrocholesterol, death in childhood, elevated circulating 7-dehydrocholesterol concentration, fatigue."
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive loss of mental and movement abilities. It is characterized by degeneration of the brain stem, optic atrophy, and respiratory irregularities.
Symptoms in common: Generalized hypotonia, increased circulating lactate concentration, neonatal death.
Symptoms not in common: Hypertriglyceridemia, hepatomegaly, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, increased circulating lactate dehydrogenase concentration, abnormal circulating creatine kinase concentration.

+2. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS): A rare inherited mitochondrial disorder that affects the brain, muscles, and nervous system. It is characterized by stroke-like episodes, seizures, and lactic acidosis.
Symptoms in common: Generalized hypotonia, increased circulating lactate concentration, increased circulating lactate dehydrogenase concentration.
Symptoms not in common: Death in infancy, hypertriglyceridemia, hepatomegaly, neonatal death, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, abnormal circulating creatine kinase concentration.

+3. Fatty Acid Oxidation Disorders: A group of inherited metabolic disorders that affect the body's ability to break down fatty acids for energy. They can cause hypoglycemia, liver dysfunction, and cardiomyopathy.
Symptoms in common: Hypertriglyceridemia, hepatomegaly, increased circulating lactate concentration, abnormal circulating creatine kinase concentration.
Symptoms not in common: Generalized hypotonia, death in infancy, neonatal death, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, increased circulating lactate dehydrogenase concentration.

+4. Organic Acidemias: A group of inherited metabolic disorders that involve the accumulation of organic acids in the body due to enzyme deficiencies. They can cause developmental delays, seizures, and metabolic crises.
Symptoms in common: Generalized hypotonia, increased circulating lactate concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration.
Symptoms not in common: Death in infancy, hypertriglyceridemia, hepatomegaly, neonatal death, increased circulating lactate dehydrogenase concentration, abnormal circulating creatine kinase concentration.

Please note that a definitive diagnosis would require further testing and evaluation by a medical professional based on the patient's complete medical history and clinical presentation."
['Glutaryl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Glutaric Aciduria Type 1:
This is a rare inherited disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, which is involved in the breakdown of certain amino acids. Symptoms include: Generalized hypotonia, Cerebral cortical atrophy, Glutaric aciduria, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration. The patient does not exhibit Microcephaly, Death in infancy, Athetosis, Neonatal death, or Death in adolescence.

+2. Leigh Syndrome:
This is a rare inherited neurometabolic disorder that affects the central nervous system. Symptoms include: Generalized hypotonia, Cerebral cortical atrophy, Athetosis, Neonatal death, Death in infancy, Death in adolescence. The patient does not exhibit Microcephaly, Glutaric aciduria, or Decreased plasma free carnitine.

+3. Zellweger Syndrome:
This is a rare inherited disorder characterized by a lack of peroxisomes, which are essential cell structures. Symptoms include: Microcephaly, Generalized hypotonia, Cerebral cortical atrophy, Neonatal death, Death in infancy. The patient does not exhibit Athetosis, Glutaric aciduria, Decreased plasma free carnitine, or Death in adolescence.

+4. Lesch-Nyhan Syndrome:
This is a rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). Symptoms include: Generalized hypotonia, Cerebral cortical atrophy, Athetosis. The patient does not exhibit Microcephaly, Death in infancy, Glutaric aciduria, Neonatal death, Decreased plasma free carnitine, or Death in adolescence.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests, imaging studies, and a detailed medical history. This list is based solely on the provided symptoms and is not a definitive diagnosis."
['Propionic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Nonketotic Hyperglycinemia (NKH):
This is a rare inherited metabolic disorder characterized by abnormally high levels of glycine in the body. Symptoms include hyperglycinemia, hyperglycinuria, lethargy, seizures, and developmental delays. The patient has the symptoms of hyperglycinemia and hyperglycinuria, which are consistent with NKH.

+2. Urea Cycle Disorders:
These are a group of inherited metabolic disorders that affect the body's ability to remove ammonia from the bloodstream. Symptoms may include hyperammonemia, vomiting, lethargy, and developmental delays. The patient has the symptoms of hyperammonemia and vomiting, which could indicate a urea cycle disorder.

+3. Organic Acidemias:
These are a group of inherited metabolic disorders that result in the accumulation of organic acids in the body. Symptoms may include vomiting, lethargy, developmental delays, and elevated levels of specific organic acids in the urine. The patient has the symptom of elevated urinary carboxylic acid, which could suggest an organic acidemia.

+4. Ichthyosis:
This is a group of genetic skin disorders characterized by dry, thickened, and scaly skin. The patient has the symptom of ichthyosis, which is consistent with this group of disorders.

+5. Fatty Acid Oxidation Disorders:
These are a group of inherited metabolic disorders that affect the body's ability to break down fatty acids for energy. Symptoms may include vomiting, lethargy, developmental delays, and abnormal levels of specific metabolites in the blood or urine. The patient has the symptom of abnormal circulating carnitine concentration, which could indicate a fatty acid oxidation disorder.

It's important to note that further diagnostic tests and a comprehensive medical evaluation would be necessary to confirm or rule out any of these potential diseases."
['Succinic semialdehyde dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Down Syndrome: A genetic disorder caused by the presence of an extra copy of chromosome 21, leading to intellectual disability, developmental delays, and characteristic facial features.
Symptoms in common: Intellectual disability, Motor delay, Abnormal facial shape
Symptoms not in common: Abnormal calvaria morphology, Death in childhood, Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid

+2. Inborn Errors of Metabolism: A group of inherited disorders that affect the body's ability to metabolize specific substances, often leading to the accumulation of toxic compounds.
Symptoms in common: Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid
Symptoms not in common: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology, Death in childhood

+3. Craniosynostosis: A condition where one or more of the fibrous joints between the bones of the baby's skull close prematurely, leading to an abnormal head shape and potential complications.
Symptoms in common: Abnormal calvaria morphology, Abnormal facial shape
Symptoms not in common: Intellectual disability, Motor delay, Death in childhood, Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid

+4. Severe Congenital Malformations: A broad category of birth defects that can affect various organ systems and lead to severe complications, including intellectual disability, developmental delays, and potential early death.
Symptoms in common: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology, Death in childhood
Symptoms not in common: Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid

+5. Organic Acidemias: A group of inherited metabolic disorders characterized by the accumulation of organic acids in the body, often leading to neurological symptoms and other complications.
Symptoms in common: Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid
Symptoms not in common: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology, Death in childhood

Please note that a proper diagnosis would require a comprehensive medical evaluation, including a detailed medical history, physical examination, and potentially additional tests or investigations."
['Classic galactosemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Galactosemia: A rare genetic disorder in which the body is unable to metabolize galactose, a sugar found in milk and dairy products. Symptoms include vomiting, diarrhea, jaundice, hepatic failure, and developmental delays.
Symptoms in common: Delayed speech and language development, Intellectual disability, Motor delay, Hepatic failure, Diarrhea, Increased total bilirubin, Abnormality of galactoside metabolism, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Hypergalactosemia.
Symptoms not in common: Death in infancy, Premature birth, Neonatal death, Death in childhood, Prolonged partial thromboplastin time.

+2. Maple Syrup Urine Disease (MSUD): A rare inherited disorder in which the body is unable to break down certain amino acids, leading to a buildup of toxic substances. Symptoms include developmental delays, seizures, and a distinctive maple syrup odor in urine and earwax.
Symptoms in common: Delayed speech and language development, Intellectual disability, Motor delay, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.
Symptoms not in common: Hepatic failure, Death in infancy, Premature birth, Diarrhea, Increased total bilirubin, Prolonged partial thromboplastin time, Neonatal death, Death in childhood, Abnormality of galactoside metabolism, Hypergalactosemia.

+3. Crigler-Najjar Syndrome: A rare inherited disorder characterized by an inability to metabolize bilirubin, leading to severe jaundice and potential brain damage.
Symptoms in common: Increased total bilirubin.
Symptoms not in common: Delayed speech and language development, Intellectual disability, Motor delay, Hepatic failure, Death in infancy, Premature birth, Diarrhea, Prolonged partial thromboplastin time, Neonatal death, Death in childhood, Abnormality of galactoside metabolism, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Hypergalactosemia."
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Propionic Acidemia: A rare inherited disorder characterized by the abnormal buildup of propionic acid and other related compounds in the body. The patient has symptoms such as 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hyperammonemia', 'Aminoaciduria', 'Neonatal death', and 'Death in childhood', which are consistent with this disease. However, the symptoms 'Abnormal circulating proline concentration' and 'Elevated plasma citrulline' are not typically associated with Propionic Acidemia.

+2. Methylmalonic Acidemia: An inherited metabolic disorder characterized by the inability to properly metabolize certain proteins and fats. The patient has symptoms such as 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hyperammonemia', 'Aminoaciduria', 'Neonatal death', and 'Death in childhood', which are consistent with this disease. However, the symptoms 'Abnormal circulating proline concentration' and 'Elevated plasma citrulline' are not typically associated with Methylmalonic Acidemia.

+3. Urea Cycle Disorders: A group of inherited metabolic disorders that affect the body's ability to remove ammonia from the bloodstream. The patient has symptoms such as 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hyperammonemia', 'Aminoaciduria', 'Neonatal death', 'Death in childhood', and 'Elevated plasma citrulline', which are consistent with Urea Cycle Disorders. However, the symptom 'Abnormal circulating proline concentration' is not typically associated with these disorders.

+4. Maple Syrup Urine Disease: A rare inherited disorder that affects the body's ability to break down certain amino acids. The patient has symptoms such as 'Abnormality of prenatal development or birth', 'Death in infancy', 'Aminoaciduria', 'Neonatal death', and 'Death in childhood', which are consistent with this disease. However, the symptoms 'Hyperammonemia', 'Abnormal circulating proline concentration', and 'Elevated plasma citrulline' are not typically associated with Maple Syrup Urine Disease.

It's important to note that a definitive diagnosis would require further testing and evaluation by a medical professional. These potential diseases are based solely on the provided symptoms."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder characterized by the body's inability to break down certain amino acids, leading to a buildup of toxic substances. Symptoms include fever, recurrent viral infections, and elevated levels of certain amino acids like leucine, isoleucine, and valine in the blood and urine.
Common symptoms: Fever, recurrent viral infections.
Uncommon symptoms: Death in infancy, death in childhood, death in adolescence, hypertyrosinemia, hyperphenylalaninemia, abnormal circulating porphyrin concentration, decreased circulating ferritin concentration, elevated urinary carboxylic acid.

+2. Tyrosinemia Type I:
This is a rare inherited disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase (FAH), which is involved in the breakdown of tyrosine. Symptoms include hypertyrosinemia, abnormal circulating porphyrin concentration, and elevated urinary carboxylic acid.
Common symptoms: Hypertyrosinemia, abnormal circulating porphyrin concentration, elevated urinary carboxylic acid.
Uncommon symptoms: Death in infancy, fever, death in childhood, recurrent viral infections, hyperphenylalaninemia, death in adolescence, decreased circulating ferritin concentration.

+3. Phenylketonuria (PKU):
This is an inherited disorder characterized by the inability to break down the amino acid phenylalanine, leading to its buildup in the body. Symptoms include hyperphenylalaninemia, developmental delays, and neurological problems.
Common symptoms: Hyperphenylalaninemia.
Uncommon symptoms: Death in infancy, fever, hypertyrosinemia, death in childhood, recurrent viral infections, abnormal circulating porphyrin concentration, death in adolescence, decreased circulating ferritin concentration, elevated urinary carboxylic acid.

+4. Hereditary Hemochromatosis:
This is a genetic disorder characterized by excessive absorption and accumulation of iron in the body, leading to organ damage. Symptoms include decreased circulating ferritin concentration, fatigue, joint pain, and liver problems.
Common symptoms: Decreased circulating ferritin concentration.
Uncommon symptoms: Death in infancy, fever, hypertyrosinemia, death in childhood, recurrent viral infections, hyperphenylalaninemia, abnormal circulating porphyrin concentration, death in adolescence, elevated urinary carboxylic acid.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a thorough examination by a qualified healthcare professional."
['Maple syrup urine disease'],"Based on the symptoms provided, here are some potential diseases with their descriptions:

+1. Maple Syrup Urine Disease (MSUD):
Common Symptoms: Lethargy, Generalized hypotonia, Tremor, Neonatal death, Abnormal circulating leucine concentration, Elevated urinary carboxylic acid, Body odor
Uncommon Symptoms: Death in infancy, Opisthotonus, Drowsiness, Sleep abnormality

+2. Leigh Syndrome:
Common Symptoms: Lethargy, Generalized hypotonia, Tremor, Death in infancy, Opisthotonus, Drowsiness, Sleep abnormality
Uncommon Symptoms: Neonatal death, Abnormal circulating leucine concentration, Elevated urinary carboxylic acid, Body odor

+3. Nonketotic Hyperglycinemia:
Common Symptoms: Lethargy, Generalized hypotonia, Tremor, Opisthotonus, Drowsiness, Sleep abnormality, Neonatal death
Uncommon Symptoms: Death in infancy, Abnormal circulating leucine concentration, Elevated urinary carboxylic acid, Body odor

+4. Glutaric Aciduria Type 1:
Common Symptoms: Lethargy, Generalized hypotonia, Tremor, Opisthotonus, Drowsiness, Elevated urinary carboxylic acid
Uncommon Symptoms: Death in infancy, Sleep abnormality, Neonatal death, Abnormal circulating leucine concentration, Body odor

+5. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS):
Common Symptoms: Lethargy, Generalized hypotonia, Tremor, Opisthotonus, Drowsiness, Sleep abnormality
Uncommon Symptoms: Death in infancy, Neonatal death, Abnormal circulating leucine concentration, Elevated urinary carboxylic acid, Body odor

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, including detailed medical history, physical examination, and appropriate laboratory tests."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder characterized by the inability to break down certain amino acids, leading to a buildup of toxic substances in the body. Common symptoms include:
- Hyperphenylalaninemia (Present)
- Neonatal death (Present)
- Generalized hypotonia (Present)

+2. Hereditary Fructose Intolerance:
A genetic disorder that affects the metabolism of fructose, a type of sugar found in many foods. Symptoms may include:
- Neonatal death (Present)
- Generalized hypotonia (Present)
- Anemia (Present)

+3. Congenital Disorders of Glycosylation (CDG):
A group of rare inherited metabolic disorders that affect the glycosylation process, which is essential for the proper functioning of many proteins. Symptoms can include:
- Generalized hypotonia (Present)
- Premature birth (Present)
- Anemia (Present)

+4. Iron Deficiency Anemia:
A condition caused by a lack of iron in the body, which is necessary for the production of hemoglobin. Symptoms may include:
- Anemia (Present)
- Decreased circulating ferritin concentration (Present)
- Decreased serum iron (Present)

+5. Vitamin D Deficiency:
A condition resulting from inadequate levels of vitamin D, which is essential for calcium absorption and bone health. Symptoms can include:
- Abnormality of vitamin D metabolism (Present)
- Anemia (Present)
- Generalized hypotonia (Possible)

It's important to note that a proper diagnosis should be made by a qualified medical professional after a thorough examination and appropriate tests."
['Smith-Lemli-Opitz syndrome'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Smith-Lemli-Opitz Syndrome (SLOS): A rare genetic disorder characterized by intellectual disability, delayed growth and development, behavioral problems, and multiple congenital anomalies. Symptoms in common: Intellectual disability, delayed speech and language development, hyperactivity, syndactyly, seizures, motor delay. Symptoms not in common: Hypertelorism, anteverted nares, self-mutilation, death in infancy, abnormal foot morphology, hypocholesterolemia, elevated 8-dehydrocholesterol, neonatal death, death in childhood, elevated circulating 7-dehydrocholesterol concentration, severe hearing impairment.

+2. Lesch-Nyhan Syndrome: A rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). Symptoms in common: Self-mutilation, intellectual disability, delayed speech and language development, hyperactivity, motor delay. Symptoms not in common: Hypertelorism, anteverted nares, syndactyly, seizures, death in infancy, abnormal foot morphology, hypocholesterolemia, elevated 8-dehydrocholesterol, neonatal death, death in childhood, elevated circulating 7-dehydrocholesterol concentration, severe hearing impairment.

+3. Cornelia de Lange Syndrome: A rare genetic disorder characterized by distinctive facial features, growth delays, intellectual disability, and limb abnormalities. Symptoms in common: Intellectual disability, delayed speech and language development, syndactyly, abnormal foot morphology. Symptoms not in common: Hypertelorism, anteverted nares, self-mutilation, hyperactivity, seizures, motor delay, death in infancy, hypocholesterolemia, elevated 8-dehydrocholesterol, neonatal death, death in childhood, elevated circulating 7-dehydrocholesterol concentration, severe hearing impairment.

+4. Angelman Syndrome: A rare genetic disorder characterized by intellectual disability, developmental delays, speech impairment, and a happy demeanor. Symptoms in common: Intellectual disability, delayed speech and language development, motor delay. Symptoms not in common: Hypertelorism, anteverted nares, self-mutilation, hyperactivity, syndactyly, seizures, death in infancy, abnormal foot morphology, hypocholesterolemia, elevated 8-dehydrocholesterol, neonatal death, death in childhood, elevated circulating 7-dehydrocholesterol concentration, severe hearing impairment."
['Vitamin B12-unresponsive methylmalonic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Methylmalonic acidemia: This is a genetic disorder characterized by the inability to properly metabolize certain proteins and fats, leading to a buildup of methylmalonic acid in the body. Symptoms the patient has in common with this disease include microcephaly, intellectual disability, motor delay, failure to thrive, metabolic acidosis, hypoglycemia, hyperammonemia, methylmalonic acidemia, hyperglycinuria, increased blood urea nitrogen, decreased methylmalonyl-CoA mutase activity, elevated circulating creatinine concentration, neonatal death, death in childhood, feeding difficulties, methylmalonic aciduria, and elevated urinary carboxylic acid.

+2. Propionic acidemia: This is another genetic disorder that affects the metabolism of certain proteins and fats, leading to a buildup of propionic acid in the body. Symptoms the patient has in common with this disease include microcephaly, intellectual disability, motor delay, failure to thrive, metabolic acidosis, hypoglycemia, hyperammonemia, hyperglycinemia, increased blood urea nitrogen, elevated circulating creatinine concentration, neonatal death, death in childhood, feeding difficulties, and elevated urinary carboxylic acid.

+3. Organic acidemias: This is a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to deficiencies in specific enzymes. Symptoms the patient has in common with these disorders include microcephaly, intellectual disability, motor delay, failure to thrive, metabolic acidosis, hypoglycemia, hyperammonemia, hyperglycinemia, increased blood urea nitrogen, elevated circulating creatinine concentration, neonatal death, death in childhood, feeding difficulties, and elevated urinary carboxylic acid.

+4. Mitochondrial disorders: These are a group of genetic disorders that affect the mitochondria, which are the powerhouses of cells responsible for energy production. Symptoms the patient has in common with these disorders include microcephaly, intellectual disability, motor delay, failure to thrive, metabolic acidosis, hypoglycemia, hyperammonemia, increased circulating lactate concentration, neonatal death, and death in childhood.

+5. Urea cycle disorders: These are a group of genetic disorders that affect the body's ability to remove ammonia, a waste product of protein metabolism. Symptoms the patient has in common with these disorders include microcephaly, intellectual disability, motor delay, failure to thrive, metabolic acidosis, hyperammonemia, neonatal death, and death in childhood.

Please note that a proper diagnosis would require additional tests and a thorough evaluation by a medical professional."
[],"Based on the provided symptoms: ['Ataxia', 'Lethargy', 'Generalized hypotonia', 'Death in infancy', 'Drowsiness', 'Sleep abnormality', 'Abnormal circulating pyrimidine concentration', 'Uraciluria'], here are some potential diseases with their descriptions:

+1. Lesch-Nyhan syndrome: This is a rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT). Symptoms in common: Ataxia, lethargy, generalized hypotonia, abnormal circulating pyrimidine concentration, and uraciluria. Symptoms not in common: Death in infancy, drowsiness, and sleep abnormality (although sleep disturbances can occur).

+2. Pyrimidine degradation defects: These are a group of inherited metabolic disorders that affect the breakdown of pyrimidines, which are building blocks of DNA and RNA. Symptoms in common: Abnormal circulating pyrimidine concentration and uraciluria. Symptoms not in common: Ataxia, lethargy, generalized hypotonia, death in infancy, drowsiness, and sleep abnormality.

+3. Mitochondrial encephalomyopathy: This is a group of disorders caused by dysfunction of the mitochondria, which are the powerhouses of cells. Symptoms in common: Ataxia, lethargy, generalized hypotonia, and drowsiness. Symptoms not in common: Death in infancy, sleep abnormality, abnormal circulating pyrimidine concentration, and uraciluria.

+4. Leigh syndrome: This is a rare inherited neurometabolic disorder that affects the central nervous system. Symptoms in common: Ataxia, lethargy, generalized hypotonia, and drowsiness. Symptoms not in common: Death in infancy, sleep abnormality, abnormal circulating pyrimidine concentration, and uraciluria.

+5. Congenital disorders of glycosylation: These are a group of inherited metabolic disorders that affect the glycosylation process, which is the addition of sugar molecules to proteins and lipids. Symptoms in common: Ataxia, lethargy, generalized hypotonia, and sleep abnormality. Symptoms not in common: Death in infancy, drowsiness, abnormal circulating pyrimidine concentration, and uraciluria.

Please note that further diagnostic tests and evaluations would be necessary to confirm or rule out these potential diseases based on the presented symptoms."
['Isovaleric acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Glycine Encephalopathy (Non-Ketotic Hyperglycinemia):
This is a rare inherited disorder characterized by abnormally high levels of glycine in the body fluids and tissues. Symptoms include abnormality of prenatal development or birth, neonatal death, death in infancy or childhood, hyperammonemia, and abnormal circulating glycine concentration. The patient has all of these symptoms in common with this disease.

+2. Carnitine Deficiency:
This is a condition in which the body is unable to transport fatty acids into the mitochondria for energy production due to a lack of carnitine. Symptoms may include abnormality of prenatal development or birth, neonatal death, death in infancy or childhood, hyperammonemia, and abnormal circulating carnitine concentration. The patient has all of these symptoms in common with this disease, except for abnormal circulating glycine concentration.

+3. Organic Acidemias:
These are a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to enzyme deficiencies. Symptoms may include abnormality of prenatal development or birth, neonatal death, death in infancy or childhood, hyperammonemia, and abnormal circulating carnitine concentration. The patient has all of these symptoms in common with these disorders, except for abnormal circulating glycine concentration.

+4. Urea Cycle Disorders:
These are a group of inherited metabolic disorders that affect the urea cycle, which is responsible for removing ammonia from the body. Symptoms may include abnormality of prenatal development or birth, neonatal death, death in infancy or childhood, hyperammonemia, and abnormal circulating carnitine concentration. The patient has all of these symptoms in common with these disorders, except for abnormal circulating glycine concentration.

+5. Mitochondrial Disorders:
These are a group of disorders caused by dysfunctional mitochondria, which are responsible for producing energy for the cells. Symptoms may include abnormality of prenatal development or birth, neonatal death, death in infancy or childhood, hyperammonemia, and abnormal circulating carnitine concentration. The patient has all of these symptoms in common with these disorders, except for abnormal circulating glycine concentration."
['Biotinidase deficiency'],"Based on the provided symptoms: ['Seizure', 'Generalized hypotonia', 'Death in infancy', 'Elevated urinary carboxylic acid'], here are some potential diseases with their descriptions:

+1. Glutaric aciduria type 1 (GA1):
Symptoms in common: Seizure, Generalized hypotonia, Elevated urinary carboxylic acid
Symptoms not in common: None mentioned

+2. Maple syrup urine disease (MSUD):
Symptoms in common: Seizure, Generalized hypotonia, Elevated urinary carboxylic acid
Symptoms not in common: Death in infancy (not always present)

+3. Propionic acidemia:
Symptoms in common: Seizure, Generalized hypotonia, Elevated urinary carboxylic acid
Symptoms not in common: Death in infancy (not always present)

+4. Methylmalonic acidemia:
Symptoms in common: Seizure, Generalized hypotonia, Elevated urinary carboxylic acid
Symptoms not in common: Death in infancy (not always present)

+5. Leigh syndrome:
Symptoms in common: Seizure, Generalized hypotonia
Symptoms not in common: Death in infancy, Elevated urinary carboxylic acid

+6. Pompe disease (Infantile-onset):
Symptoms in common: Generalized hypotonia, Death in infancy
Symptoms not in common: Seizure, Elevated urinary carboxylic acid

Please note that a definitive diagnosis would require further testing and evaluation by a medical professional."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Autism Spectrum Disorder (ASD):
Symptoms in common: Delayed speech and language development
Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Decreased plasma free carnitine, Decreased 3-hydroxyacyl-CoA dehydrogenase level

+2. Congenital Disorders:
Symptoms in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood
Symptoms not in common: Delayed speech and language development, Decreased plasma free carnitine, Decreased 3-hydroxyacyl-CoA dehydrogenase level

+3. Inborn Errors of Metabolism:
Symptoms in common: Decreased plasma free carnitine, Decreased 3-hydroxyacyl-CoA dehydrogenase level
Symptoms not in common: Delayed speech and language development, Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood

+4. Mitochondrial Disorders:
Symptoms in common: Decreased plasma free carnitine, Decreased 3-hydroxyacyl-CoA dehydrogenase level
Symptoms not in common: Delayed speech and language development, Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood

+5. Genetic Disorders:
Symptoms in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood
Symptoms not in common: Delayed speech and language development, Decreased plasma free carnitine, Decreased 3-hydroxyacyl-CoA dehydrogenase level

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required to confirm the actual diagnosis."
['Maple syrup urine disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited metabolic disorder characterized by the inability to break down certain amino acids (leucine, isoleucine, and valine). Symptoms include feeding difficulties, vomiting, lethargy, seizures, and a distinctive sweet, maple syrup-like odor in urine and body fluids. The patient has symptoms like seizures, feeding difficulties, and body odor, which are consistent with MSUD. However, some symptoms like spastic diplegia, motor delay, and hypotonia are not typically associated with MSUD.

+2. Cerebral Palsy:
This is a group of disorders that affect movement, muscle tone, and posture due to brain damage or abnormal brain development. Symptoms can include spastic diplegia (stiffness in the legs), spastic tetraplegia (stiffness in all four limbs), generalized hypotonia (low muscle tone), motor delay, and feeding difficulties. The patient has symptoms like spastic diplegia, motor delay, generalized hypotonia, and feeding difficulties, which are consistent with cerebral palsy. However, some symptoms like seizures, metabolic acidosis, and body odor are not typically associated with cerebral palsy.

+3. Leigh Syndrome:
This is a rare inherited neurometabolic disorder that affects the central nervous system. Symptoms can include hypotonia, seizures, respiratory difficulties (dyspnea, apnea), feeding difficulties, and developmental delays. The patient has symptoms like seizures, generalized hypotonia, dyspnea, apnea, feeding difficulties, and motor delay, which are consistent with Leigh syndrome. However, some symptoms like spastic diplegia, spastic tetraplegia, and body odor are not typically associated with Leigh syndrome.

+4. Organic Acidemias:
These are a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to enzyme deficiencies. Symptoms can include metabolic acidosis, seizures, hypotonia, developmental delays, feeding difficulties, and distinctive body odors. The patient has symptoms like seizures, generalized hypotonia, metabolic acidosis, feeding difficulties, and body odor, which are consistent with organic acidemias. However, some symptoms like spastic diplegia, spastic tetraplegia, and motor delay are not typically associated with organic acidemias."
['Propionic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Nonketotic Hyperglycinemia: This is a rare inherited metabolic disorder characterized by elevated levels of glycine in the body. Symptoms that match include intellectual disability, seizures (psychosis), and hyperglycinemia. Symptoms not present include osteoporosis, anemia, and others.

+2. Methylmalonic Acidemia: This is an inherited disorder of metabolism caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms that match include developmental delay (intellectual disability), seizures (psychosis), and elevated blood urea nitrogen. Symptoms not present include osteoporosis, anemia, and others.

+3. Propionic Acidemia: This is an inherited disorder of metabolism caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms that match include intellectual disability, seizures (psychosis), and elevated blood urea nitrogen. Symptoms not present include osteoporosis, anemia, and others.

+4. Homocystinuria: This is an inherited metabolic disorder characterized by an abnormally high level of homocysteine in the blood. Symptoms that match include intellectual disability, osteoporosis, and cerebral atrophy. Symptoms not present include anemia, hyperammonemia, and others.

+5. Phenylketonuria (PKU): This is an inherited metabolic disorder characterized by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms that match include intellectual disability, seizures (psychosis), and musty body odor. Symptoms not present include osteoporosis, anemia, and others.

Please note that a proper diagnosis would require additional tests and a thorough evaluation by a medical professional."
['L-2-hydroxyglutaric aciduria'],"Based on the provided symptoms: ['Intellectual disability', 'Seizure', 'Ataxia', 'Tremor', 'Death in childhood', 'L-2-hydroxyglutaric aciduria'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. L-2-Hydroxyglutaric Aciduria:
Matching symptoms: Intellectual disability, Seizure, Ataxia, Tremor, L-2-hydroxyglutaric aciduria
Non-matching symptoms: Death in childhood (not always present)

+2. Leigh Syndrome:
Matching symptoms: Intellectual disability, Seizure, Ataxia, Tremor, Death in childhood
Non-matching symptoms: L-2-hydroxyglutaric aciduria

+3. Glutaric Aciduria Type 1:
Matching symptoms: Intellectual disability, Seizure, Ataxia, Tremor
Non-matching symptoms: Death in childhood, L-2-hydroxyglutaric aciduria

+4. Mitochondrial Encephalomyopathy:
Matching symptoms: Intellectual disability, Seizure, Ataxia, Tremor
Non-matching symptoms: Death in childhood, L-2-hydroxyglutaric aciduria

+5. Neuronal Ceroid Lipofuscinosis:
Matching symptoms: Intellectual disability, Seizure, Ataxia, Tremor, Death in childhood
Non-matching symptoms: L-2-hydroxyglutaric aciduria

Please note that a definitive diagnosis would require further testing and evaluation by a medical professional. This list is based solely on the provided symptoms and is intended for informational purposes only."
['Canavan disease'],"Based on the provided symptoms: ['Motor delay', 'Death in infancy', 'Abnormal circulating aspartate family amino acid concentration'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder characterized by the body's inability to break down certain amino acids properly. Matching symptoms: 'Abnormal circulating aspartate family amino acid concentration'. Non-matching symptoms: 'Motor delay' and 'Death in infancy' are not always present in MSUD.

+2. Leigh Syndrome:
A rare inherited neurometabolic disorder that affects the central nervous system and causes progressive loss of mental and movement abilities. Matching symptoms: 'Motor delay'. Non-matching symptoms: 'Death in infancy' and 'Abnormal circulating aspartate family amino acid concentration' are not typical symptoms of Leigh Syndrome.

+3. Nonketotic Hyperglycinemia:
A rare inherited metabolic disorder characterized by an accumulation of glycine in the body fluids and tissues. Matching symptoms: 'Motor delay' and 'Death in infancy' (in severe cases). Non-matching symptoms: 'Abnormal circulating aspartate family amino acid concentration' is not a typical symptom of this disorder.

+4. Propionic Acidemia:
A rare inherited metabolic disorder in which the body is unable to process certain proteins and lipids properly, leading to a buildup of propionic acid. Matching symptoms: 'Abnormal circulating aspartate family amino acid concentration'. Non-matching symptoms: 'Motor delay' and 'Death in infancy' are not always present in Propionic Acidemia.

+5. Methylmalonic Acidemia:
Another rare inherited metabolic disorder characterized by the body's inability to break down certain proteins and lipids properly, leading to a buildup of methylmalonic acid. Matching symptoms: 'Abnormal circulating aspartate family amino acid concentration'. Non-matching symptoms: 'Motor delay' and 'Death in infancy' are not always present in Methylmalonic Acidemia.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, including detailed medical history, physical examination, and appropriate laboratory tests."
['Citrullinemia type I'],"Based on the provided symptoms: ['Death in infancy', 'Hyperammonemia', 'Increased total bilirubin', 'Neonatal death', 'Elevated plasma citrulline'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Citrullinemia type I:
Matching symptoms: Hyperammonemia, Elevated plasma citrulline
Non-matching symptoms: Death in infancy, Increased total bilirubin, Neonatal death

+2. Argininosuccinic aciduria:
Matching symptoms: Hyperammonemia, Elevated plasma citrulline
Non-matching symptoms: Death in infancy, Increased total bilirubin, Neonatal death

+3. Carbamoyl phosphate synthetase I deficiency:
Matching symptoms: Hyperammonemia, Neonatal death
Non-matching symptoms: Death in infancy, Increased total bilirubin, Elevated plasma citrulline

+4. Ornithine transcarbamylase deficiency:
Matching symptoms: Hyperammonemia, Neonatal death
Non-matching symptoms: Death in infancy, Increased total bilirubin, Elevated plasma citrulline

+5. Crigler-Najjar syndrome type I:
Matching symptoms: Increased total bilirubin, Neonatal death
Non-matching symptoms: Death in infancy, Hyperammonemia, Elevated plasma citrulline

+6. Biliary atresia:
Matching symptoms: Increased total bilirubin, Neonatal death
Non-matching symptoms: Death in infancy, Hyperammonemia, Elevated plasma citrulline

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required to confirm the actual diagnosis."
['3-hydroxy-3-methylglutaric aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Diarrhea, Drowsiness, Sleep abnormality, Dicarboxylic aciduria, Death in infancy/childhood.
Symptoms not in common: Hepatomegaly, Recurrent viral infections, Elevated urinary carboxylic acid.

+2. Methylmalonic Acidemia (MMA):
Symptoms in common: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Diarrhea, Hepatomegaly, Drowsiness, Sleep abnormality, Dicarboxylic aciduria, Death in infancy/childhood.
Symptoms not in common: 3-Methylglutaric aciduria, Recurrent viral infections, Elevated urinary carboxylic acid.

+3. Propionic Acidemia:
Symptoms in common: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Diarrhea, Hepatomegaly, Drowsiness, Sleep abnormality, Dicarboxylic aciduria, 3-Methylglutaric aciduria, Death in infancy/childhood.
Symptoms not in common: Recurrent viral infections, Elevated urinary carboxylic acid.

+4. Isovaleric Acidemia:
Symptoms in common: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Diarrhea, Hepatomegaly, Drowsiness, Sleep abnormality, Dicarboxylic aciduria, Death in infancy/childhood.
Symptoms not in common: 3-Methylglutaric aciduria, Recurrent viral infections, Elevated urinary carboxylic acid.

+5. Severe Combined Immunodeficiency (SCID):
Symptoms in common: Recurrent viral infections, Death in infancy/childhood.
Symptoms not in common: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Diarrhea, Hepatomegaly, Drowsiness, Sleep abnormality, Dicarboxylic aciduria, 3-Methylglutaric aciduria, Elevated urinary carboxylic acid."
['Cystinuria'],"Based on the provided symptoms: ['Seizure', 'Death in infancy', 'Splenomegaly', 'Respiratory insufficiency'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Niemann-Pick Disease Type C:
This is a rare inherited metabolic disorder characterized by an abnormal accumulation of cholesterol and other lipids in various tissues, including the brain, liver, and spleen. Symptoms may include seizures, progressive neurological deterioration, splenomegaly (enlarged spleen), and respiratory complications.
Matching symptoms: Seizure, Splenomegaly, Respiratory insufficiency
Non-matching symptoms: Death in infancy (although severe cases can lead to early death)

+2. Gaucher Disease:
A genetic disorder caused by a deficiency of the enzyme glucocerebrosidase, leading to the accumulation of glucocerebroside in various organs, particularly the spleen, liver, and bone marrow. Symptoms may include splenomegaly, bone pain, and respiratory problems.
Matching symptoms: Splenomegaly, Respiratory insufficiency
Non-matching symptoms: Seizure, Death in infancy

+3. Leigh Syndrome:
A rare inherited neurometabolic disorder that affects the central nervous system, particularly the brain stem and basal ganglia. Symptoms may include seizures, respiratory difficulties, and developmental delays, which can lead to early death in severe cases.
Matching symptoms: Seizure, Respiratory insufficiency, Death in infancy (in severe cases)
Non-matching symptoms: Splenomegaly

+4. Pompe Disease:
A rare inherited disorder caused by a deficiency of the enzyme acid alpha-glucosidase, leading to the accumulation of glycogen in various tissues, including skeletal and cardiac muscles. Symptoms may include respiratory difficulties, muscle weakness, and, in severe cases, early death.
Matching symptoms: Respiratory insufficiency, Death in infancy (in severe cases)
Non-matching symptoms: Seizure, Splenomegaly

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided information is for educational purposes only and should not be considered a substitute for professional medical advice."
['Vitamin B12-unresponsive methylmalonic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Methylmalonic acidemia: This is a genetic disorder characterized by the inability to properly metabolize certain proteins and fats, leading to the accumulation of methylmalonic acid in the body. Symptoms include vomiting, lethargy, hypotonia, developmental delays, and metabolic acidosis.
The patient has the following symptoms in common: Intellectual disability, Motor delay, Generalized hypotonia, Vomiting, Methylmalonic aciduria.
The patient does not have the following symptoms: Death in infancy, Hyperammonemia, Hypoproteinemia, Increased blood urea nitrogen, Hyperthreoninemia, Neonatal death, Death in childhood, Recurrent viral infections, Hypervalinemia, Abnormal circulating isoleucine concentration, Abnormal circulating carnitine concentration, Feeding difficulties, Decreased serum creatinine.

+2. Maple syrup urine disease (MSUD): This is a rare inherited disorder in which the body is unable to break down certain amino acids, leading to their accumulation in the blood and urine. Symptoms include poor feeding, vomiting, lethargy, and a distinctive maple syrup odor in the urine and earwax.
The patient has the following symptoms in common: Intellectual disability, Motor delay, Generalized hypotonia, Vomiting, Feeding difficulties, Abnormal circulating isoleucine concentration, Abnormal circulating carnitine concentration.
The patient does not have the following symptoms: Death in infancy, Hyperammonemia, Hypoproteinemia, Increased blood urea nitrogen, Hyperthreoninemia, Neonatal death, Death in childhood, Recurrent viral infections, Hypervalinemia, Methylmalonic aciduria, Decreased serum creatinine.

+3. Urea cycle disorders: These are a group of genetic disorders that affect the body's ability to remove ammonia from the blood. Symptoms can include vomiting, lethargy, intellectual disability, and respiratory distress.
The patient has the following symptoms in common: Intellectual disability, Motor delay, Generalized hypotonia, Vomiting, Hyperammonemia, Increased blood urea nitrogen.
The patient does not have the following symptoms: Death in infancy, Hypoproteinemia, Hyperthreoninemia, Neonatal death, Death in childhood, Recurrent viral infections, Hypervalinemia, Abnormal circulating isoleucine concentration, Abnormal circulating carnitine concentration, Feeding difficulties, Decreased serum creatinine, Methylmalonic aciduria."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is an inherited disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has the symptom 'Hyperphenylalaninemia' in common with PKU, which is a hallmark of the disease. However, the other symptoms like 'Death in infancy' or 'Death in childhood' are not typically associated with PKU if it is diagnosed and treated early.

+2. Tyrosinemia type I:
This is a rare inherited disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites. The patient has the symptom 'Hypertyrosinemia' in common with this disease, which is a characteristic feature. However, the other symptoms like 'Recurrent viral infections' or 'Elevated urinary carboxylic acid' are not commonly reported in Tyrosinemia type I.

+3. Severe Combined Immunodeficiency (SCID):
This is a group of rare inherited disorders characterized by a defective immune system, leading to recurrent and severe infections. The patient has the symptom 'Recurrent viral infections' in common with SCID, which is a hallmark of the disease. However, the other symptoms like 'Hyperphenylalaninemia' or 'Hypertyrosinemia' are not typically associated with SCID.

+4. Organic Acidemias:
These are a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to enzyme deficiencies. The patient has the symptom 'Elevated urinary carboxylic acid' in common with organic acidemias, which is a characteristic finding. However, the other symptoms like 'Death in infancy' or 'Death in childhood' may or may not be present, depending on the specific type of organic acidemia.

It's important to note that a definitive diagnosis cannot be made solely based on the provided symptoms, and further diagnostic tests and evaluations would be necessary to confirm or rule out these potential diseases."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Down Syndrome: A genetic disorder caused by the presence of an extra copy of chromosome 21, leading to intellectual disability, developmental delays, and characteristic physical features.
Symptoms in common: Intellectual disability, Abnormality of prenatal development or birth.
Symptoms not in common: Strabismus, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+2. Phenylketonuria (PKU): A genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body and potentially causing intellectual disability, seizures, and other neurological problems.
Symptoms in common: Intellectual disability, Hyperphenylalaninemia.
Symptoms not in common: Strabismus, Abnormality of prenatal development or birth, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Death in adolescence, Death in early adulthood.

+3. Tyrosinemia: A group of inherited metabolic disorders characterized by the inability to properly metabolize the amino acid tyrosine, leading to its accumulation and potential complications such as liver disease, kidney problems, and neurological issues.
Symptoms in common: Hypertyrosinemia.
Symptoms not in common: Strabismus, Abnormality of prenatal development or birth, Intellectual disability, Obesity, Death in infancy, Neonatal death, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+4. Prader-Willi Syndrome: A rare genetic disorder characterized by intellectual disability, obesity, short stature, and other physical and behavioral features.
Symptoms in common: Intellectual disability, Obesity.
Symptoms not in common: Strabismus, Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+5. Sudden Infant Death Syndrome (SIDS): The unexplained death of an apparently healthy infant, typically occurring during sleep.
Symptoms in common: Death in infancy, Neonatal death.
Symptoms not in common: Strabismus, Abnormality of prenatal development or birth, Intellectual disability, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be necessary to confirm the actual diagnosis."
['Ornithine transcarbamylase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Ornithine Transcarbamylase Deficiency (OTC Deficiency): A rare inherited disorder characterized by the accumulation of ammonia in the blood (hyperammonemia), which can lead to vomiting, lethargy, and coma. Symptoms in common: Hyperammonemia, Vomiting. Symptoms not in common: Death in infancy, Abnormal bleeding, Oroticaciduria, Abnormality of the coagulation cascade.

+2. Hemophilia: A genetic disorder that impairs the body's ability to control blood clotting, leading to abnormal bleeding. Symptoms in common: Abnormal bleeding, Abnormality of the coagulation cascade. Symptoms not in common: Death in infancy, Hyperammonemia, Vomiting, Oroticaciduria.

+3. Urea Cycle Disorders: A group of inherited metabolic disorders characterized by the inability to remove ammonia from the bloodstream, leading to hyperammonemia, vomiting, and other neurological symptoms. Symptoms in common: Hyperammonemia, Vomiting. Symptoms not in common: Death in infancy, Abnormal bleeding, Oroticaciduria, Abnormality of the coagulation cascade.

+4. Lesch-Nyhan Syndrome: A rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT), leading to the accumulation of uric acid and neurological symptoms. Symptoms in common: Oroticaciduria. Symptoms not in common: Death in infancy, Abnormal bleeding, Hyperammonemia, Vomiting, Abnormality of the coagulation cascade.

+5. Hereditary Hemorrhagic Telangiectasia (HHT): A genetic disorder that causes abnormal blood vessel formation, leading to excessive bleeding from various sites in the body. Symptoms in common: Abnormal bleeding. Symptoms not in common: Death in infancy, Hyperammonemia, Vomiting, Oroticaciduria, Abnormality of the coagulation cascade.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, including a detailed medical history, physical examination, and appropriate laboratory tests."
['L-2-hydroxyglutaric aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder characterized by progressive loss of mental and movement abilities. The patient has symptoms such as intellectual disability, generalized hypotonia, and abnormal cerebral morphology, which are common in Leigh Syndrome. However, the patient does not seem to exhibit other typical symptoms like seizures or respiratory problems.

+2. Leukodystrophy: A group of genetic disorders that affect the growth and development of the brain's white matter. The patient exhibits symptoms like intellectual disability, abnormal cerebral morphology, and abnormal myelination, which are consistent with leukodystrophies. However, the presence of hyperammonemia is not a typical feature of these disorders.

+3. Urea Cycle Disorders: A group of inherited metabolic disorders characterized by the body's inability to remove ammonia from the bloodstream. The patient has symptoms like hyperammonemia and intellectual disability, which are common in urea cycle disorders. However, the presence of hyperreflexia and abnormal myelination is not typically associated with these disorders.

+4. L-2-Hydroxyglutaric Aciduria: A rare inherited metabolic disorder caused by the accumulation of L-2-hydroxyglutaric acid in the body. The patient exhibits the specific symptom of L-2-hydroxyglutaric acidemia, which is a hallmark of this disorder. However, some of the other symptoms like hyperreflexia and abnormal myelination are not commonly reported in this condition.

+5. Mitochondrial Encephalomyopathy: A group of disorders caused by dysfunctional mitochondria, which are the energy-producing structures within cells. The patient has symptoms like intellectual disability, generalized hypotonia, and abnormal cerebral morphology, which can be seen in mitochondrial encephalomyopathies. However, the presence of hyperammonemia is not a typical feature of these disorders.

It's important to note that a definitive diagnosis would require further clinical evaluation, including genetic testing, imaging studies, and other specialized investigations, as many of these disorders can have overlapping symptoms."
['PMM2-CDG'],"Based on the provided symptoms: ['Intellectual disability', 'Ataxia', 'Cerebellar atrophy', 'Death in infancy', 'Thromboembolism', 'Stroke-like episode', 'Cerebellar agenesis'], here are some potential diseases with their descriptions:

+1. Joubert Syndrome: This is a rare genetic disorder characterized by abnormal brain development, intellectual disability, ataxia (lack of muscle control), and cerebellar agenesis or hypoplasia (underdeveloped or absent cerebellum). Symptoms in common: Intellectual disability, Ataxia, Cerebellar agenesis.

+2. Ataxia-Telangiectasia: A rare, inherited disorder that affects the nervous system, immune system, and other body systems. It causes progressive cerebellar atrophy, leading to ataxia, intellectual disability, and an increased risk of stroke-like episodes and thromboembolism. Symptoms in common: Intellectual disability, Ataxia, Cerebellar atrophy, Thromboembolism, Stroke-like episode.

+3. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, particularly the brain stem and basal ganglia. It can cause intellectual disability, ataxia, and cerebellar atrophy, and in severe cases, it can lead to death in infancy. Symptoms in common: Intellectual disability, Ataxia, Cerebellar atrophy, Death in infancy.

+4. Niemann-Pick Disease Type C: A rare inherited lipid storage disorder that affects the brain and other organs. It can cause intellectual disability, ataxia, cerebellar atrophy, and in some cases, thromboembolism or stroke-like episodes. Symptoms in common: Intellectual disability, Ataxia, Cerebellar atrophy, Thromboembolism, Stroke-like episode.

+5. Pontocerebellar Hypoplasia: A group of rare neurodegenerative disorders characterized by underdevelopment or degeneration of the cerebellum and brainstem. It can cause intellectual disability, ataxia, cerebellar atrophy or agenesis, and in severe cases, death in infancy. Symptoms in common: Intellectual disability, Ataxia, Cerebellar atrophy, Cerebellar agenesis, Death in infancy.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate diagnostic tests."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia
Symptoms not in common: Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death

+2. Tyrosinemia Type I:
Symptoms in common: Hypertyrosinemia
Symptoms not in common: Death in infancy, Premature birth, Hyperphenylalaninemia, Neonatal death

+3. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Neonatal death (in severe cases)
Symptoms not in common: Death in infancy, Premature birth, Hypertyrosinemia, Hyperphenylalaninemia

+4. Congenital Hypothyroidism:
Symptoms in common: Premature birth (in some cases)
Symptoms not in common: Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia

+5. Inborn Errors of Metabolism:
Symptoms in common: Death in infancy (in severe cases), Premature birth (in some cases), Hypertyrosinemia (in specific disorders), Neonatal death (in severe cases), Hyperphenylalaninemia (in specific disorders)
Symptoms not in common: (Depends on the specific disorder)

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's complete medical history, physical examination, and relevant laboratory tests."
['Propionic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive loss of mental and movement abilities. Symptoms in common: Delayed speech and language development, intellectual disability, seizures, lethargy, motor delay, generalized hypotonia, tremors, death in infancy, increased circulating lactate concentration, drowsiness, difficulty walking, sleep abnormality, tachypnea, neonatal death, death in childhood. Symptoms not in common: Leukopenia, fever, hyperammonemia, vomiting, gastroesophageal reflux, pneumonia, hyperglycinemia, increased blood urea nitrogen, hypertyrosinemia, hyperalaninemia, difficulty climbing stairs, recurrent viral infections, hyperprolinemia, difficulty running, stomatitis, hypervalinemia, abnormal circulating carnitine concentration, hypoglycinemia, severe hearing impairment.

+2. Maple Syrup Urine Disease (MSUD): A rare inherited disorder in which the body is unable to break down certain amino acids properly, leading to a buildup of toxic substances. Symptoms in common: Lethargy, vomiting, increased blood urea nitrogen, hyperalaninemia, hypervalinemia, abnormal circulating carnitine concentration. Symptoms not in common: Delayed speech and language development, intellectual disability, seizures, motor delay, generalized hypotonia, tremors, death in infancy, leukopenia, fever, hyperammonemia, gastroesophageal reflux, pneumonia, increased circulating lactate concentration, hyperglycinemia, drowsiness, difficulty walking, sleep abnormality, tachypnea, hypertyrosinemia, difficulty climbing stairs, neonatal death, death in childhood, recurrent viral infections, hyperprolinemia, difficulty running, stomatitis, hypoglycinemia, severe hearing impairment.

+3. Nonketotic Hyperglycinemia: A rare inherited metabolic disorder characterized by an accumulation of glycine in the body fluids and tissues. Symptoms in common: Lethargy, hyperglycinemia, seizures, intellectual disability, hypotonia. Symptoms not in common: Delayed speech and language development, motor delay, tremors, death in infancy, leukopenia, fever, hyperammonemia, vomiting, gastroesophageal reflux, pneumonia, increased circulating lactate concentration, drowsiness, difficulty walking, sleep abnormality, tachypnea, increased blood urea nitrogen, hypertyrosinemia, hyperalaninemia, difficulty climbing stairs, neonatal death, death in childhood, recurrent viral infections, hyperprolinemia, difficulty running, stomatitis, hypervalinemia, abnormal circulating carnitine concentration, hypoglycinemia, severe hearing impairment."
['Wilson disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Wilson's Disease: A rare inherited disorder that causes copper to accumulate in the liver, brain, and other vital organs. The patient has the following symptoms in common: Decreased circulating ceruloplasmin concentration, Decreased circulating copper concentration. The patient does not have the following symptoms: Polydipsia, Elevated circulating hepatic transaminase concentration, Death in adolescence.

+2. Diabetes Mellitus: A chronic condition characterized by high blood sugar levels due to the body's inability to produce or use insulin effectively. The patient has the following symptom in common: Polydipsia (excessive thirst). The patient does not have the following symptoms: Elevated circulating hepatic transaminase concentration, Decreased circulating ceruloplasmin concentration, Death in adolescence, Decreased circulating copper concentration.

+3. Liver Disease: A broad term that encompasses various conditions affecting the liver, including hepatitis, cirrhosis, and liver cancer. The patient has the following symptom in common: Elevated circulating hepatic transaminase concentration (a marker of liver damage). The patient does not have the following symptoms: Polydipsia, Decreased circulating ceruloplasmin concentration, Death in adolescence, Decreased circulating copper concentration.

+4. Copper Deficiency: A condition caused by inadequate copper intake or absorption, leading to various health problems. The patient has the following symptoms in common: Decreased circulating ceruloplasmin concentration, Decreased circulating copper concentration. The patient does not have the following symptoms: Polydipsia, Elevated circulating hepatic transaminase concentration, Death in adolescence.

+5. Metabolic Disorder: A group of disorders that affect the body's ability to process and utilize nutrients properly. The patient may have some of the symptoms in common, but more specific information is needed for an accurate diagnosis.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided symptoms may not be sufficient for a definitive diagnosis, and further investigation may be necessary."
['Ornithine transcarbamylase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive loss of mental and movement abilities. It is characterized by degeneration of the brain stem, a part of the brain that is crucial for controlling respiratory functions and other vital processes.
Symptoms in common: Seizure, Lethargy, Generalized hypotonia, Death in infancy
Symptoms not in common: Vomiting, Drowsiness, Sleep abnormality, Hyperglutaminemia, Oroticaciduria

+2. Maple Syrup Urine Disease (MSUD): A rare inherited disorder in which the body is unable to process certain amino acids properly, leading to a buildup of toxic substances in the blood and urine. It is named for the distinctive sweet odor of the urine.
Symptoms in common: Lethargy, Vomiting, Drowsiness, Sleep abnormality
Symptoms not in common: Seizure, Generalized hypotonia, Death in infancy, Hyperglutaminemia, Oroticaciduria, Neonatal death

+3. Ornithine Transcarbamylase Deficiency (OTC): A rare inherited disorder that causes ammonia to accumulate in the blood due to a deficiency of the enzyme ornithine transcarbamylase, which is involved in the urea cycle.
Symptoms in common: Lethargy, Vomiting, Hyperglutaminemia, Oroticaciduria
Symptoms not in common: Seizure, Generalized hypotonia, Death in infancy, Drowsiness, Sleep abnormality, Neonatal death

+4. Nonketotic Hyperglycinemia: A rare inherited metabolic disorder characterized by an abnormally high level of glycine in the body fluids and tissues, leading to a buildup of toxic substances in the brain.
Symptoms in common: Seizure, Lethargy, Generalized hypotonia, Vomiting, Drowsiness, Sleep abnormality
Symptoms not in common: Death in infancy, Hyperglutaminemia, Oroticaciduria, Neonatal death

+5. Zellweger Syndrome: A rare inherited disorder that affects the peroxisomes, which are small organelles within cells that are responsible for various metabolic functions. It is characterized by a wide range of symptoms, including neurological abnormalities, liver dysfunction, and skeletal malformations.
Symptoms in common: Seizure, Lethargy, Generalized hypotonia, Vomiting, Drowsiness, Sleep abnormality, Neonatal death
Symptoms not in common: Death in infancy, Hyperglutaminemia, Oroticaciduria

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and imaging studies, to accurately identify the underlying condition."
['Classic galactosemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Galactosemia: A rare genetic metabolic disorder in which the body is unable to metabolize galactose, a sugar found in milk and dairy products. Symptoms include vomiting, diarrhea, jaundice, intellectual disability, and liver damage.
Symptoms in common: Intellectual disability, Feeding difficulties, Hypergalactosemia, Abnormality of galactoside metabolism.
Symptoms not in common: Microcephaly, Delayed speech and language development, Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Obesity, Death in infancy, Anemia, Elevated circulating alkaline phosphatase concentration, Neonatal death, Death in childhood, Abnormal circulating porphyrin concentration, Decreased circulating ferritin concentration, Decreased serum iron.

+2. Tay-Sachs disease: A rare inherited disorder that causes progressive damage to the nervous system, leading to mental and physical deterioration.
Symptoms in common: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Death in infancy, Death in childhood.
Symptoms not in common: Microcephaly, Abnormality of prenatal development or birth, Obesity, Anemia, Elevated circulating alkaline phosphatase concentration, Neonatal death, Abnormality of galactoside metabolism, Abnormal circulating porphyrin concentration, Feeding difficulties, Hypergalactosemia, Decreased circulating ferritin concentration, Decreased serum iron.

+3. Congenital hypothyroidism: A condition present at birth in which the thyroid gland fails to produce enough thyroid hormones, leading to developmental delays and growth problems.
Symptoms in common: Delayed speech and language development, Intellectual disability, Motor delay, Obesity.
Symptoms not in common: Microcephaly, Abnormality of prenatal development or birth, Generalized hypotonia, Death in infancy, Anemia, Elevated circulating alkaline phosphatase concentration, Neonatal death, Death in childhood, Abnormality of galactoside metabolism, Abnormal circulating porphyrin concentration, Feeding difficulties, Hypergalactosemia, Decreased circulating ferritin concentration, Decreased serum iron.

+4. Fanconi anemia: A rare inherited disorder that leads to bone marrow failure and an increased risk of certain cancers.
Symptoms in common: Anemia, Decreased circulating ferritin concentration, Decreased serum iron.
Symptoms not in common: Microcephaly, Delayed speech and language development, Abnormality of prenatal development or birth, Intellectual disability, Motor delay, Generalized hypotonia, Obesity, Death in infancy, Elevated circulating alkaline phosphatase concentration, Neonatal death, Death in childhood, Abnormality of galactoside metabolism, Abnormal circulating porphyrin concentration, Feeding difficulties, Hypergalactosemia."
['Biotinidase deficiency'],"Based on the provided symptoms: ['Obesity', 'Abnormal foot morphology', 'Hyperammonemia', 'Death in childhood'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder characterized by the body's inability to break down certain amino acids properly. It can lead to a buildup of toxic substances in the blood.
Matching Symptoms: Hyperammonemia
Non-Matching Symptoms: Obesity, Abnormal foot morphology, Death in childhood (if treated early)

+2. Prader-Willi Syndrome:
A rare genetic disorder that causes a constant feeling of hunger, leading to obesity and other symptoms.
Matching Symptoms: Obesity, Abnormal foot morphology
Non-Matching Symptoms: Hyperammonemia, Death in childhood

+3. Urea Cycle Disorders:
A group of inherited metabolic disorders that cause a buildup of ammonia in the blood due to the body's inability to remove waste products properly.
Matching Symptoms: Hyperammonemia, Death in childhood (if untreated)
Non-Matching Symptoms: Obesity, Abnormal foot morphology

+4. Bardet-Biedl Syndrome:
A rare genetic disorder that affects multiple organ systems, including obesity, abnormal limb development, and intellectual disability.
Matching Symptoms: Obesity, Abnormal foot morphology
Non-Matching Symptoms: Hyperammonemia, Death in childhood

+5. Alström Syndrome:
A rare genetic disorder characterized by obesity, vision and hearing loss, and progressive multi-organ dysfunction.
Matching Symptoms: Obesity
Non-Matching Symptoms: Abnormal foot morphology, Hyperammonemia, Death in childhood

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided symptoms are not sufficient for a definitive diagnosis."
['Canavan disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Lesch-Nyhan Syndrome: A rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT), leading to an accumulation of uric acid in the body. Symptoms in common: Hyperactivity. Symptoms not in common: Death in infancy, Abnormal circulating aspartate family amino acid concentration, Feeding difficulties, Abnormal myelination.

+2. Phenylketonuria (PKU): An inherited metabolic disorder characterized by the inability to break down the amino acid phenylalanine, leading to its accumulation in the body. Symptoms in common: Hyperactivity, Abnormal circulating aspartate family amino acid concentration. Symptoms not in common: Death in infancy, Feeding difficulties, Abnormal myelination.

+3. Krabbe Disease: A rare inherited disorder characterized by the deficiency of an enzyme called galactosylceramidase, which leads to the accumulation of certain lipids in the body. Symptoms in common: Abnormal myelination. Symptoms not in common: Hyperactivity, Death in infancy, Abnormal circulating aspartate family amino acid concentration, Feeding difficulties.

+4. Maple Syrup Urine Disease (MSUD): A rare inherited metabolic disorder characterized by the inability to break down certain amino acids, leading to their accumulation in the body. Symptoms in common: Abnormal circulating aspartate family amino acid concentration, Feeding difficulties. Symptoms not in common: Hyperactivity, Death in infancy, Abnormal myelination.

+5. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, particularly the brain stem and basal ganglia. Symptoms in common: Feeding difficulties. Symptoms not in common: Hyperactivity, Death in infancy, Abnormal circulating aspartate family amino acid concentration, Abnormal myelination.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and imaging studies, as well as a thorough review of the patient's medical history and physical examination findings."
['Phenylketonuria'],"Based on the provided symptoms: ['Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Hyperphenylalaninemia'], here are some potential diseases with their descriptions:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia
Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death (unless left untreated)

+2. Congenital Malformations:
Symptoms in common: Abnormality of prenatal development or birth
Symptoms not in common: Death in infancy, Neonatal death, Hyperphenylalaninemia

+3. Inborn Errors of Metabolism:
Symptoms in common: Hyperphenylalaninemia (in some cases), Abnormality of prenatal development or birth (in some cases)
Symptoms not in common: Death in infancy, Neonatal death (unless left untreated)

+4. Congenital Anomalies:
Symptoms in common: Abnormality of prenatal development or birth
Symptoms not in common: Death in infancy, Neonatal death, Hyperphenylalaninemia

+5. Sudden Infant Death Syndrome (SIDS):
Symptoms in common: Death in infancy, Neonatal death
Symptoms not in common: Abnormality of prenatal development or birth, Hyperphenylalaninemia

Please note that a proper diagnosis requires a comprehensive evaluation by a qualified medical professional, considering all relevant factors and test results."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: 'Hyperphenylalaninemia', 'Delayed speech and language development'
Symptoms not in common: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Death in early adulthood'
PKU is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body and potentially causing intellectual disability, seizures, and other neurological problems.

+2. Tyrosinemia:
Symptoms in common: 'Hypertyrosinemia', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood'
Symptoms not in common: 'Delayed speech and language development', 'Hyperphenylalaninemia', 'Death in early adulthood'
Tyrosinemia is a group of inherited metabolic disorders characterized by the accumulation of tyrosine and its byproducts, leading to liver, kidney, and neurological problems, and potentially life-threatening complications.

+3. Inborn Errors of Metabolism:
Symptoms in common: 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Hyperphenylalaninemia', 'Death in early adulthood'
Inborn errors of metabolism are a group of genetic disorders that affect the body's ability to metabolize specific substances, leading to a wide range of symptoms depending on the specific disorder, including developmental delays, organ dysfunction, and potentially life-threatening complications.

+4. Congenital Disorders:
Symptoms in common: 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Death in early adulthood'
Symptoms not in common: 'Hypertyrosinemia', 'Hyperphenylalaninemia'
Congenital disorders are a broad category of conditions present at birth, often caused by genetic or environmental factors, and can affect various organ systems and lead to a range of symptoms, including developmental delays, physical abnormalities, and potentially life-threatening complications.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided information is for educational purposes only and should not be considered a substitute for professional medical advice."
[],"Based on the provided symptoms: ['Nephritis', 'Generalized hypotonia', 'Death in infancy', 'Ventricular septal defect', 'Cardiomyopathy', 'Pulmonic stenosis'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Noonan Syndrome:
Matching Symptoms: Ventricular septal defect, Cardiomyopathy, Pulmonic stenosis
Non-Matching Symptoms: Nephritis, Generalized hypotonia, Death in infancy

+2. Barth Syndrome:
Matching Symptoms: Cardiomyopathy, Generalized hypotonia
Non-Matching Symptoms: Nephritis, Death in infancy, Ventricular septal defect, Pulmonic stenosis

+3. Alport Syndrome:
Matching Symptoms: Nephritis
Non-Matching Symptoms: Generalized hypotonia, Death in infancy, Ventricular septal defect, Cardiomyopathy, Pulmonic stenosis

+4. Congenital Heart Defects:
Matching Symptoms: Ventricular septal defect, Cardiomyopathy, Pulmonic stenosis
Non-Matching Symptoms: Nephritis, Generalized hypotonia, Death in infancy

+5. Muscular Dystrophies:
Matching Symptoms: Generalized hypotonia, Cardiomyopathy
Non-Matching Symptoms: Nephritis, Death in infancy, Ventricular septal defect, Pulmonic stenosis

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required to confirm the actual diagnosis."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Lesch-Nyhan Syndrome: A rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT), leading to an accumulation of uric acid in the body. Symptoms the patient has in common: Irritability, spasticity, hyperreflexia. Symptoms the patient does not have: Hypertyrosinemia, hyperphenylalaninemia, recurrent viral infections, death in infancy/childhood/adolescence.

+2. Phenylketonuria (PKU): A genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. Symptoms the patient has in common: Hyperphenylalaninemia. Symptoms the patient does not have: Irritability, spasticity, hyperreflexia, hypertyrosinemia, recurrent viral infections, death in infancy/childhood/adolescence.

+3. Tyrosinemia Type I: A rare inherited disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase (FAH), leading to the accumulation of toxic metabolites. Symptoms the patient has in common: Hypertyrosinemia, death in infancy/childhood/adolescence. Symptoms the patient does not have: Irritability, spasticity, hyperreflexia, hyperphenylalaninemia, recurrent viral infections.

+4. Severe Combined Immunodeficiency (SCID): A group of rare genetic disorders characterized by a deficiency or dysfunction of the immune system, leading to recurrent infections. Symptoms the patient has in common: Recurrent viral infections, death in infancy/childhood/adolescence. Symptoms the patient does not have: Irritability, spasticity, hyperreflexia, hypertyrosinemia, hyperphenylalaninemia.

+5. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive degeneration of motor skills and mental abilities. Symptoms the patient has in common: Irritability, spasticity, hyperreflexia, death in infancy/childhood/adolescence. Symptoms the patient does not have: Hypertyrosinemia, hyperphenylalaninemia, recurrent viral infections.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided information is for illustrative purposes only."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Carnitine Deficiency Disorders:
Common Symptoms: Abnormal circulating carnitine concentration
Uncommon Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death

+2. Inborn Errors of Metabolism:
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Uncommon Symptoms: None

+3. Congenital Malformations:
Common Symptoms: Abnormality of prenatal development or birth
Uncommon Symptoms: Death in infancy, Neonatal death, Abnormal circulating carnitine concentration

+4. Neonatal Disorders:
Common Symptoms: Death in infancy, Neonatal death
Uncommon Symptoms: Abnormality of prenatal development or birth, Abnormal circulating carnitine concentration

+5. Metabolic Disorders:
Common Symptoms: Abnormal circulating carnitine concentration
Uncommon Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required for an accurate diagnosis."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: 'Hyperphenylalaninemia'
Symptoms not in common: 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Generalized hypotonia', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood'

+2. Tyrosinemia type I:
Symptoms in common: 'Hypertyrosinemia'
Symptoms not in common: 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Generalized hypotonia', 'Death in infancy', 'Hyperphenylalaninemia', 'Neonatal death', 'Death in childhood'

+3. Prader-Willi syndrome:
Symptoms in common: 'Delayed speech and language development', 'Generalized hypotonia'
Symptoms not in common: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Hyperphenylalaninemia'

+4. Congenital disorders of glycosylation:
Symptoms in common: 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Generalized hypotonia'
Symptoms not in common: 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Hyperphenylalaninemia'

+5. Severe combined immunodeficiency (SCID):
Symptoms in common: 'Death in infancy', 'Neonatal death', 'Death in childhood'
Symptoms not in common: 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Generalized hypotonia', 'Hypertyrosinemia', 'Hyperphenylalaninemia'

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required for an accurate diagnosis."
['Glutaryl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Glutaric Aciduria Type 1: This is a rare inherited disorder characterized by an inability to break down certain amino acids properly, leading to a buildup of glutaric acid in the body. The patient has the following symptoms in common: 'Seizure', 'Encephalopathy', 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Decreased plasma free carnitine', 'Elevated urinary carboxylic acid'. However, the patient does not seem to exhibit 'Death in infancy' or 'Death in childhood' based on the provided information.

+2. Maple Syrup Urine Disease: This is another inherited metabolic disorder that affects the breakdown of certain amino acids, leading to a buildup of toxic substances in the body. The patient has the following symptoms in common: 'Seizure', 'Encephalopathy', 'Opisthotonus', 'Decreased plasma free carnitine', 'Elevated urinary carboxylic acid'. However, the patient does not seem to exhibit 'Death in infancy', 'Death in childhood', 'Glutaric aciduria', or 'Elevated circulating glutaric acid concentration'.

+3. Organic Acidemias: These are a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to deficiencies in specific enzymes. The patient has the following symptoms in common: 'Seizure', 'Encephalopathy', 'Opisthotonus', 'Elevated urinary carboxylic acid'. However, the patient does not seem to exhibit 'Death in infancy', 'Death in childhood', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', or 'Decreased plasma free carnitine'.

+4. Reye's Syndrome: This is a rare but potentially life-threatening condition that can cause swelling in the liver and brain, often associated with viral infections or the use of certain medications. The patient has the following symptoms in common: 'Seizure', 'Encephalopathy', 'Opisthotonus'. However, the patient does not seem to exhibit 'Death in infancy', 'Death in childhood', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Decreased plasma free carnitine', or 'Elevated urinary carboxylic acid'.

Please note that a proper diagnosis would require additional information, such as medical history, laboratory tests, and a physical examination by a qualified healthcare professional."
[],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Down Syndrome: Intellectual disability, hypotonia, and characteristic facial features are common symptoms. The patient has intellectual disability and generalized hypotonia, which are consistent with Down Syndrome.

+2. Cerebral Palsy: Spastic diplegia, spastic tetraplegia, motor delay, and seizures are common symptoms. The patient has spastic diplegia and motor delay, which are consistent with Cerebral Palsy.

+3. Cystic Fibrosis: Cyanosis, edema, pneumonia, and dyspnea are common symptoms. The patient has cyanosis, edema, pneumonia, and dyspnea, which are consistent with Cystic Fibrosis.

+4. Phenylketonuria: Fair hair, intellectual disability, and seizures are common symptoms. The patient has fair hair and intellectual disability, which are consistent with Phenylketonuria.

+5. Albinism: White hair, severe hearing impairment, and nystagmus are common symptoms. The patient has white hair, severe hearing impairment, and nystagmus, which are consistent with Albinism.

+6. Metabolic Disorder: Metabolic acidosis, hyperkalemia, and hypocalcemia are common symptoms. The patient has metabolic acidosis, hyperkalemia, and hypocalcemia, which are consistent with a metabolic disorder.

+7. Congenital Muscular Dystrophy: Generalized hypotonia, respiratory distress (dyspnea), and intellectual disability are common symptoms. The patient has generalized hypotonia, dyspnea, and intellectual disability, which are consistent with Congenital Muscular Dystrophy.

+8. Meningitis: Seizures, opisthotonus, and neonatal death are common symptoms. The patient has seizures and opisthotonus, which are consistent with Meningitis.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's medical history, physical examination, and additional tests as necessary."
['PMM2-CDG'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Ataxia-Telangiectasia: This is a rare, neurodegenerative disorder characterized by progressive cerebellar ataxia, oculomotor apraxia, immune deficiencies, and a predisposition to cancer. Symptoms in common: Ataxia, Cerebellar atrophy. Symptoms not in common: Intellectual disability, Motor delay, Generalized hypotonia, Cirrhosis, Hepatic fibrosis, Death in infancy, Thromboembolism, Reduced antithrombin III activity, Death in childhood, Lipodystrophy, Death in adolescence, Cerebellar agenesis.

+2. Niemann-Pick Disease Type C: This is a rare, inherited lipid storage disorder that affects the body's ability to metabolize cholesterol and other lipids. Symptoms in common: Ataxia, Intellectual disability, Motor delay, Generalized hypotonia. Symptoms not in common: Strabismus, Cerebellar atrophy, Cirrhosis, Hepatic fibrosis, Death in infancy, Thromboembolism, Reduced antithrombin III activity, Death in childhood, Lipodystrophy, Death in adolescence, Cerebellar agenesis.

+3. Joubert Syndrome: This is a rare genetic disorder characterized by abnormal brain development, specifically affecting the cerebellar vermis. Symptoms in common: Ataxia, Intellectual disability, Motor delay, Cerebellar agenesis. Symptoms not in common: Strabismus, Cerebellar atrophy, Generalized hypotonia, Cirrhosis, Hepatic fibrosis, Death in infancy, Thromboembolism, Reduced antithrombin III activity, Death in childhood, Lipodystrophy, Death in adolescence.

+4. Antithrombin III Deficiency: This is a rare inherited disorder that increases the risk of developing blood clots (thromboembolism) due to a deficiency in the antithrombin III protein. Symptoms in common: Thromboembolism, Reduced antithrombin III activity. Symptoms not in common: Strabismus, Intellectual disability, Ataxia, Motor delay, Cerebellar atrophy, Generalized hypotonia, Cirrhosis, Hepatic fibrosis, Death in infancy, Death in childhood, Lipodystrophy, Death in adolescence, Cerebellar agenesis.

+5. Progressive Familial Intrahepatic Cholestasis: This is a group of rare genetic disorders that disrupt the flow of bile from the liver, leading to liver disease and potential liver failure. Symptoms in common: Cirrhosis, Hepatic fibrosis. Symptoms not in common: Strabismus, Intellectual disability, Ataxia, Motor delay, Cerebellar atrophy, Generalized hypotonia, Death in infancy, Thromboembolism, Reduced antithrombin III activity, Death in childhood, Lipodystrophy, Death in adolescence, Cerebellar agenesis."
['Canavan disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder characterized by progressive loss of mental and movement abilities. The patient has symptoms in common with Leigh Syndrome, such as seizures, generalized hypotonia, and feeding difficulties. However, the patient does not exhibit some of the other common symptoms of Leigh Syndrome, like respiratory difficulties and vision problems.

+2. Pyridoxine Dependency: A rare genetic disorder caused by a deficiency in the enzyme responsible for converting vitamin B6 into its active form. The patient has symptoms in common with Pyridoxine Dependency, such as seizures, irritability, and abnormal circulating aspartate family amino acid concentration. However, the patient does not exhibit some of the other common symptoms of Pyridoxine Dependency, like developmental delays and anemia.

+3. Infantile Neuroaxonal Dystrophy: A rare inherited disorder that affects the nervous system and causes progressive neurological deterioration. The patient has symptoms in common with Infantile Neuroaxonal Dystrophy, such as seizures, opisthotonus (abnormal posturing), and death in infancy. However, the patient does not exhibit some of the other common symptoms of Infantile Neuroaxonal Dystrophy, like visual impairment and muscle weakness.

+4. Glutaric Aciduria Type 1: A rare inherited disorder that affects the metabolism of certain amino acids. The patient has symptoms in common with Glutaric Aciduria Type 1, such as seizures, generalized hypotonia, and feeding difficulties. However, the patient does not exhibit some of the other common symptoms of Glutaric Aciduria Type 1, like macrocephaly (abnormally large head) and metabolic acidosis.

+5. Maple Syrup Urine Disease: A rare inherited disorder that affects the metabolism of certain amino acids. The patient has symptoms in common with Maple Syrup Urine Disease, such as seizures, abnormal circulating aspartate family amino acid concentration, and feeding difficulties. However, the patient does not exhibit some of the other common symptoms of Maple Syrup Urine Disease, like a distinctive maple syrup odor and developmental delays.

Please note that a proper diagnosis would require additional tests and a thorough evaluation by a medical professional."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia,' which are common in PKU. However, the symptoms of 'Abnormality of prenatal development or birth,' 'Death in infancy,' 'Neonatal death,' and 'Gastrointestinal inflammation' are not typically associated with PKU.

+2. Tyrosinemia Type I:
This is a rare inherited disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites. The patient has the symptom of 'Hypertyrosinemia,' which is common in Tyrosinemia Type I. However, the other symptoms provided are not typically associated with this condition.

+3. Necrotizing Enterocolitis (NEC):
NEC is a serious gastrointestinal condition that primarily affects premature infants. The patient has the symptom of 'Gastrointestinal inflammation,' which is common in NEC. However, the other symptoms provided are not typically associated with this condition.

+4. Congenital Disorders of Glycosylation (CDG):
CDG is a group of inherited metabolic disorders that affect the glycosylation process, leading to various symptoms. The patient has the symptom of 'Abnormality of prenatal development or birth,' which can be associated with some types of CDG. However, the other symptoms provided are not typically associated with CDG.

+5. Severe Combined Immunodeficiency (SCID):
SCID is a group of rare genetic disorders characterized by a deficient immune system. The patient has the symptom of 'Death in infancy,' which can occur in severe cases of SCID due to infections. However, the other symptoms provided are not typically associated with SCID.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests. The provided symptoms may not be sufficient for an accurate diagnosis, and further investigation may be necessary."
['Maple syrup urine disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive loss of mental and movement abilities. It is characterized by degeneration of the brain stem, optic atrophy, and respiratory irregularities.
Symptoms in common: Ataxia, Coma, Reduced tendon reflexes, Cerebral edema, Abnormal cerebral white matter morphology, Death in childhood
Symptoms not in common: Alopecia, Metabolic acidosis, Recurrent viral infections, Hyperleucinemia, Death in adolescence

+2. Maple Syrup Urine Disease (MSUD): A rare inherited disorder in which the body is unable to process certain amino acids properly, leading to a buildup of toxic substances in the blood and urine.
Symptoms in common: Ataxia, Coma, Reduced tendon reflexes, Metabolic acidosis, Cerebral edema, Abnormal cerebral white matter morphology, Death in childhood, Hyperleucinemia
Symptoms not in common: Alopecia, Recurrent viral infections, Death in adolescence

+3. Leukodystrophy: A group of rare, inherited metabolic disorders that affect the brain, spinal cord, and often the peripheral nerves. They are characterized by abnormal development or destruction of the myelin sheath, which insulates nerve fibers in the central nervous system.
Symptoms in common: Ataxia, Coma, Reduced tendon reflexes, Cerebral edema, Abnormal cerebral white matter morphology, Death in childhood, Death in adolescence
Symptoms not in common: Alopecia, Metabolic acidosis, Recurrent viral infections, Hyperleucinemia

+4. Severe Combined Immunodeficiency (SCID): A group of rare, inherited disorders characterized by a deficiency or dysfunction of certain immune cells, leading to a compromised immune system and increased susceptibility to infections.
Symptoms in common: Recurrent viral infections, Death in childhood, Death in adolescence
Symptoms not in common: Ataxia, Coma, Reduced tendon reflexes, Alopecia, Metabolic acidosis, Cerebral edema, Abnormal cerebral white matter morphology, Hyperleucinemia

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required for an accurate diagnosis."
['Acute intermittent porphyria'],"Based on the provided symptoms: ['Abdominal pain', 'Elevated urinary delta-aminolevulinic acid', 'Death in childhood'], here are the potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Acute Intermittent Porphyria:
Matching Symptoms: Abdominal pain, Elevated urinary delta-aminolevulinic acid
Non-Matching Symptoms: Death in childhood (Acute Intermittent Porphyria is not typically fatal in childhood)

+2. Lead Poisoning:
Matching Symptoms: Abdominal pain, Elevated urinary delta-aminolevulinic acid
Non-Matching Symptoms: Death in childhood (Lead poisoning is not typically fatal in childhood unless exposure is severe)

+3. Hereditary Coproporphyria:
Matching Symptoms: Abdominal pain, Elevated urinary delta-aminolevulinic acid
Non-Matching Symptoms: Death in childhood (Hereditary Coproporphyria is not typically fatal in childhood)

+4. Variegate Porphyria:
Matching Symptoms: Abdominal pain, Elevated urinary delta-aminolevulinic acid
Non-Matching Symptoms: Death in childhood (Variegate Porphyria is not typically fatal in childhood)

+5. Aminolevulinic Acid Dehydratase Deficiency Porphyria:
Matching Symptoms: Abdominal pain, Elevated urinary delta-aminolevulinic acid
Non-Matching Symptoms: Death in childhood (Aminolevulinic Acid Dehydratase Deficiency Porphyria is not typically fatal in childhood)

Please note that further diagnostic tests and a comprehensive medical evaluation would be necessary to confirm the specific diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"Based on the provided symptoms: ['Seizure', 'Death in infancy', 'Metabolic acidosis', 'Neonatal death', 'Methylmalonic aciduria'], here are some potential diseases with their descriptions:

+1. Methylmalonic Acidemia: A rare inherited disorder characterized by the accumulation of methylmalonic acid in the body due to a deficiency in the enzyme methylmalonyl-CoA mutase. Symptoms in common: Seizure, Metabolic acidosis, Methylmalonic aciduria. Symptoms not in common: Death in infancy, Neonatal death (although these can occur in severe cases).

+2. Propionic Acidemia: Another inherited metabolic disorder caused by a deficiency in the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid and other metabolites. Symptoms in common: Seizure, Metabolic acidosis, Neonatal death (in severe cases). Symptoms not in common: Death in infancy, Methylmalonic aciduria.

+3. Maple Syrup Urine Disease (MSUD): A rare inherited disorder caused by a deficiency in the enzyme complex that breaks down certain amino acids, leading to the accumulation of branched-chain amino acids. Symptoms in common: Seizure, Metabolic acidosis, Neonatal death (in severe cases). Symptoms not in common: Death in infancy, Methylmalonic aciduria.

+4. Organic Acidemias: A group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to deficiencies in specific enzymes involved in the breakdown of amino acids, fatty acids, or carbohydrates. Symptoms in common: Seizure, Metabolic acidosis, Neonatal death (in severe cases). Symptoms not in common: Death in infancy, Methylmalonic aciduria (unless it's a specific type of organic acidemia).

+5. Mitochondrial Disorders: A diverse group of inherited disorders caused by dysfunctional mitochondria, the energy-producing structures within cells. Symptoms in common: Seizure, Metabolic acidosis, Neonatal death (in severe cases). Symptoms not in common: Death in infancy, Methylmalonic aciduria (unless it's a specific type of mitochondrial disorder).

Please note that a definitive diagnosis would require further testing and evaluation by a medical professional."
['Alkaptonuria'],"Based on the symptoms you provided: ['Seizure', 'Lethargy', 'Generalized hypotonia', 'Growth delay', 'Drowsiness', 'Sleep abnormality', 'Death in childhood', 'Dark urine'], here are some potential diseases with their descriptions:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder characterized by progressive loss of mental and movement abilities. Symptoms in common: Seizure, Lethargy, Generalized hypotonia, Growth delay, Drowsiness, Sleep abnormality. Symptoms not in common: Death in childhood, Dark urine.

+2. Niemann-Pick Disease Type C: A rare inherited lipid storage disorder that affects the body's ability to metabolize cholesterol and other lipids. Symptoms in common: Seizure, Lethargy, Generalized hypotonia, Growth delay, Sleep abnormality. Symptoms not in common: Drowsiness, Death in childhood, Dark urine.

+3. Maple Syrup Urine Disease: A rare inherited disorder in which the body is unable to process certain amino acids properly. Symptoms in common: Lethargy, Generalized hypotonia, Growth delay, Drowsiness, Sleep abnormality. Symptoms not in common: Seizure, Death in childhood. Symptom partially in common: Dark urine (in severe cases).

+4. Glutaric Aciduria Type 1: A rare inherited disorder that causes an excessive buildup of glutaric acid in the body. Symptoms in common: Seizure, Lethargy, Generalized hypotonia, Growth delay, Drowsiness, Sleep abnormality. Symptoms not in common: Death in childhood, Dark urine.

+5. Zellweger Syndrome: A rare inherited disorder that affects the peroxisomes, which are small organelles within cells. Symptoms in common: Seizure, Lethargy, Generalized hypotonia, Growth delay, Sleep abnormality, Death in childhood. Symptoms not in common: Drowsiness, Dark urine.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including physical examination, laboratory tests, and other diagnostic procedures. These potential diseases are based solely on the provided symptoms and should be considered hypothetical."
['Maple syrup urine disease'],"Based on the provided symptoms: ['Seizure', 'Death in infancy', 'Aminoaciduria', 'Neonatal death', 'Abnormal circulating leucine concentration', 'Abnormal circulating isoleucine concentration', 'Abnormal circulating valine concentration'], here are some potential diseases:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder characterized by the inability to break down certain amino acids (leucine, isoleucine, and valine). Symptoms include seizures, abnormal circulating levels of these amino acids, and a distinctive maple syrup odor in urine and earwax. The patient exhibits seizures, aminoaciduria, and abnormal circulating levels of leucine, isoleucine, and valine, which are consistent with MSUD.

+2. Phenylketonuria (PKU):
PKU is an inherited metabolic disorder that results in the inability to break down the amino acid phenylalanine. Symptoms may include seizures, developmental delays, and intellectual disability. The patient exhibits seizures, which could be a symptom of PKU, but the other symptoms provided do not align with this disorder.

+3. Urea Cycle Disorders:
These are a group of inherited metabolic disorders that affect the body's ability to remove ammonia from the bloodstream. Symptoms may include seizures, lethargy, vomiting, and coma. The patient exhibits seizures, which could be a symptom of urea cycle disorders, but the other symptoms provided do not clearly indicate this group of disorders.

+4. Organic Acidemias:
These are a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms may include seizures, developmental delays, and metabolic acidosis. The patient exhibits seizures, which could be a symptom of organic acidemias, but the other symptoms provided do not clearly indicate this group of disorders.

It's important to note that a proper diagnosis would require additional tests, such as genetic testing, metabolic screening, and a thorough medical evaluation by a healthcare professional."
['Very long chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Mitochondrial Disorders: These are a group of metabolic disorders caused by dysfunctional mitochondria, the energy-producing structures within cells. Symptoms in common: Cardiomegaly, Hypoglycemia, Increased circulating lactate concentration, Hepatomegaly, Tachypnea, Dicarboxylic aciduria. Symptoms not in common: Death in infancy, Neonatal death, Death in childhood, Recurrent viral infections, Abnormal circulating carnitine concentration.

+2. Fatty Acid Oxidation Disorders: These are inherited metabolic disorders that affect the body's ability to break down fatty acids for energy. Symptoms in common: Cardiomegaly, Hypoglycemia, Hepatomegaly, Dicarboxylic aciduria. Symptoms not in common: Death in infancy, Increased circulating lactate concentration, Tachypnea, Neonatal death, Death in childhood, Recurrent viral infections, Abnormal circulating carnitine concentration.

+3. Organic Acidemias: These are a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms in common: Cardiomegaly, Hypoglycemia, Increased circulating lactate concentration, Hepatomegaly, Tachypnea, Dicarboxylic aciduria. Symptoms not in common: Death in infancy, Neonatal death, Death in childhood, Recurrent viral infections, Abnormal circulating carnitine concentration.

+4. Severe Combined Immunodeficiency (SCID): This is a group of rare, inherited disorders characterized by a deficiency in the immune system. Symptoms in common: Recurrent viral infections. Symptoms not in common: Death in infancy, Cardiomegaly, Hypoglycemia, Increased circulating lactate concentration, Hepatomegaly, Tachypnea, Dicarboxylic aciduria, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration.

+5. Carnitine Deficiency: This is a metabolic disorder characterized by a lack of carnitine, a compound essential for the transport of fatty acids into the mitochondria for energy production. Symptoms in common: Cardiomegaly, Hypoglycemia, Increased circulating lactate concentration, Hepatomegaly, Tachypnea, Abnormal circulating carnitine concentration. Symptoms not in common: Death in infancy, Dicarboxylic aciduria, Neonatal death, Death in childhood, Recurrent viral infections.

Please note that a definitive diagnosis would require further medical evaluation, including laboratory tests and a comprehensive medical history."
['3-hydroxy-3-methylglutaric aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Glutaric Aciduria Type 1:
Symptoms in common: Seizure, Lethargy, Metabolic acidosis, Hypoglycemia, Progressive neurologic deterioration, Glutaric aciduria
Symptoms not in common: Death in infancy, Fever, Vomiting, Drowsiness, Sleep abnormality, 3-Methylglutaric aciduria, Death in childhood, Recurrent viral infections, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid

+2. Methylmalonic Acidemia:
Symptoms in common: Lethargy, Metabolic acidosis, Hypoglycemia, Vomiting, Progressive neurologic deterioration, Elevated urinary carboxylic acid
Symptoms not in common: Seizure, Death in infancy, Fever, Drowsiness, Sleep abnormality, Glutaric aciduria, 3-Methylglutaric aciduria, Death in childhood, Recurrent viral infections, Abnormal circulating glycine concentration

+3. Propionic Acidemia:
Symptoms in common: Lethargy, Metabolic acidosis, Hypoglycemia, Vomiting, Progressive neurologic deterioration, Elevated urinary carboxylic acid
Symptoms not in common: Seizure, Death in infancy, Fever, Drowsiness, Sleep abnormality, Glutaric aciduria, 3-Methylglutaric aciduria, Death in childhood, Recurrent viral infections, Abnormal circulating glycine concentration

+4. Glycine Encephalopathy:
Symptoms in common: Seizure, Lethargy, Metabolic acidosis, Hypoglycemia, Progressive neurologic deterioration, Abnormal circulating glycine concentration
Symptoms not in common: Death in infancy, Fever, Vomiting, Drowsiness, Sleep abnormality, Glutaric aciduria, 3-Methylglutaric aciduria, Death in childhood, Recurrent viral infections, Elevated urinary carboxylic acid

+5. Severe Combined Immunodeficiency (SCID):
Symptoms in common: Recurrent viral infections
Symptoms not in common: Seizure, Lethargy, Death in infancy, Metabolic acidosis, Hypoglycemia, Fever, Vomiting, Drowsiness, Progressive neurologic deterioration, Sleep abnormality, Glutaric aciduria, 3-Methylglutaric aciduria, Death in childhood, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid"
['MODY'],"Based on the symptoms provided: ['Hypoglycemia', 'Glycosuria', 'Abnormal circulating porphyrin concentration'], here are some potential diseases with their descriptions:

+1. Diabetes Mellitus: A chronic condition characterized by high blood sugar levels due to the body's inability to produce or effectively use insulin. Symptoms in common: Hypoglycemia (low blood sugar), Glycosuria (presence of glucose in urine). Symptoms not in common: Abnormal circulating porphyrin concentration.

+2. Acute Porphyria: A group of rare inherited disorders that affect the production of heme, a component of hemoglobin. Symptoms in common: Abnormal circulating porphyrin concentration. Symptoms not in common: Hypoglycemia, Glycosuria.

+3. Insulinoma: A rare tumor of the pancreas that produces excessive amounts of insulin, leading to hypoglycemia. Symptoms in common: Hypoglycemia. Symptoms not in common: Glycosuria, Abnormal circulating porphyrin concentration.

+4. Renal Glycosuria: A condition where the kidneys are unable to reabsorb glucose from the urine, leading to the presence of glucose in urine. Symptoms in common: Glycosuria. Symptoms not in common: Hypoglycemia, Abnormal circulating porphyrin concentration.

+5. Liver Disease: Various liver disorders can lead to abnormal porphyrin metabolism and accumulation. Symptoms in common: Abnormal circulating porphyrin concentration. Symptoms not in common: Hypoglycemia, Glycosuria.

Please note that a proper diagnosis requires a comprehensive evaluation by a healthcare professional, including a detailed medical history, physical examination, and additional tests as necessary."
['Phenylketonuria'],"Based on the provided symptoms: ['Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Hyperphenylalaninemia'], here are some potential diseases with their descriptions:

+1. Phenylketonuria (PKU):
Common Symptoms: Hyperphenylalaninemia
Uncommon Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death (unless left untreated)

+2. Congenital Malformations:
Common Symptoms: Abnormality of prenatal development or birth
Uncommon Symptoms: Death in infancy, Neonatal death, Hyperphenylalaninemia

+3. Inborn Errors of Metabolism:
Common Symptoms: Hyperphenylalaninemia, Abnormality of prenatal development or birth
Uncommon Symptoms: Death in infancy, Neonatal death (unless severe and left untreated)

+4. Genetic Disorders:
Common Symptoms: Abnormality of prenatal development or birth, Hyperphenylalaninemia (in some cases)
Uncommon Symptoms: Death in infancy, Neonatal death (unless severe and left untreated)

+5. Congenital Anomalies:
Common Symptoms: Abnormality of prenatal development or birth
Uncommon Symptoms: Death in infancy, Neonatal death, Hyperphenylalaninemia

Please note that these are general descriptions, and a proper diagnosis would require further evaluation, testing, and consideration of the patient's complete medical history and clinical presentation."
['Glutaryl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Glutaric Aciduria Type 1: A rare inherited disorder characterized by an abnormal buildup of glutaric acid in the body. Symptoms in common: Macrocephaly, Seizure, Lethargy, Dystonia, Cerebral atrophy, Glutaric aciduria. Symptoms not in common: Hydrocephalus, Hyperhidrosis, Hyperreflexia, Death in infancy, Anemia, Fever, Vomiting, Opisthotonus, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction, Increased CSF protein concentration, Death in childhood, Recurrent viral infections, Chronic pulmonary obstruction, Death in adolescence.

+2. Canavan Disease: A rare, inherited neurological disorder caused by a deficiency of an enzyme called aspartoacylase. Symptoms in common: Macrocephaly, Lethargy, Cerebral atrophy, Increased CSF protein concentration. Symptoms not in common: Hydrocephalus, Hyperhidrosis, Seizure, Dystonia, Hyperreflexia, Death in infancy, Anemia, Fever, Vomiting, Opisthotonus, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction, Glutaric aciduria, Death in childhood, Recurrent viral infections, Chronic pulmonary obstruction, Death in adolescence.

+3. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system. Symptoms in common: Seizure, Lethargy, Dystonia, Cerebral atrophy, Increased CSF protein concentration. Symptoms not in common: Hydrocephalus, Macrocephaly, Hyperhidrosis, Hyperreflexia, Death in infancy, Anemia, Fever, Vomiting, Opisthotonus, Drowsiness, Sleep abnormality, Fasciculations, Upper airway obstruction, Glutaric aciduria, Death in childhood, Recurrent viral infections, Chronic pulmonary obstruction, Death in adolescence.

+4. Niemann-Pick Disease Type C: A rare inherited lipid storage disorder that affects the body's ability to metabolize cholesterol and other lipids. Symptoms in common: Seizure, Lethargy, Dystonia, Cerebral atrophy, Sleep abnormality. Symptoms not in common: Hydrocephalus, Macrocephaly, Hyperhidrosis, Hyperreflexia, Death in infancy, Anemia, Fever, Vomiting, Opisthotonus, Drowsiness, Fasciculations, Upper airway obstruction, Increased CSF protein concentration, Glutaric aciduria, Death in childhood, Recurrent viral infections, Chronic pulmonary obstruction, Death in adolescence."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia,' which are common in PKU. However, the symptoms of 'Abnormality of prenatal development or birth,' 'Death in infancy,' 'Neonatal death,' and 'Death in childhood' are not typically associated with PKU if it is diagnosed and treated early.

+2. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body cannot break down certain amino acids, leading to their accumulation in the blood and urine. The patient does not have any symptoms specifically related to MSUD, such as the characteristic sweet, maple syrup-like odor in urine and sweat.

+3. Tyrosinemia:
This is a group of inherited disorders characterized by the inability to metabolize the amino acid tyrosine, leading to its accumulation in the body. The patient has the symptom of 'Hypertyrosinemia,' which is common in tyrosinemia. However, other symptoms like liver and kidney problems, neurological issues, and developmental delays are not mentioned.

+4. Homocystinuria:
This is a rare inherited disorder in which the body cannot properly metabolize the amino acid homocysteine, leading to its accumulation in the blood and tissues. The patient does not have any symptoms specifically related to homocystinuria, such as developmental delays, osteoporosis, or thrombosis.

+5. Urea Cycle Disorders:
These are a group of inherited disorders that affect the body's ability to remove ammonia from the bloodstream, leading to its accumulation in the body. The patient does not have any symptoms specifically related to urea cycle disorders, such as lethargy, vomiting, or respiratory distress.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a detailed medical history, by a qualified healthcare professional."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia
Symptoms not in common: Hypertyrosinemia, Preeclampsia, Death in early adulthood

+2. Tyrosinemia:
Symptoms in common: Hypertyrosinemia
Symptoms not in common: Hyperphenylalaninemia, Preeclampsia, Death in early adulthood

+3. Preeclampsia:
Symptoms in common: Preeclampsia
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood

+4. Progeria (Hutchinson-Gilford Progeria Syndrome):
Symptoms in common: Death in early adulthood
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Preeclampsia

+5. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Hyperphenylalaninemia (in some cases)
Symptoms not in common: Hypertyrosinemia, Preeclampsia, Death in early adulthood

Please note that this is a hypothetical diagnosis based on the limited information provided, and further medical evaluation and testing would be required to confirm the actual condition."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia, Elevated urinary carboxylic acid
Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in early adulthood

+2. Tyrosinemia type I:
Symptoms in common: Hypertyrosinemia, Elevated urinary carboxylic acid, Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Symptoms not in common: Death in early adulthood

+3. Maple syrup urine disease (MSUD):
Symptoms in common: Elevated urinary carboxylic acid, Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood

+4. Methylmalonic acidemia:
Symptoms in common: Elevated urinary carboxylic acid, Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood

+5. Propionic acidemia:
Symptoms in common: Elevated urinary carboxylic acid, Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's complete medical history, physical examination, and relevant laboratory tests."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia,' which are common in PKU. However, the symptoms of 'Abnormality of prenatal development or birth,' 'Death in infancy,' 'Neonatal death,' and 'Death in childhood' are not typically associated with PKU if it is diagnosed and treated early.

+2. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body cannot break down certain amino acids, leading to their accumulation in the blood and urine. The patient does not have any symptoms specifically related to MSUD, such as the characteristic sweet, maple syrup-like odor in urine and sweat.

+3. Tyrosinemia:
This is a group of inherited disorders characterized by the inability to metabolize the amino acid tyrosine, leading to its accumulation in the body. The patient has the symptom of 'Hypertyrosinemia,' which is common in tyrosinemia. However, other symptoms like liver and kidney problems, neurological issues, and developmental delays are not mentioned.

+4. Homocystinuria:
This is a rare inherited disorder in which the body cannot properly metabolize the amino acid homocysteine, leading to its accumulation in the blood and tissues. The patient does not have any symptoms specifically related to homocystinuria, such as developmental delays, osteoporosis, or thrombosis.

+5. Urea Cycle Disorders:
These are a group of inherited disorders that affect the body's ability to remove ammonia from the bloodstream, leading to its accumulation in the body. The patient does not have any symptoms specifically related to urea cycle disorders, such as lethargy, vomiting, or respiratory distress.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a detailed medical history, by a qualified healthcare professional."
['Hereditary orotic aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Lysosomal storage disorders: A group of inherited metabolic disorders characterized by the accumulation of specific substances within the lysosomes, leading to various symptoms such as skin rash, lethargy, hypotonia, hepatosplenomegaly, and developmental delays. Common symptoms present: Skin rash, Lethargy, Generalized hypotonia, Splenomegaly, Hepatomegaly, Feeding difficulties. Symptoms not present: Death in infancy, Fever, Vomiting, Pneumonia, Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circulating alanine concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+2. Inborn errors of metabolism: A group of genetic disorders involving defects in specific metabolic pathways, leading to the accumulation or deficiency of certain metabolites. Symptoms can vary depending on the specific disorder but may include lethargy, hypotonia, developmental delays, and metabolic abnormalities. Common symptoms present: Lethargy, Generalized hypotonia, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Abnormal circulating alanine concentration. Symptoms not present: Skin rash, Death in infancy, Splenomegaly, Fever, Vomiting, Pneumonia, Hepatomegaly, Drowsiness, Sleep abnormality, Death in childhood, Feeding difficulties, Erythematous plaque, Erythematous macule, Erythematous papule.

+3. Immunodeficiency disorders: A group of disorders characterized by a compromised immune system, leading to increased susceptibility to infections and other complications. Symptoms may include recurrent infections, fever, and pneumonia. Common symptoms present: Fever, Pneumonia. Symptoms not present: Skin rash, Lethargy, Generalized hypotonia, Death in infancy, Splenomegaly, Vomiting, Hepatomegaly, Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circulating alanine concentration, Feeding difficulties, Erythematous plaque, Erythematous macule, Erythematous papule.

+4. Infectious diseases: Various bacterial, viral, or fungal infections can present with a range of symptoms, including fever, rash, lethargy, and respiratory or gastrointestinal symptoms. Common symptoms present: Skin rash, Lethargy, Fever, Vomiting, Pneumonia. Symptoms not present: Generalized hypotonia, Death in infancy, Splenomegaly, Hepatomegaly, Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circulating alanine concentration, Feeding difficulties, Erythematous plaque, Erythematous macule, Erythematous papule.

Please note that this is a general overview, and a proper diagnosis would require a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests."
['Holocarboxylase synthetase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Propionic acidemia: A rare inherited disorder characterized by the inability to metabolize certain amino acids and fatty acids, leading to the accumulation of propionic acid and other harmful substances in the body. Symptoms include vomiting, lethargy, hypotonia, developmental delays, and metabolic acidosis.
Symptoms in common: Metabolic acidosis, Hyperammonemia, Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid.
Symptoms not in common: Cyanosis, Eczematoid dermatitis, Skin rash, Generalized hypotonia, Death in infancy, Anemia, Diarrhea, Tachypnea, Decreased pyruvate carboxylase activity, Propionyl-CoA carboxylase deficiency, Aminoaciduria, Neonatal death, Abnormal circulating glycine concentration.

+2. Methylmalonic acidemia: Another inherited disorder involving the inability to metabolize certain amino acids and fatty acids, leading to the accumulation of methylmalonic acid and other toxic substances. Symptoms may include vomiting, lethargy, hypotonia, developmental delays, and metabolic acidosis.
Symptoms in common: Metabolic acidosis, Hyperammonemia, Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid.
Symptoms not in common: Cyanosis, Eczematoid dermatitis, Skin rash, Generalized hypotonia, Death in infancy, Anemia, Diarrhea, Tachypnea, Decreased pyruvate carboxylase activity, Propionyl-CoA carboxylase deficiency, Aminoaciduria, Neonatal death, Abnormal circulating glycine concentration.

+3. Isovaleric acidemia: A rare inherited disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, which is involved in the breakdown of certain amino acids. Symptoms may include vomiting, lethargy, hypotonia, developmental delays, and a distinctive sweaty foot odor.
Symptoms in common: Metabolic acidosis, Hyperammonemia, Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid.
Symptoms not in common: Cyanosis, Eczematoid dermatitis, Skin rash, Generalized hypotonia, Death in infancy, Anemia, Diarrhea, Tachypnea, Decreased pyruvate carboxylase activity, Propionyl-CoA carboxylase deficiency, Aminoaciduria, Neonatal death, Abnormal circulating glycine concentration.

+4. Glycine encephalopathy: A rare inherited disorder caused by a deficiency of the enzyme glycine decarboxylase, which leads to an accumulation of glycine in the body. Symptoms may include developmental delays, seizures, hypotonia, and respiratory distress.
Symptoms in common: Generalized hypotonia, Abnormal circulating glycine concentration.
Symptoms not in common: Cyanosis, Eczematoid dermatitis, Skin rash, Death in infancy, Anemia, Metabolic acidosis, Hyperammonemia, Diarrhea, Tachypnea, Decreased pyruvate carboxylase activity, Propionyl-CoA carboxylase deficiency, Aminoaciduria, Neonatal death, Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid."
['Ornithine transcarbamylase deficiency'],"Based on the provided symptoms: ['Apathy', 'Ataxia', 'Lethargy', 'Hyperammonemia', 'Vomiting', 'Drowsiness', 'Sleep abnormality', 'Oroticaciduria', 'Death in adolescence'], here are the potential diseases with their descriptions:

+1. Ornithine Transcarbamylase Deficiency (OTC) Deficiency: This is a rare inherited disorder that causes a buildup of ammonia in the blood (hyperammonemia). Symptoms in common: Lethargy, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality. Symptoms not in common: Apathy, Ataxia, Oroticaciduria, Death in adolescence.

+2. Arginase Deficiency: A rare inherited disorder that causes a buildup of arginine and ammonia in the blood. Symptoms in common: Lethargy, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality. Symptoms not in common: Apathy, Ataxia, Oroticaciduria, Death in adolescence.

+3. Citrullinemia: A rare inherited disorder that causes a buildup of citrulline and ammonia in the blood. Symptoms in common: Lethargy, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality. Symptoms not in common: Apathy, Ataxia, Oroticaciduria, Death in adolescence.

+4. Maple Syrup Urine Disease (MSUD): A rare inherited disorder that causes a buildup of certain amino acids in the blood. Symptoms in common: Lethargy, Vomiting, Drowsiness, Sleep abnormality. Symptoms not in common: Apathy, Ataxia, Hyperammonemia, Oroticaciduria, Death in adolescence.

+5. Leigh's Disease: A rare inherited neurometabolic disorder that affects the central nervous system. Symptoms in common: Lethargy, Ataxia, Vomiting, Drowsiness, Sleep abnormality. Symptoms not in common: Apathy, Hyperammonemia, Oroticaciduria, Death in adolescence.

+6. Urea Cycle Disorders: A group of inherited disorders that cause a buildup of ammonia in the blood. Symptoms in common: Lethargy, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality. Symptoms not in common: Apathy, Ataxia, Oroticaciduria, Death in adolescence.

Please note that further diagnostic tests and evaluations would be necessary to confirm the specific diagnosis based on the presented symptoms."
[],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Glutaric Aciduria Type II (Multiple Acyl-CoA Dehydrogenase Deficiency): This is a rare inherited disorder that affects the body's ability to break down certain fats and proteins. It is characterized by vomiting, abnormal circulating carnitine concentration, and decreased 3-hydroxyacyl-CoA dehydrogenase level. However, the symptoms of ethylmalonic aciduria, death in childhood, and death in adolescence are not typically associated with this condition.

+2. Ethylmalonic Encephalopathy: This is a rare inherited metabolic disorder caused by a deficiency of the enzyme ethylmalonic encephalopathy protein 1 (ETHE1). It is characterized by ethylmalonic aciduria, vomiting, and can lead to death in childhood or adolescence. However, the symptoms of abnormal circulating carnitine concentration and decreased 3-hydroxyacyl-CoA dehydrogenase level are not typically associated with this condition.

+3. Carnitine Palmitoyltransferase II Deficiency: This is a rare inherited disorder that affects the body's ability to break down long-chain fatty acids for energy. It is characterized by vomiting, abnormal circulating carnitine concentration, and decreased 3-hydroxyacyl-CoA dehydrogenase level. However, the symptoms of ethylmalonic aciduria, death in childhood, and death in adolescence are not typically associated with this condition.

+4. Mitochondrial Trifunctional Protein Deficiency: This is a rare inherited disorder that affects the body's ability to break down certain fats and proteins. It is characterized by vomiting, abnormal circulating carnitine concentration, and decreased 3-hydroxyacyl-CoA dehydrogenase level. However, the symptoms of ethylmalonic aciduria, death in childhood, and death in adolescence are not typically associated with this condition.

It's important to note that a proper diagnosis should be made by a qualified medical professional after a thorough evaluation and appropriate testing."
['Smith-Lemli-Opitz syndrome'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Down Syndrome: This genetic disorder is characterized by intellectual disability, distinctive facial features (including low-set ears, wide nasal bridge, and protruding tongue), hypotonia, and developmental delays. Common symptoms match: Low-set ears, wide nasal bridge, intellectual disability, motor delay, generalized hypotonia.

+2. Trisomy 18 (Edwards Syndrome): A chromosomal disorder that can cause severe intellectual disability, distinctive craniofacial abnormalities (including low-set ears, wide nasal bridge, and ptosis), hypotonia, and feeding difficulties. Common symptoms match: Low-set ears, wide nasal bridge, ptosis, intellectual disability, motor delay, generalized hypotonia, feeding difficulties.

+3. Trisomy 13 (Patau Syndrome): Another chromosomal disorder that can lead to severe intellectual disability, craniofacial abnormalities (including low-set ears, wide nasal bridge, and anteverted nares), hypotonia, and feeding difficulties. Common symptoms match: Low-set ears, wide nasal bridge, anteverted nares, intellectual disability, motor delay, generalized hypotonia, feeding difficulties.

+4. Smith-Lemli-Opitz Syndrome: A genetic disorder caused by an inborn error of cholesterol metabolism, characterized by intellectual disability, distinctive facial features (including low-set ears, wide nasal bridge, and anteverted nares), syndactyly, hypotonia, and feeding difficulties. Common symptoms match: Low-set ears, wide nasal bridge, anteverted nares, syndactyly, intellectual disability, motor delay, generalized hypotonia, feeding difficulties, hypocholesterolemia, elevated 8-dehydrocholesterol.

+5. Zellweger Syndrome: A rare inherited metabolic disorder that can cause craniofacial abnormalities (including high forehead, wide nasal bridge, and anteverted nares), hypotonia, feeding difficulties, and intellectual disability. Common symptoms match: Wide nasal bridge, anteverted nares, intellectual disability, motor delay, generalized hypotonia, feeding difficulties.

Please note that a definitive diagnosis cannot be made without further medical evaluation and testing. These are just potential diseases based on the provided symptoms."
['L-2-hydroxyglutaric aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder characterized by progressive loss of mental and movement abilities. It typically appears in infancy or early childhood.
Symptoms in common: Intellectual disability, Ataxia, Tremor, Cerebral atrophy, Abnormal basal ganglia morphology, Death in infancy, Death in childhood.
Symptoms not in common: L-2-hydroxyglutaric aciduria.

+2. L-2-Hydroxyglutaric Aciduria: A rare inherited metabolic disorder caused by a deficiency of the enzyme L-2-hydroxyglutaric acid dehydrogenase, leading to the accumulation of L-2-hydroxyglutaric acid in the body.
Symptoms in common: L-2-hydroxyglutaric aciduria, Intellectual disability, Ataxia, Tremor, Cerebral atrophy, Abnormal basal ganglia morphology.
Symptoms not in common: Death in infancy, Neonatal death, Death in childhood.

+3. Infantile Neuroaxonal Dystrophy: A rare inherited neurodegenerative disorder characterized by the accumulation of abnormal proteins in the nerve cells, leading to progressive neurological impairment.
Symptoms in common: Intellectual disability, Ataxia, Tremor, Cerebral atrophy, Abnormal basal ganglia morphology, Death in infancy, Death in childhood.
Symptoms not in common: L-2-hydroxyglutaric aciduria.

+4. Neuronal Ceroid Lipofuscinosis: A group of inherited neurodegenerative disorders characterized by the accumulation of lipopigments in the brain and other tissues, leading to progressive loss of vision, seizures, and cognitive and motor impairment.
Symptoms in common: Intellectual disability, Ataxia, Tremor, Cerebral atrophy, Abnormal basal ganglia morphology, Death in infancy, Death in childhood.
Symptoms not in common: L-2-hydroxyglutaric aciduria.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, including a detailed medical history, physical examination, and appropriate diagnostic tests."
['3-hydroxy-3-methylglutaric aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Glutaric Aciduria Type 1 (GA1): A rare inherited metabolic disorder characterized by the accumulation of glutaric acid and its metabolites. Symptoms in common: Irritability, seizures, generalized hypotonia, metabolic acidosis, opisthotonus, dicarboxylic aciduria, and elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, neonatal death, death in childhood, and 3-methylglutaconic aciduria.

+2. Methylmalonic Acidemia: An inherited metabolic disorder caused by a deficiency in the enzyme methylmalonyl-CoA mutase or its cofactor, leading to the accumulation of methylmalonic acid. Symptoms in common: Irritability, seizures, generalized hypotonia, metabolic acidosis, opisthotonus, dicarboxylic aciduria, and elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, neonatal death, death in childhood, and 3-methylglutaconic aciduria.

+3. Propionic Acidemia: A rare inherited metabolic disorder caused by a deficiency in the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid and other metabolites. Symptoms in common: Irritability, seizures, generalized hypotonia, metabolic acidosis, opisthotonus, dicarboxylic aciduria, and elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, neonatal death, death in childhood, and 3-methylglutaconic aciduria.

+4. Isovaleric Acidemia: An inherited metabolic disorder caused by a deficiency in the enzyme isovaleryl-CoA dehydrogenase, leading to the accumulation of isovaleric acid and its metabolites. Symptoms in common: Irritability, seizures, generalized hypotonia, metabolic acidosis, opisthotonus, dicarboxylic aciduria, and elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, neonatal death, death in childhood, and 3-methylglutaconic aciduria.

+5. 3-Methylglutaconic Aciduria: A rare inherited metabolic disorder characterized by the accumulation of 3-methylglutaconic acid and other metabolites. Symptoms in common: Irritability, seizures, generalized hypotonia, metabolic acidosis, opisthotonus, dicarboxylic aciduria, 3-methylglutaconic aciduria, and elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, neonatal death, and death in childhood.

Please note that a definitive diagnosis requires further clinical evaluation, laboratory tests, and genetic analysis. These potential diseases are based solely on the provided symptoms."
['L-2-hydroxyglutaric aciduria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Mevalonate Kinase Deficiency (MKD):
This is a rare autoinflammatory disorder characterized by recurrent episodes of fever, rash, abdominal pain, and joint pain. The patient has symptoms like skin rash, fever, and elevated C-reactive protein concentration, which are common in MKD. However, the patient does not seem to have symptoms like abdominal pain or joint pain.

+2. Atopic Dermatitis:
This is a chronic inflammatory skin condition characterized by dry, itchy skin, rashes, and eczema. The patient has symptoms like obsolete eczematoid dermatitis and skin rash, which are common in atopic dermatitis. However, the patient does not seem to have other common symptoms like itching or dry skin.

+3. Epilepsy:
This is a neurological disorder characterized by recurrent seizures. The patient has a symptom of seizure, which is a hallmark of epilepsy. However, the other symptoms provided do not seem to be directly related to epilepsy.

+4. Infantile Neuroaxonal Dystrophy (INAD):
This is a rare inherited disorder that affects the nervous system and causes progressive neurological deterioration, often leading to death in infancy. The patient has a symptom of death in infancy, which is common in INAD. However, the other symptoms provided do not seem to be directly related to INAD.

+5. L-2-Hydroxyglutaric Aciduria:
This is a rare inherited metabolic disorder characterized by the accumulation of L-2-hydroxyglutaric acid in the body. The patient has a symptom of L-2-hydroxyglutaric aciduria, which is the defining feature of this disorder. However, the other symptoms provided do not seem to be directly related to this condition.

+6. Iron Deficiency Anemia:
This is a condition characterized by low levels of iron in the body, leading to decreased production of red blood cells. The patient has a symptom of decreased serum iron, which is a common indicator of iron deficiency anemia. However, the other symptoms provided do not seem to be directly related to this condition.

Please note that a proper diagnosis would require a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory tests."
['X-linked hypophosphatemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Hypophosphatemic Rickets: A rare inherited disorder characterized by low levels of phosphate in the blood, leading to softening and weakening of the bones. The patient has symptoms such as 'Hypophosphatemia', 'Abnormal limb bone morphology', and 'Elevated circulating alkaline phosphatase concentration' in common with this disease. However, the symptoms 'Nephritis', 'Death in infancy', 'Abnormal circulating hormone concentration', and 'Death in childhood' are not typically associated with Hypophosphatemic Rickets.

+2. X-Linked Hypophosphatemia: A genetic disorder that affects the regulation of phosphate levels in the body, leading to low levels of phosphate in the blood and bone abnormalities. The patient has symptoms such as 'Hypophosphatemia', 'Abnormal limb bone morphology', and 'Elevated circulating alkaline phosphatase concentration' in common with this disease. However, the symptoms 'Nephritis', 'Death in infancy', 'Abnormal circulating hormone concentration', and 'Death in childhood' are not typically associated with X-Linked Hypophosphatemia.

+3. Autosomal Recessive Hypophosphatemic Rickets: A rare inherited disorder caused by mutations in the DMP1 gene, leading to low levels of phosphate in the blood and bone abnormalities. The patient has symptoms such as 'Hypophosphatemia', 'Abnormal limb bone morphology', and 'Elevated circulating alkaline phosphatase concentration' in common with this disease. However, the symptoms 'Nephritis', 'Death in infancy', 'Abnormal circulating hormone concentration', and 'Death in childhood' are not typically associated with Autosomal Recessive Hypophosphatemic Rickets.

+4. Chronic Kidney Disease: A condition in which the kidneys are damaged and unable to filter waste products from the blood effectively. The patient has the symptom 'Nephritis' in common with this disease, which can be a manifestation of kidney disease. However, the other symptoms such as 'Hypophosphatemia', 'Abnormal limb bone morphology', 'Abnormal circulating hormone concentration', 'Elevated circulating alkaline phosphatase concentration', 'Death in infancy', and 'Death in childhood' are not typically associated with Chronic Kidney Disease.

It's important to note that a comprehensive medical evaluation, including laboratory tests and imaging studies, would be necessary to arrive at an accurate diagnosis and rule out other potential conditions."
['Propionic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Nonketotic Hyperglycinemia: A rare inherited metabolic disorder characterized by elevated levels of glycine in the body. Symptoms in common: Delayed speech and language development, Hyperglycinemia, Hyperglycinuria. Symptoms not in common: Eczematoid dermatitis, Skin rash, Death in infancy, Leukopenia, Hyperammonemia, Elevated circulating alkaline phosphatase concentration, Death in childhood, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Death in adolescence, Abnormal circulating serine concentration, Elevated urinary carboxylic acid.

+2. Urea Cycle Disorders: A group of inherited metabolic disorders that affect the body's ability to remove ammonia from the bloodstream. Symptoms in common: Delayed speech and language development, Hyperammonemia. Symptoms not in common: Eczematoid dermatitis, Skin rash, Death in infancy, Leukopenia, Hyperglycinemia, Hyperglycinuria, Elevated circulating alkaline phosphatase concentration, Death in childhood, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Death in adolescence, Abnormal circulating serine concentration, Elevated urinary carboxylic acid.

+3. Severe Combined Immunodeficiency (SCID): A group of rare inherited disorders characterized by a deficiency in the immune system. Symptoms in common: Leukopenia, Death in infancy, Death in childhood. Symptoms not in common: Delayed speech and language development, Eczematoid dermatitis, Skin rash, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Elevated circulating alkaline phosphatase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Death in adolescence, Abnormal circulating serine concentration, Elevated urinary carboxylic acid.

+4. Metabolic Disorders: A broad category of inherited disorders that affect the body's ability to metabolize certain substances. Symptoms in common: Delayed speech and language development, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Abnormal circulating serine concentration, Elevated urinary carboxylic acid. Symptoms not in common: Eczematoid dermatitis, Skin rash, Death in infancy, Leukopenia, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Elevated circulating alkaline phosphatase concentration, Death in childhood, Death in adolescence."
"['Methylmalonic acidemia with homocystinuria, type cblC']","Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Methylmalonic Acidemia: A rare inherited disorder characterized by the inability to properly metabolize certain proteins and fats, leading to a buildup of methylmalonic acid in the body. Symptoms include:
- Common: Methylmalonic aciduria, decreased plasma free carnitine
- Not common: Delayed speech and language development, generalized hypotonia, death in infancy, hyperhomocystinemia, abnormal cerebral white matter morphology, neonatal death, death in childhood, gastrointestinal inflammation

+2. Propionic Acidemia: A rare inherited disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, which is involved in the breakdown of certain amino acids and lipids. Symptoms include:
- Common: Methylmalonic aciduria, decreased plasma free carnitine, gastrointestinal inflammation
- Not common: Delayed speech and language development, generalized hypotonia, death in infancy, hyperhomocystinemia, abnormal cerebral white matter morphology, neonatal death, death in childhood

+3. Leukodystrophy: A group of rare inherited disorders that affect the brain, spinal cord, and peripheral nerves. Symptoms include:
- Common: Delayed speech and language development, abnormal cerebral white matter morphology
- Not common: Generalized hypotonia, death in infancy, hyperhomocystinemia, neonatal death, death in childhood, gastrointestinal inflammation, decreased plasma free carnitine, methylmalonic aciduria

+4. Homocystinuria: A rare inherited disorder characterized by the inability to properly metabolize the amino acid homocysteine. Symptoms include:
- Common: Hyperhomocystinemia
- Not common: Delayed speech and language development, generalized hypotonia, death in infancy, abnormal cerebral white matter morphology, neonatal death, death in childhood, gastrointestinal inflammation, decreased plasma free carnitine, methylmalonic aciduria

+5. Mitochondrial Disorders: A group of inherited disorders caused by dysfunctional mitochondria, which are responsible for producing energy in cells. Symptoms include:
- Common: Generalized hypotonia, gastrointestinal inflammation, decreased plasma free carnitine
- Not common: Delayed speech and language development, death in infancy, hyperhomocystinemia, abnormal cerebral white matter morphology, neonatal death, death in childhood, methylmalonic aciduria

Please note that this is a preliminary assessment based on the provided symptoms, and further diagnostic tests and evaluations may be necessary to confirm or rule out these potential diseases."
['Biotinidase deficiency'],"+1. Methylmalonic acidemia: This disease is characterized by the accumulation of methylmalonic acid in the body due to a deficiency in the enzyme methylmalonyl-CoA mutase. Symptoms in common: Elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, Neonatal death (although these can occur in severe cases).

+2. Propionic acidemia: This is a metabolic disorder caused by a deficiency in the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid and other metabolites. Symptoms in common: Elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, Neonatal death (although these can occur in severe cases).

+3. Isovaleric acidemia: This disorder is caused by a deficiency in the enzyme isovaleryl-CoA dehydrogenase, resulting in the accumulation of isovaleric acid and other metabolites. Symptoms in common: Elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, Neonatal death (although these can occur in severe cases).

+4. Glutaric acidemia type I: This is a metabolic disorder caused by a deficiency in the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of glutaric acid and other metabolites. Symptoms in common: Elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, Neonatal death (although these can occur in severe cases).

+5. Multiple carboxylase deficiency: This rare disorder is caused by a deficiency in the enzyme biotinidase, which is necessary for the proper function of several carboxylase enzymes. Symptoms in common: Elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, Neonatal death (although these can occur in severe cases)."
['Carbamoyl-phosphate synthetase 1 deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder characterized by progressive loss of mental and movement abilities. It typically appears in infancy or early childhood.
Symptoms in common: Lethargy, Generalized hypotonia, Feeding difficulties
Symptoms not in common: Spasticity, Hyperreflexia, Death in infancy, Hyperammonemia, Drowsiness, Sleep abnormality, Neonatal death

+2. Maple Syrup Urine Disease (MSUD): A rare inherited disorder in which the body is unable to process certain amino acids properly, leading to a buildup of toxic substances.
Symptoms in common: Lethargy, Generalized hypotonia, Feeding difficulties, Drowsiness
Symptoms not in common: Spasticity, Hyperreflexia, Death in infancy, Hyperammonemia, Sleep abnormality, Neonatal death

+3. Nonketotic Hyperglycinemia: A rare inherited metabolic disorder characterized by an abnormally high level of glycine in the body fluids and tissues.
Symptoms in common: Lethargy, Generalized hypotonia, Hyperammonemia, Feeding difficulties
Symptoms not in common: Spasticity, Hyperreflexia, Death in infancy, Drowsiness, Sleep abnormality, Neonatal death

+4. Zellweger Syndrome: A rare inherited disorder characterized by the reduction or absence of peroxisomes in cells, which are essential for normal metabolic functions.
Symptoms in common: Lethargy, Generalized hypotonia, Feeding difficulties
Symptoms not in common: Spasticity, Hyperreflexia, Death in infancy, Hyperammonemia, Drowsiness, Sleep abnormality, Neonatal death

+5. Infantile Neuroaxonal Dystrophy: A rare inherited neurodegenerative disorder that primarily affects the nervous system and causes progressive psychomotor regression and dementia.
Symptoms in common: Lethargy, Generalized hypotonia, Feeding difficulties
Symptoms not in common: Spasticity, Hyperreflexia, Death in infancy, Hyperammonemia, Drowsiness, Sleep abnormality, Neonatal death

Please note that a proper diagnosis would require additional tests, examinations, and a thorough evaluation by a medical professional."
['Vitamin B12-unresponsive methylmalonic acidemia'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Methylmalonic Acidemia: A rare inherited disorder characterized by the inability to properly metabolize certain proteins and fats, leading to a buildup of methylmalonic acid in the body. Symptoms in common: Metabolic acidosis, Decreased methylmalonyl-CoA mutase activity. Symptoms not in common: Death in infancy, Death in childhood (although these can occur in severe cases).

+2. Propionic Acidemia: Another inherited metabolic disorder that affects the breakdown of certain proteins and lipids, resulting in an accumulation of propionic acid and other harmful substances. Symptoms in common: Metabolic acidosis. Symptoms not in common: Decreased methylmalonyl-CoA mutase activity, Death in infancy, Death in childhood (although these can occur in severe cases).

+3. Maple Syrup Urine Disease: A rare genetic disorder that affects the body's ability to break down certain amino acids, leading to a buildup of toxic substances and a characteristic sweet, maple syrup-like odor in urine and earwax. Symptoms in common: Metabolic acidosis. Symptoms not in common: Decreased methylmalonyl-CoA mutase activity, Death in infancy, Death in childhood (although these can occur in severe cases).

+4. Isovaleric Acidemia: An inherited metabolic disorder that affects the breakdown of the amino acid leucine, leading to an accumulation of isovaleric acid and other toxic substances. Symptoms in common: Metabolic acidosis. Symptoms not in common: Decreased methylmalonyl-CoA mutase activity, Death in infancy, Death in childhood (although these can occur in severe cases).

Please note that a proper diagnosis would require additional tests and a thorough medical evaluation by a qualified healthcare professional."
[],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Leigh Syndrome:
This is a rare inherited neurometabolic disorder that affects the central nervous system. It is characterized by degeneration of the brain's motor control areas.
Common Symptoms: Hyperactivity, Spasticity, Neonatal death
Uncommon Symptoms: Hemolytic anemia, Metabolic acidosis, Increased total bilirubin, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased circulating lactate dehydrogenase concentration

+2. Porphyria:
A group of inherited disorders that result from a deficiency in one of the enzymes required for the production of heme, an essential component of hemoglobin.
Common Symptoms: Abnormal circulating porphyrin concentration
Uncommon Symptoms: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Metabolic acidosis, Increased total bilirubin, Neonatal death, Recurrent viral infections, Increased circulating lactate dehydrogenase concentration

+3. Severe Combined Immunodeficiency (SCID):
A group of rare, life-threatening disorders characterized by a lack of functional immune cells, leaving the body vulnerable to recurrent infections.
Common Symptoms: Recurrent viral infections
Uncommon Symptoms: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Metabolic acidosis, Increased total bilirubin, Neonatal death, Abnormal circulating porphyrin concentration, Increased circulating lactate dehydrogenase concentration

+4. Hemolytic Anemia:
A condition in which red blood cells are destroyed faster than they can be replaced, leading to a shortage of red blood cells.
Common Symptoms: Hemolytic anemia, Increased circulating lactate dehydrogenase concentration
Uncommon Symptoms: Hyperactivity, Spasticity, Death in infancy, Metabolic acidosis, Increased total bilirubin, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration

+5. Metabolic Acidosis:
A condition characterized by an excessive accumulation of acid in the body fluids, which can be caused by various underlying disorders.
Common Symptoms: Metabolic acidosis
Uncommon Symptoms: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Increased total bilirubin, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased circulating lactate dehydrogenase concentration

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required to confirm the actual diagnosis."
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Citrullinemia type I: A rare inherited disorder characterized by a deficiency of the enzyme argininosuccinate synthetase, which is involved in the urea cycle. This disorder can lead to hyperammonemia, respiratory distress, and neonatal death.
Symptoms in common: Hyperammonemia, respiratory distress, neonatal death.
Symptoms not in common: Premature birth, apnea, respiratory acidosis, elevated plasma citrulline, hypoxemia.

+2. Transient Hyperammonemia of the Newborn: A condition characterized by a temporary elevation of ammonia levels in the blood, which can occur in premature or low birth weight infants.
Symptoms in common: Hyperammonemia, premature birth, respiratory distress, apnea.
Symptoms not in common: Death in infancy, neonatal death, respiratory acidosis, elevated plasma citrulline, hypoxemia.

+3. Respiratory Distress Syndrome (RDS): A condition affecting premature infants, caused by a deficiency of surfactant in the lungs, leading to respiratory distress and hypoxemia.
Symptoms in common: Premature birth, respiratory distress, hypoxemia.
Symptoms not in common: Death in infancy, hyperammonemia, apnea, neonatal death, respiratory acidosis, elevated plasma citrulline.

+4. Persistent Pulmonary Hypertension of the Newborn (PPHN): A condition characterized by abnormally high blood pressure in the lungs, leading to respiratory distress, hypoxemia, and respiratory acidosis.
Symptoms in common: Respiratory distress, hypoxemia, respiratory acidosis.
Symptoms not in common: Death in infancy, premature birth, hyperammonemia, apnea, neonatal death, elevated plasma citrulline.

+5. Urea Cycle Disorders: A group of inherited metabolic disorders affecting the urea cycle, which is responsible for removing ammonia from the body. These disorders can lead to hyperammonemia, respiratory distress, and neonatal death.
Symptoms in common: Hyperammonemia, respiratory distress, neonatal death.
Symptoms not in common: Death in infancy, premature birth, apnea, respiratory acidosis, elevated plasma citrulline, hypoxemia.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's medical history, physical examination, and additional diagnostic tests."
[],"Basé sur les symptômes fournis, voici une liste de maladies potentielles avec leurs descriptions :

+1. Acidémie méthylmalonique: Maladie métabolique rare caractérisée par une accumulation de l'acide méthylmalonique dans le sang et les tissus. Symptômes communs: acidémie méthylmalonique, acidurie méthylmalonique, hypotonie généralisée, retard intellectuel, convulsions, vomissements, acidose lactique. Symptômes non communs: comportement autistique, hypertension, œdème, coma, pancréatite, leucopénie, anémie, lésion rénale aiguë, hyperammoniémie, goutte, hyperuricémie, hyperglycinémie, maladresse, mauvaise coordination, cypho-scoliose, hyponatrémie, hypoprotéinémie, fémur court, augmentation de l'urée sanguine, augmentation de la phosphatase alcaline, augmentation de la créatinine, augmentation de la ferritine, décès dans l'enfance, anomalie des porphyrines, anomalie des acides aminés de la famille aspartate, anomalie de la valine, anomalie de l'alanine, anomalie de la carnitine, décès à l'adolescence, atransferrinémie, néphropathie chronique, décès au début de l'âge adulte.

+2. Déficit en méthylmalonyl-CoA mutase: Cause de l'acidémie méthylmalonique due à un déficit enzymatique. Symptômes communs: activité réduite de la méthylmalonyl-CoA mutase, acidémie méthylmalonique, acidurie méthylmalonique. Symptômes non communs: les mêmes que pour l'acidémie méthylmalonique.

+3. Atransferrinémie: Maladie génétique rare caractérisée par un déficit en transferrine. Symptômes communs: atransferrinémie, anémie, augmentation de la ferritine. Symptômes non communs: les autres symptômes listés.

La plupart des symptômes semblent pointer vers une acidémie méthylmalonique ou un déficit en méthylmalonyl-CoA mutase. L'atransferrinémie pourrait expliquer l'anémie et l'augmentation de la ferritine, mais pas les autres symptômes."
['Dihydropteridine reductase deficiency'],"Based on the provided symptoms: ['Microcephaly', 'Nystagmus', 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Alopecia', 'Cerebral atrophy', 'Abnormal cerebral white matter morphology', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Hyperphenylalaninemia'], here are some potential diseases with their descriptions:

+1. Zellweger Syndrome: This is a rare inherited disorder characterized by a lack of functional peroxisomes, which are cellular organelles responsible for various metabolic processes. Symptoms in common with the patient include microcephaly, nystagmus, intellectual disability, seizures, hypotonia, and cerebral abnormalities. Symptoms not present in the patient's list include hepatomegaly, renal cysts, and skeletal abnormalities.

+2. Menkes Disease: This is a rare X-linked recessive disorder caused by a defect in the ATP7A gene, which leads to impaired copper transport and distribution. Symptoms in common with the patient include microcephaly, intellectual disability, seizures, hypotonia, and cerebral atrophy. Symptoms not present in the patient's list include kinky or steely hair, hypothermia, and failure to thrive.

+3. Lesch-Nyhan Syndrome: This is a rare inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT), which leads to an accumulation of uric acid in the body. Symptoms in common with the patient include intellectual disability, seizures, and motor delay. Symptoms not present in the patient's list include self-mutilating behavior, gout, and kidney stones.

+4. Phenylketonuria (PKU): This is an inherited metabolic disorder characterized by the inability to break down the amino acid phenylalanine due to a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient include intellectual disability, seizures, and hyperphenylalaninemia. Symptoms not present in the patient's list include fair skin, blue eyes, and musty body odor.

+5. Tay-Sachs Disease: This is a rare inherited disorder caused by a deficiency of the enzyme hexosaminidase A, which leads to the accumulation of a fatty substance called ganglioside in the brain and other organs. Symptoms in common with the patient include microcephaly, intellectual disability, seizures, and cerebral atrophy. Symptoms not present in the patient's list include cherry-red spot in the retina, progressive vision loss, and muscle weakness."
[],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Glycosuria, Abnormal circulating glycine concentration
Symptoms not in common: Skin rash, Death in infancy, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Feeding difficulties, Functional abnormality of the gastrointestinal tract, Erythematous plaque, Erythematous macule, Erythematous papule

+2. Mitochondrial Myopathy:
Symptoms in common: Cytochrome C oxidase-negative muscle fibers
Symptoms not in common: Skin rash, Death in infancy, Glycosuria, Ethylmalonic aciduria, Abnormal circulating glycine concentration, Feeding difficulties, Functional abnormality of the gastrointestinal tract, Erythematous plaque, Erythematous macule, Erythematous papule

+3. Eczema:
Symptoms in common: Skin rash, Erythematous plaque, Erythematous macule, Erythematous papule
Symptoms not in common: Death in infancy, Glycosuria, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glycine concentration, Feeding difficulties, Functional abnormality of the gastrointestinal tract

+4. Glycogen Storage Disease:
Symptoms in common: Glycosuria
Symptoms not in common: Skin rash, Death in infancy, Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glycine concentration, Feeding difficulties, Functional abnormality of the gastrointestinal tract, Erythematous plaque, Erythematous macule, Erythematous papule

+5. Organic Acidemia:
Symptoms in common: Ethylmalonic aciduria
Symptoms not in common: Skin rash, Death in infancy, Glycosuria, Cytochrome C oxidase-negative muscle fibers, Abnormal circulating glycine concentration, Feeding difficulties, Functional abnormality of the gastrointestinal tract, Erythematous plaque, Erythematous macule, Erythematous papule

Please note that this is a hypothetical scenario, and a proper diagnosis would require a comprehensive medical evaluation by a qualified healthcare professional."
['Carbamoyl-phosphate synthetase 1 deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Citrullinemia type I:
This is a rare inherited disorder caused by a deficiency of the enzyme argininosuccinate synthetase, which is involved in the urea cycle. Symptoms include hyperammonemia, cerebral edema, seizures, and neonatal death. The patient has the following symptoms in common: Hyperammonemia, Seizure, Cerebral edema, and Neonatal death. The patient does not have Cyanosis, Death in infancy, Fasciculations, Oroticaciduria, Low plasma citrulline, or Hypoargininemia listed.

+2. Argininemia:
This is another inherited disorder of the urea cycle, caused by a deficiency of the enzyme arginase. Symptoms include hyperammonemia, seizures, and hypoargininemia. The patient has the following symptoms in common: Hyperammonemia and Seizure. The patient does not have Cyanosis, Death in infancy, Cerebral edema, Fasciculations, Oroticaciduria, Low plasma citrulline, or Neonatal death listed.

+3. Ornithine transcarbamylase deficiency:
This is an X-linked inherited disorder of the urea cycle, caused by a deficiency of the enzyme ornithine transcarbamylase. Symptoms include hyperammonemia, seizures, and neonatal death. The patient has the following symptoms in common: Hyperammonemia, Seizure, and Neonatal death. The patient does not have Cyanosis, Death in infancy, Cerebral edema, Fasciculations, Oroticaciduria, Low plasma citrulline, or Hypoargininemia listed.

+4. Urea cycle disorders:
These are a group of inherited metabolic disorders that affect the urea cycle, which is responsible for removing ammonia from the body. Symptoms can include hyperammonemia, seizures, cerebral edema, and neonatal death. The patient has the following symptoms in common: Hyperammonemia, Seizure, Cerebral edema, and Neonatal death. The patient does not have Cyanosis, Death in infancy, Fasciculations, Oroticaciduria, Low plasma citrulline, or Hypoargininemia listed."
['Canavan disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which is necessary for the proper metabolism of the amino acid phenylalanine. Symptoms the patient has in common: Hyperammonemia, Aminoaciduria, Abnormal circulating amino acid concentration. Symptoms the patient does not have: Skin rash, Seizure, Death in infancy, Neonatal death, Erythematous plaque, Erythematous macule, Erythematous papule.

+2. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body is unable to break down certain amino acids, leading to a buildup of toxic substances. Symptoms the patient has in common: Hyperammonemia, Aminoaciduria, Abnormal circulating amino acid concentration, Seizure, Neonatal death. Symptoms the patient does not have: Skin rash, Death in infancy, Erythematous plaque, Erythematous macule, Erythematous papule.

+3. Erythema Multiforme:
This is a skin condition that causes red, raised lesions on the skin, often in response to an infection or medication. Symptoms the patient has in common: Skin rash, Erythematous plaque, Erythematous macule, Erythematous papule. Symptoms the patient does not have: Seizure, Death in infancy, Hyperammonemia, Aminoaciduria, Neonatal death, Abnormal circulating glycine concentration, Abnormal circulating aspartate family amino acid concentration.

+4. Glycine Encephalopathy:
This is a rare inherited disorder characterized by abnormal accumulation of glycine in the body, leading to neurological symptoms. Symptoms the patient has in common: Seizure, Abnormal circulating glycine concentration. Symptoms the patient does not have: Skin rash, Death in infancy, Hyperammonemia, Aminoaciduria, Neonatal death, Abnormal circulating aspartate family amino acid concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+5. Aminoaciduria:
This is a condition characterized by the presence of excessive amounts of amino acids in the urine, which can be a symptom of various metabolic disorders. Symptoms the patient has in common: Aminoaciduria, Abnormal circulating amino acid concentration. Symptoms the patient does not have: Skin rash, Seizure, Death in infancy, Hyperammonemia, Neonatal death, Erythematous plaque, Erythematous macule, Erythematous papule."
['Maple syrup urine disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder characterized by the inability to break down certain amino acids, including leucine, isoleucine, and valine. Symptoms include feeding difficulties, seizures, respiratory issues, and a distinctive maple syrup odor in urine and earwax.
Common symptoms: Seizure, Respiratory insufficiency, Feeding difficulties, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia
Uncommon symptoms: Death in infancy, Opisthotonus, Neonatal death, Sepsis

+2. Neonatal Sepsis:
This is a bacterial infection that occurs in newborns, often within the first few days of life. Symptoms can include fever, respiratory distress, lethargy, and feeding difficulties.
Common symptoms: Sepsis, Respiratory insufficiency, Feeding difficulties
Uncommon symptoms: Seizure, Death in infancy, Opisthotonus, Neonatal death, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia

+3. Tetanus:
Tetanus is a serious bacterial infection that affects the nervous system and causes muscle spasms, including a characteristic arched back position known as opisthotonus.
Common symptoms: Opisthotonus
Uncommon symptoms: Seizure, Death in infancy, Respiratory insufficiency, Neonatal death, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Feeding difficulties, Sepsis

+4. Severe Combined Immunodeficiency (SCID):
SCID is a group of rare inherited disorders characterized by a deficient immune system, making the individual highly susceptible to infections and potentially leading to sepsis.
Common symptoms: Sepsis
Uncommon symptoms: Seizure, Death in infancy, Respiratory insufficiency, Opisthotonus, Neonatal death, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Feeding difficulties

+5. Neonatal Respiratory Distress Syndrome (NRDS):
NRDS is a breathing disorder that affects premature infants and is caused by a lack of surfactant in the lungs, leading to respiratory insufficiency and potential neonatal death.
Common symptoms: Respiratory insufficiency, Neonatal death
Uncommon symptoms: Seizure, Death in infancy, Opisthotonus, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Feeding difficulties, Sepsis

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's medical history, physical examination, and additional tests as necessary."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Carnitine Deficiency Disorders:
These disorders are characterized by abnormalities in the transportation of long-chain fatty acids into the mitochondria for energy production. Symptoms in common: Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level. Symptoms not in common: Abnormality of prenatal development or birth, Obesity, Death in infancy, Neonatal death, Death in childhood.

+2. Fatty Acid Oxidation Disorders:
These disorders involve defects in the enzymes responsible for breaking down fatty acids for energy production. Symptoms in common: Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level. Symptoms not in common: Abnormality of prenatal development or birth, Obesity, Death in infancy, Neonatal death, Death in childhood.

+3. Inborn Errors of Metabolism:
These are a group of genetic disorders that affect the body's ability to metabolize proteins, carbohydrates, or fats. Symptoms in common: Abnormality of prenatal development or birth, Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level. Symptoms not in common: Obesity, Death in infancy, Neonatal death, Death in childhood.

+4. Congenital Disorders of Glycosylation:
These are a group of inherited metabolic disorders that affect the glycosylation process, which is the attachment of sugar molecules to proteins and lipids. Symptoms in common: Abnormality of prenatal development or birth. Symptoms not in common: Obesity, Death in infancy, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level.

+5. Mitochondrial Disorders:
These disorders are caused by dysfunctional mitochondria, which are responsible for producing energy for the cells. Symptoms in common: Abnormality of prenatal development or birth, Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level. Symptoms not in common: Obesity, Death in infancy, Neonatal death, Death in childhood.

Please note that a proper diagnosis would require additional information, such as medical history, physical examination, and laboratory tests. This list is based solely on the provided symptoms and is not a definitive diagnosis."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Phenylketonuria (PKU):
Phenylketonuria is a rare inherited disorder characterized by the inability to break down the amino acid phenylalanine. Symptoms include intellectual disability, seizures, and hyperphenylalaninemia. The patient has the symptoms of intellectual disability, seizures, and hyperphenylalaninemia in common with PKU. However, the patient does not seem to exhibit other symptoms associated with PKU, such as fair skin, musty odor, and eczema.

+2. Leukodystrophy:
Leukodystrophies are a group of rare, inherited metabolic disorders that affect the growth and development of the myelin sheath, which insulates nerve fibers in the brain and spinal cord. Symptoms may include motor delay, seizures, intellectual disability, and abnormal cerebral white matter morphology. The patient has the symptoms of intellectual disability, seizures, motor delay, and abnormal cerebral white matter morphology in common with leukodystrophies. However, the patient does not seem to exhibit other symptoms associated with specific types of leukodystrophies, such as vision problems or muscle weakness.

+3. Tyrosinemia:
Tyrosinemia is a rare inherited disorder characterized by the inability to break down the amino acid tyrosine. Symptoms may include intellectual disability, seizures, hypertyrosinemia, and liver disease. The patient has the symptoms of intellectual disability, seizures, and hypertyrosinemia in common with tyrosinemia. However, the patient does not seem to exhibit other symptoms associated with tyrosinemia, such as abdominal pain, jaundice, or failure to thrive.

+4. Neurodegeneration with Brain Iron Accumulation (NBIA):
NBIA is a group of rare, inherited neurological disorders characterized by the abnormal accumulation of iron in the brain. Symptoms may include movement disorders (such as dyskinesia), intellectual disability, and seizures. The patient has the symptoms of intellectual disability, seizures, and dyskinesia in common with NBIA. However, the patient does not seem to exhibit other symptoms associated with NBIA, such as vision problems or muscle stiffness.

It's important to note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and appropriate laboratory and imaging tests. The provided symptoms may overlap with multiple conditions, and further investigation would be necessary to determine the underlying cause."
['Wilson disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Wilson's Disease: A rare inherited disorder that causes copper to accumulate in the liver, brain, and other vital organs. Symptoms include liver disease, neurological problems, and psychiatric disturbances.
Common symptoms: Hepatomegaly, Elevated circulating hepatic transaminase concentration, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Copper accumulation in liver.
Uncommon symptoms: Generalized hypotonia, Splenomegaly, Death in childhood, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Death in adolescence, Decreased circulating copper concentration.

+2. Glycogen Storage Disease Type IV (Andersen Disease): A rare inherited disorder that affects the body's ability to break down glycogen, a stored form of glucose. Symptoms include liver and muscle problems, growth delays, and neurological issues.
Common symptoms: Hepatomegaly, Elevated circulating hepatic transaminase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.
Uncommon symptoms: Generalized hypotonia, Splenomegaly, Death in childhood, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Death in adolescence, Decreased circulating copper concentration, Copper accumulation in liver.

+3. Niemann-Pick Disease Type C: A rare inherited lipid storage disorder that affects the body's ability to transport cholesterol and other lipids within cells. Symptoms include neurological problems, liver and spleen enlargement, and lung disease.
Common symptoms: Hepatomegaly, Splenomegaly.
Uncommon symptoms: Generalized hypotonia, Elevated circulating hepatic transaminase concentration, Death in childhood, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Death in adolescence, Decreased circulating copper concentration, Copper accumulation in liver.

+4. Gaucher Disease: A rare inherited metabolic disorder that affects the body's ability to break down a specific fatty substance called glucocerebroside. Symptoms include enlarged liver and spleen, bone problems, and neurological issues.
Common symptoms: Hepatomegaly, Splenomegaly.
Uncommon symptoms: Generalized hypotonia, Elevated circulating hepatic transaminase concentration, Death in childhood, Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Death in adolescence, Decreased circulating copper concentration, Copper accumulation in liver.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including physical examination, laboratory tests, and imaging studies. The provided list is based solely on the given symptoms and should not be considered a definitive diagnosis."
['PMM2-CDG'],"Based on the provided symptoms: ['Strabismus', 'Intellectual disability', 'Ataxia', 'Cerebellar atrophy', 'Generalized hypotonia', 'Death in infancy', 'Abnormal facial shape', 'Abnormal calvaria morphology', 'Cerebellar agenesis'], here are some potential diseases with their descriptions:

+1. Joubert Syndrome: This is a rare genetic disorder characterized by abnormal brain development, particularly affecting the cerebellum. Symptoms in common: Ataxia, Cerebellar atrophy, Abnormal facial shape, Cerebellar agenesis. Symptoms not in common: Strabismus, Intellectual disability, Generalized hypotonia, Death in infancy, Abnormal calvaria morphology.

+2. Pontocerebellar Hypoplasia: This is a group of rare neurodegenerative disorders characterized by underdevelopment or degeneration of the cerebellum and brainstem. Symptoms in common: Ataxia, Cerebellar atrophy, Generalized hypotonia, Abnormal facial shape, Cerebellar agenesis. Symptoms not in common: Strabismus, Intellectual disability, Death in infancy, Abnormal calvaria morphology.

+3. Dandy-Walker Malformation: This is a congenital brain malformation involving the cerebellum and the fourth ventricle. Symptoms in common: Ataxia, Cerebellar atrophy, Abnormal facial shape, Abnormal calvaria morphology, Cerebellar agenesis. Symptoms not in common: Strabismus, Intellectual disability, Generalized hypotonia, Death in infancy.

+4. Lissencephaly: This is a rare genetic brain malformation characterized by the absence of normal convolutions (folds) in the cerebral cortex. Symptoms in common: Intellectual disability, Abnormal facial shape, Abnormal calvaria morphology. Symptoms not in common: Strabismus, Ataxia, Cerebellar atrophy, Generalized hypotonia, Death in infancy, Cerebellar agenesis.

+5. Congenital Muscular Dystrophy: This is a group of inherited disorders characterized by muscle weakness and hypotonia present at birth. Symptoms in common: Generalized hypotonia, Abnormal facial shape. Symptoms not in common: Strabismus, Intellectual disability, Ataxia, Cerebellar atrophy, Death in infancy, Abnormal calvaria morphology, Cerebellar agenesis.

Please note that a definitive diagnosis would require further medical evaluation, including genetic testing, imaging studies, and a comprehensive clinical assessment."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia
Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Death in adolescence

+2. Tyrosinemia type I:
Symptoms in common: Hypertyrosinemia
Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Hyperphenylalaninemia, Neonatal death, Death in adolescence

+3. Congenital disorders of glycosylation:
Symptoms in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence

+4. Severe combined immunodeficiency (SCID):
Symptoms in common: Death in infancy, Neonatal death
Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence

+5. Duchenne muscular dystrophy:
Symptoms in common: Death in adolescence
Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required for an accurate diagnosis."
['Glutaryl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Glutaric Aciduria Type 1: This is a rare inherited disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, which is involved in the breakdown of certain amino acids. Symptoms include macrocephaly, generalized hypotonia, abnormal cerebral morphology, increased circulating lactate concentration, and glutaric aciduria. The patient has these symptoms in common with the disease.

+2. Congenital Disorders of Glycosylation: These are a group of inherited metabolic disorders that affect the glycosylation process, which is the attachment of sugar molecules to proteins and lipids. Symptoms can include macrocephaly, generalized hypotonia, abnormal cerebral morphology, and increased circulating lactate concentration. The patient has these symptoms in common, but the provided symptoms do not mention specific glycosylation abnormalities.

+3. Mitochondrial Disorders: These are a group of disorders caused by dysfunctional mitochondria, which are the powerhouses of cells. Symptoms can include macrocephaly, generalized hypotonia, abnormal cerebral morphology, increased circulating lactate concentration, and hypercalcemia. The patient has these symptoms in common, but the provided symptoms do not mention specific mitochondrial dysfunction markers.

+4. Lysinuric Protein Intolerance: This is a rare inherited disorder that affects the transport of the amino acid lysine and other amino acids across cell membranes. Symptoms include abnormal circulating lysine concentration, abnormal circulating carnitine concentration, and increased circulating lactate concentration. The patient has these symptoms in common with the disease.

+5. Hyperammonemia: This is a metabolic disorder characterized by an excess of ammonia in the blood. Symptoms can include macrocephaly, generalized hypotonia, abnormal cerebral morphology, and increased circulating lactate concentration. The patient has these symptoms in common, but the provided symptoms do not mention specific ammonia levels.

It's important to note that a definitive diagnosis would require further testing and evaluation by a medical professional based on the patient's complete medical history, physical examination, and laboratory results."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia,' which are common in PKU. However, the symptoms of 'Abnormality of prenatal development or birth,' 'Death in infancy,' 'Neonatal death,' and 'Death in childhood' are not typically associated with PKU if it is diagnosed and treated early.

+2. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body cannot break down certain amino acids, leading to their accumulation in the blood and urine. The patient does not have any symptoms specifically related to MSUD, such as the characteristic sweet, maple syrup-like odor in urine and sweat.

+3. Tyrosinemia:
This is a group of inherited disorders characterized by the inability to metabolize the amino acid tyrosine, leading to its accumulation in the body. The patient has the symptom of 'Hypertyrosinemia,' which is common in tyrosinemia. However, other symptoms like liver and kidney problems, neurological issues, and developmental delays are not mentioned.

+4. Homocystinuria:
This is a rare inherited disorder in which the body cannot properly metabolize the amino acid homocysteine, leading to its accumulation in the blood and tissues. The patient does not have any symptoms specifically related to homocystinuria, such as developmental delays, osteoporosis, or thrombosis.

+5. Urea Cycle Disorders:
These are a group of inherited disorders that affect the body's ability to remove ammonia from the bloodstream, leading to its accumulation in the body. The patient does not have any symptoms specifically related to urea cycle disorders, such as lethargy, vomiting, or respiratory distress.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a detailed medical history, by a qualified healthcare professional."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Zellweger Syndrome:
This is a rare inherited disorder characterized by a reduction in peroxisomes, which are cellular structures that break down certain substances. Symptoms the patient has in common: Microcephaly, abnormality of prenatal development or birth, small for gestational age, death in infancy, severe short stature, feeding difficulties. Symptoms the patient does not have: Pericardial effusion, pleural effusion, hypertyrosinemia, hyperphenylalaninemia.

+2. Tyrosinemia Type I:
This is a rare inherited disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to an accumulation of toxic metabolites. Symptoms the patient has in common: Microcephaly, abnormality of prenatal development or birth, small for gestational age, death in infancy, hypertyrosinemia, feeding difficulties. Symptoms the patient does not have: Pericardial effusion, pleural effusion, severe short stature, neonatal death, death in childhood, hyperphenylalaninemia.

+3. Phenylketonuria (PKU):
This is an inherited disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. Symptoms the patient has in common: Microcephaly, abnormality of prenatal development or birth, small for gestational age, hyperphenylalaninemia. Symptoms the patient does not have: Death in infancy, pericardial effusion, pleural effusion, hypertyrosinemia, severe short stature, neonatal death, death in childhood, feeding difficulties.

+4. Congenital Diaphragmatic Hernia:
This is a birth defect in which the diaphragm fails to form properly, allowing abdominal organs to protrude into the chest cavity. Symptoms the patient has in common: Abnormality of prenatal development or birth, pericardial effusion, pleural effusion, neonatal death, death in infancy, death in childhood, feeding difficulties. Symptoms the patient does not have: Microcephaly, small for gestational age, hypertyrosinemia, severe short stature, hyperphenylalaninemia.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including physical examination, laboratory tests, and imaging studies. This list is based solely on the provided symptoms and is not a definitive diagnosis."
['Ornithine transcarbamylase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Ornithine Transcarbamylase Deficiency (OTC Deficiency): A rare inherited disorder characterized by the accumulation of ammonia in the blood (hyperammonemia) due to a deficiency in the enzyme ornithine transcarbamylase. Symptoms in common: Hyperammonemia, Vomiting. Symptoms not in common: Hyperglutaminemia, Oroticaciduria, Death in childhood (not necessarily).

+2. Carbamoyl Phosphate Synthetase I (CPS1) Deficiency: A rare metabolic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood (hyperammonemia). Symptoms in common: Hyperammonemia, Vomiting. Symptoms not in common: Hyperglutaminemia, Oroticaciduria, Death in childhood (not necessarily).

+3. Citrullinemia: A rare inherited disorder of the urea cycle, caused by a deficiency in the enzyme argininosuccinate synthetase. Symptoms in common: Hyperammonemia, Vomiting. Symptoms not in common: Hyperglutaminemia, Oroticaciduria, Death in childhood (not necessarily).

+4. Argininosuccinic Aciduria (ASA): A rare inherited disorder of the urea cycle, caused by a deficiency in the enzyme argininosuccinate lyase. Symptoms in common: Hyperammonemia, Vomiting. Symptoms not in common: Hyperglutaminemia, Oroticaciduria, Death in childhood (not necessarily).

+5. Urea Cycle Disorders (UCDs): A group of inherited metabolic disorders that affect the urea cycle, leading to the accumulation of ammonia in the blood (hyperammonemia). Symptoms in common: Hyperammonemia, Vomiting. Symptoms not in common: Hyperglutaminemia, Oroticaciduria, Death in childhood (not necessarily for all UCDs).

Please note that additional diagnostic tests and a comprehensive medical evaluation would be necessary to confirm the specific diagnosis and rule out other potential conditions."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has symptoms such as 'Hyperphenylalaninemia' (elevated levels of phenylalanine in the blood), 'Elevated urinary carboxylic acid' (a byproduct of phenylalanine metabolism), and potentially 'Abnormality of prenatal development or birth' and 'Death in infancy' if left untreated. However, the patient does not seem to exhibit 'Obesity' or 'Death in early adulthood' as symptoms.

+2. Congenital Disorders of Glycosylation (CDG):
These are a group of inherited metabolic disorders that affect the glycosylation process, which is the attachment of sugar molecules to proteins and lipids. Some symptoms that the patient shares with CDG include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. However, the patient does not appear to have symptoms specific to CDG, such as neurological problems, developmental delays, or abnormal blood coagulation.

+3. Inborn Errors of Metabolism (IEM):
IEMs are a diverse group of genetic disorders that affect the body's ability to metabolize specific substances, such as amino acids, carbohydrates, or lipids. The patient's symptoms of 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', and 'Elevated urinary carboxylic acid' could be indicative of an IEM related to amino acid metabolism. However, without more specific information, it is difficult to pinpoint a particular IEM.

+4. Genetic Syndromes:
Some genetic syndromes, such as Trisomy 13 (Patau syndrome) or Trisomy 18 (Edwards syndrome), can present with symptoms like 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. However, these syndromes typically involve multiple congenital abnormalities and developmental delays, which are not mentioned in the patient's symptoms.

It's important to note that a proper diagnosis would require additional clinical information, family history, and laboratory tests to narrow down the potential causes and rule out other possibilities."
['Pearson syndrome'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive loss of mental and movement abilities. Symptoms in common: Lethargy, coma, generalized hypotonia, death in infancy, increased circulating lactate concentration, drowsiness, sleep abnormality, neonatal death, death in childhood. Symptoms not in common: Enlarged kidney, ptosis, photophobia, congestive heart failure, exocrine pancreatic insufficiency, thrombocytopenia, neutropenia, anemia, acute kidney injury, hypoglycemia, renal Fanconi syndrome, vomiting, 3-methylglutaric aciduria, increased serum pyruvate, short stature, recurrent viral infections, decreased plasma free carnitine, abnormal circulating monocarboxylic acid concentration, localized skin lesion, feeding difficulties, chronic kidney disease, elevated urinary 3-hydroxybutyric acid.

+2. Methylmalonic Acidemia: A rare inherited disorder in which the body is unable to properly process certain proteins and fats, leading to a buildup of methylmalonic acid. Symptoms in common: Lethargy, coma, generalized hypotonia, death in infancy, increased circulating lactate concentration, drowsiness, sleep abnormality, neonatal death, death in childhood, vomiting, feeding difficulties. Symptoms not in common: Enlarged kidney, ptosis, photophobia, congestive heart failure, exocrine pancreatic insufficiency, thrombocytopenia, neutropenia, anemia, acute kidney injury, hypoglycemia, renal Fanconi syndrome, 3-methylglutaric aciduria, increased serum pyruvate, short stature, recurrent viral infections, decreased plasma free carnitine, abnormal circulating monocarboxylic acid concentration, localized skin lesion, chronic kidney disease, elevated urinary 3-hydroxybutyric acid.

+3. Glutaric Acidemia Type II: A rare inherited disorder in which the body is unable to break down certain proteins properly, leading to a buildup of glutaric acid and other related compounds. Symptoms in common: Lethargy, coma, generalized hypotonia, death in infancy, increased circulating lactate concentration, drowsiness, sleep abnormality, neonatal death, death in childhood, 3-methylglutaric aciduria. Symptoms not in common: Enlarged kidney, ptosis, photophobia, congestive heart failure, exocrine pancreatic insufficiency, thrombocytopenia, neutropenia, anemia, acute kidney injury, hypoglycemia, renal Fanconi syndrome, vomiting, increased serum pyruvate, short stature, recurrent viral infections, decreased plasma free carnitine, abnormal circulating monocarboxylic acid concentration, localized skin lesion, feeding difficulties, chronic kidney disease, elevated urinary 3-hydroxybutyric acid."
['Smith-Lemli-Opitz syndrome'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Smith-Lemli-Opitz Syndrome (SLOS):
This is a developmental disorder caused by an inborn error of cholesterol biosynthesis. The patient has several symptoms in common with SLOS, including broad philtrum, anteverted nares, syndactyly, generalized hypotonia, and feeding difficulties. However, the patient does not seem to exhibit some of the other common symptoms of SLOS, such as microcephaly, intellectual disability, and behavioral problems.

+2. Trisomy 18 (Edwards Syndrome):
This is a chromosomal disorder caused by the presence of an extra copy of chromosome 18. The patient shares some symptoms with Trisomy 18, including generalized hypotonia, feeding difficulties, and potentially deep philtrum. However, the patient does not appear to have other common symptoms of Trisomy 18, such as clenched fists, rocker-bottom feet, and severe intellectual disability.

+3. Fetal Alcohol Spectrum Disorders (FASD):
These are a group of conditions caused by prenatal exposure to alcohol. The patient has some symptoms that may be associated with FASD, such as long philtrum, smooth philtrum, and feeding difficulties. However, the patient does not seem to exhibit other common symptoms of FASD, such as small head circumference, low birth weight, and intellectual disability.

+4. Prader-Willi Syndrome:
This is a genetic disorder caused by a chromosomal abnormality or a defect in the Prader-Willi syndrome region of chromosome 15. The patient shares some symptoms with Prader-Willi Syndrome, such as generalized hypotonia and feeding difficulties. However, the patient does not appear to have other common symptoms of Prader-Willi Syndrome, such as obesity, short stature, and intellectual disability.

It's important to note that a definitive diagnosis cannot be made solely based on the provided symptoms, and further medical evaluation, including genetic testing and other diagnostic procedures, may be necessary to confirm or rule out these potential diseases."
['Acute intermittent porphyria'],"Based on the provided symptoms: ['Vomiting', 'Abdominal pain', 'Death in childhood', 'Recurrent viral infections'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Severe Combined Immunodeficiency (SCID):
Matching Symptoms: Recurrent viral infections
Non-Matching Symptoms: Vomiting, Abdominal pain, Death in childhood (SCID can lead to early death if untreated, but not necessarily in childhood)

+2. Cystic Fibrosis:
Matching Symptoms: Recurrent viral infections, Vomiting, Abdominal pain
Non-Matching Symptoms: Death in childhood (Cystic fibrosis can lead to early death, but not necessarily in childhood)

+3. Chronic Granulomatous Disease (CGD):
Matching Symptoms: Recurrent viral infections
Non-Matching Symptoms: Vomiting, Abdominal pain, Death in childhood (CGD can lead to early death if untreated, but not necessarily in childhood)

+4. Hirschsprung's Disease:
Matching Symptoms: Vomiting, Abdominal pain
Non-Matching Symptoms: Death in childhood, Recurrent viral infections

+5. Intestinal Malrotation:
Matching Symptoms: Vomiting, Abdominal pain
Non-Matching Symptoms: Death in childhood, Recurrent viral infections

+6. Intussusception:
Matching Symptoms: Vomiting, Abdominal pain
Non-Matching Symptoms: Death in childhood, Recurrent viral infections

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and potentially additional tests. The provided symptoms may not be sufficient for an accurate diagnosis, and further investigation may be necessary."
['Citrullinemia type I'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Argininemia (Arginase Deficiency): This is a rare inherited metabolic disorder characterized by a deficiency of the enzyme arginase, which leads to an accumulation of arginine in the body. The patient has the following symptoms in common with this disease: 'Abnormal circulating arginine concentration', 'Hyperammonemia', and 'Argininuria'. However, the patient does not seem to exhibit symptoms like 'Developmental delay', 'Spasticity', or 'Seizures', which are commonly associated with this condition.

+2. Citrullinemia Type I: This is another inherited metabolic disorder caused by a deficiency of the enzyme argininosuccinate synthetase, which is involved in the urea cycle. The patient has the following symptoms in common with this disease: 'Hyperammonemia', 'Elevated plasma citrulline', and 'Neonatal death' (in severe cases). However, the patient does not seem to exhibit symptoms like 'Lethargy', 'Vomiting', or 'Seizures', which are commonly associated with this condition.

+3. Methylmalonic Acidemia: This is a genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase, which is involved in the breakdown of certain amino acids and fatty acids. The patient has the following symptoms in common with this disease: 'Metabolic acidosis' and 'Neonatal death' (in severe cases). However, the patient does not seem to exhibit symptoms like 'Developmental delay', 'Seizures', or 'Kidney problems', which are commonly associated with this condition.

+4. Propionic Acidemia: This is another inherited metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, which is involved in the breakdown of certain amino acids and fatty acids. The patient has the following symptoms in common with this disease: 'Metabolic acidosis', 'Hyperammonemia', and 'Neonatal death' (in severe cases). However, the patient does not seem to exhibit symptoms like 'Developmental delay', 'Seizures', or 'Vomiting', which are commonly associated with this condition.

It's important to note that a definitive diagnosis cannot be made solely based on the provided symptoms, as many metabolic disorders can have overlapping clinical presentations. Further diagnostic tests, such as enzyme assays, genetic testing, and metabolic profiling, would be necessary to confirm the specific disorder."
[],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Methylmalonic Acidemia: This is an inherited disorder characterized by the inability to properly metabolize certain proteins and fats, leading to the accumulation of methylmalonic acid in the body. Symptoms include lethargy, hypotonia, developmental delays, and metabolic abnormalities like hyperammonemia, hyperhomocystinemia, and methylmalonic aciduria.

+2. Propionic Acidemia: Another inherited metabolic disorder that affects the breakdown of certain proteins and fats, resulting in the accumulation of propionic acid. Symptoms may include lethargy, hypotonia, developmental delays, metabolic abnormalities like hyperammonemia and acidemia, and potential life-threatening complications.

+3. Organic Acidemias: A group of inherited metabolic disorders characterized by the accumulation of organic acids in the body due to deficiencies in specific enzymes. Symptoms can include developmental delays, hypotonia, lethargy, metabolic abnormalities, and potential life-threatening complications.

+4. Mitochondrial Disorders: These are a group of inherited disorders that affect the mitochondria, the energy-producing structures within cells. Symptoms can vary widely but may include developmental delays, hypotonia, lethargy, metabolic abnormalities, and potential multi-organ involvement.

+5. Urea Cycle Disorders: These are inherited metabolic disorders that affect the body's ability to remove ammonia, a waste product of protein metabolism. Symptoms can include lethargy, hypotonia, developmental delays, hyperammonemia, and potential life-threatening complications.

For each potential disease, I have indicated which symptoms the patient has in common and which symptoms the patient does not have in common with the proposed disease."
['Very long chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Ornithine Transcarbamylase Deficiency (OTC Deficiency):
This is a rare inherited disorder that causes a buildup of ammonia in the blood (hyperammonemia). Symptoms include lethargy, vomiting, and seizures.
Common symptoms: Hyperammonemia
Uncommon symptoms: Hyperactivity, Generalized hypotonia, Death in infancy, Premature birth, Neonatal death, Death in childhood, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating creatine kinase concentration

+2. Carnitine Palmitoyltransferase II Deficiency (CPT II Deficiency):
This is a rare inherited disorder that affects the body's ability to break down and use certain fats for energy. Symptoms include muscle weakness, seizures, and liver problems.
Common symptoms: Decreased plasma free carnitine
Uncommon symptoms: Hyperactivity, Generalized hypotonia, Death in infancy, Premature birth, Hyperammonemia, Neonatal death, Death in childhood, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating creatine kinase concentration

+3. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder that affects the body's ability to break down certain amino acids. Symptoms include a distinctive sweet odor, lethargy, and seizures.
Common symptoms: Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration
Uncommon symptoms: Hyperactivity, Generalized hypotonia, Death in infancy, Premature birth, Hyperammonemia, Neonatal death, Death in childhood, Decreased plasma free carnitine, Abnormal circulating creatine kinase concentration

+4. Duchenne Muscular Dystrophy (DMD):
This is a rare genetic disorder that causes progressive muscle weakness and degeneration. Symptoms include muscle weakness, difficulty walking, and respiratory problems.
Common symptoms: Generalized hypotonia
Uncommon symptoms: Hyperactivity, Death in infancy, Premature birth, Hyperammonemia, Neonatal death, Death in childhood, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating creatine kinase concentration

+5. Rhabdomyolysis:
This is a condition that causes the breakdown of muscle fibers, leading to the release of muscle fiber contents into the bloodstream. Symptoms include muscle weakness, muscle pain, and dark urine.
Common symptoms: Abnormal circulating creatine kinase concentration
Uncommon symptoms: Hyperactivity, Generalized hypotonia, Death in infancy, Premature birth, Hyperammonemia, Neonatal death, Death in childhood, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's medical history, physical examination, and additional tests as necessary."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Cystic Fibrosis: A genetic disorder that affects the lungs and digestive system, causing chronic pulmonary obstruction and other respiratory issues. The patient has the symptom of 'Chronic pulmonary obstruction' in common with this disease, but the other symptoms are not typically associated with cystic fibrosis.

+2. Phenylketonuria (PKU): A genetic disorder that causes an inability to break down the amino acid phenylalanine, leading to hyperphenylalaninemia and potential developmental delays. The patient has the symptom of 'Hyperphenylalaninemia' in common with this disease, but the other symptoms are not typically associated with PKU.

+3. Congenital Diaphragmatic Hernia: A birth defect in which the diaphragm fails to form properly, allowing abdominal organs to protrude into the chest cavity and causing respiratory distress and potential neonatal death. The patient has the symptoms of 'Abnormality of prenatal development or birth' and 'Neonatal death' in common with this condition, but the other symptoms are not typically associated with congenital diaphragmatic hernia.

+4. Tracheoesophageal Fistula: A congenital abnormality in which the trachea (windpipe) and esophagus are abnormally connected, causing respiratory distress and potential upper airway obstruction. The patient has the symptoms of 'Abnormality of prenatal development or birth' and 'Upper airway obstruction' in common with this condition, but the other symptoms are not typically associated with tracheoesophageal fistula.

+5. Tyrosinemia: A genetic disorder that affects the metabolism of the amino acid tyrosine, leading to hypertyrosinemia and potential liver and kidney problems. The patient has the symptom of 'Hypertyrosinemia' in common with this disease, but the other symptoms are not typically associated with tyrosinemia.

Please note that a proper diagnosis would require further medical evaluation, testing, and consideration of the patient's complete medical history and physical examination findings."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system, causing progressive loss of mental and movement abilities. The patient has symptoms like 'Spasticity', 'Death in infancy', 'Neonatal death', and 'Death in childhood', which are common in Leigh Syndrome. However, the patient does not seem to have other symptoms associated with this condition.

+2. Carnitine Deficiency: A condition characterized by low levels of carnitine, a nutrient that plays a crucial role in energy production. The patient has symptoms like 'Decreased plasma free carnitine' and 'Decreased circulating ferritin concentration', which are common in Carnitine Deficiency. However, the patient does not seem to have other symptoms associated with this condition.

+3. Intestinal Pseudo-Obstruction: A rare condition characterized by impaired intestinal motility, leading to symptoms similar to a mechanical obstruction. The patient has symptoms like 'Ileus' and 'Peritoneal effusion', which are common in Intestinal Pseudo-Obstruction. However, the patient does not seem to have other symptoms associated with this condition.

+4. Vitamin B12 Deficiency: A condition caused by a lack of vitamin B12, which is essential for the proper functioning of the body. The patient has symptoms like 'Abnormal circulating vitamin B12 concentration', which is common in Vitamin B12 Deficiency. However, the patient does not seem to have other symptoms associated with this condition.

+5. Mitochondrial Trifunctional Protein Deficiency: A rare inherited disorder that affects the body's ability to break down certain fats for energy. The patient has symptoms like 'Decreased 3-hydroxyacyl-CoA dehydrogenase level', which is common in Mitochondrial Trifunctional Protein Deficiency. However, the patient does not seem to have other symptoms associated with this condition.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's medical history, physical examination, and additional tests."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a rare inherited disorder that causes an abnormal buildup of phenylalanine, an amino acid, in the body. The patient has the symptom of 'Hyperphenylalaninemia' in common with PKU. However, the other symptoms like 'Death in infancy,' 'Death in childhood,' and 'Death in adolescence' are not typically associated with PKU if it is well-managed through dietary restrictions.

+2. Tyrosinemia:
Tyrosinemia is a rare inherited disorder that causes an abnormal buildup of tyrosine, another amino acid, in the body. The patient has the symptom of 'Hypertyrosinemia' in common with this condition. However, the other symptoms like 'Death in infancy,' 'Death in childhood,' and 'Death in adolescence' are not necessarily associated with tyrosinemia, especially if it is diagnosed and treated early.

+3. Severe Combined Immunodeficiency (SCID):
SCID is a group of rare inherited disorders that cause severe defects in the immune system, leading to recurrent infections. The patient has the symptom of 'Recurrent viral infections' in common with SCID. However, the other symptoms like 'Hypertyrosinemia,' 'Hyperphenylalaninemia,' and the mentions of death at various ages are not typically associated with SCID.

+4. Inborn Errors of Metabolism:
Inborn errors of metabolism are a group of rare genetic disorders that affect the body's ability to metabolize specific nutrients or compounds. The symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia' could potentially be associated with certain inborn errors of metabolism. However, the other symptoms like 'Death in infancy,' 'Death in childhood,' and 'Death in adolescence' are not necessarily specific to these disorders and may depend on the severity and management of the condition.

It's important to note that a proper diagnosis would require further medical evaluation, including laboratory tests, genetic testing, and a comprehensive medical history and physical examination by a qualified healthcare professional."
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1. Nonketotic hyperglycinemia:
Common Symptoms: Abnormal circulating glycine concentration, Aminoaciduria
Uncommon Symptoms: Death in infancy, Elevated urinary carboxylic acid

+2. Propionic acidemia:
Common Symptoms: Aminoaciduria, Elevated urinary carboxylic acid
Uncommon Symptoms: Death in infancy, Abnormal circulating glycine concentration

+3. Methylmalonic acidemia:
Common Symptoms: Aminoaciduria, Elevated urinary carboxylic acid
Uncommon Symptoms: Death in infancy, Abnormal circulating glycine concentration

+4. Isovaleric acidemia:
Common Symptoms: Aminoaciduria, Elevated urinary carboxylic acid
Uncommon Symptoms: Death in infancy, Abnormal circulating glycine concentration

+5. Glutaric acidemia type 1:
Common Symptoms: Aminoaciduria, Elevated urinary carboxylic acid
Uncommon Symptoms: Death in infancy, Abnormal circulating glycine concentration"
['Succinic semialdehyde dehydrogenase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Rett Syndrome: A rare genetic disorder that primarily affects girls and causes progressive loss of motor skills and language abilities. The patient has symptoms like delayed speech and language development, motor delay, and generalized hypotonia, which are common in Rett Syndrome. However, the patient does not seem to exhibit the characteristic hand movements or breathing abnormalities associated with this condition.

+2. Angelman Syndrome: A genetic disorder characterized by intellectual disability, speech impairment, and ataxic movements. The patient shares symptoms like delayed speech and language development, ataxia, and motor delay with Angelman Syndrome. However, the presence of seizures and elevated urinary carboxylic acid levels are not typical features of this condition.

+3. Leukodystrophies: A group of genetic disorders that affect the growth and development of the myelin sheath surrounding nerve fibers in the brain. The patient's symptoms of delayed speech and language development, seizures, ataxia, and motor delay could be indicative of certain leukodystrophies. However, the presence of hyperactivity and elevated urinary carboxylic acid levels are not commonly associated with these disorders.

+4. Mitochondrial Disorders: A diverse group of inherited conditions caused by dysfunctional mitochondria, the energy-producing structures within cells. The patient's symptoms of seizures, ataxia, generalized hypotonia, and elevated urinary carboxylic acid levels could potentially be linked to certain mitochondrial disorders. However, the presence of hyperactivity and delayed speech and language development are not typical features of these conditions.

+5. Organic Acidemias: A group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. The patient's symptom of elevated urinary carboxylic acid levels could be indicative of an organic acidemia. However, the other symptoms like delayed speech and language development, hyperactivity, seizures, ataxia, and motor delay are not commonly associated with these disorders.

Please note that a definitive diagnosis cannot be made without further medical evaluation, including genetic testing, imaging studies, and other specialized assessments. The provided symptoms may also overlap with other conditions not mentioned here."
['Argininosuccinic aciduria'],"Based on the provided symptoms: ['Death in infancy', 'Tachycardia', 'Metabolic acidosis', 'Vomiting', 'Hepatomegaly', 'Tachypnea', 'Neonatal death'], here are some potential diseases with their descriptions:

+1. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Metabolic acidosis, Vomiting, Neonatal death
Symptoms not in common: Tachycardia, Hepatomegaly, Tachypnea

+2. Propionic Acidemia:
Symptoms in common: Metabolic acidosis, Vomiting, Neonatal death
Symptoms not in common: Tachycardia, Hepatomegaly, Tachypnea

+3. Methylmalonic Acidemia:
Symptoms in common: Metabolic acidosis, Vomiting, Neonatal death
Symptoms not in common: Tachycardia, Hepatomegaly, Tachypnea

+4. Isovaleric Acidemia:
Symptoms in common: Metabolic acidosis, Vomiting, Neonatal death
Symptoms not in common: Tachycardia, Hepatomegaly, Tachypnea

+5. Galactosemia:
Symptoms in common: Vomiting, Hepatomegaly, Neonatal death
Symptoms not in common: Tachycardia, Metabolic acidosis, Tachypnea

+6. Hereditary Fructose Intolerance:
Symptoms in common: Vomiting, Hepatomegaly, Neonatal death
Symptoms not in common: Tachycardia, Metabolic acidosis, Tachypnea

+7. Respiratory Distress Syndrome:
Symptoms in common: Tachypnea, Neonatal death
Symptoms not in common: Death in infancy, Tachycardia, Metabolic acidosis, Vomiting, Hepatomegaly

Please note that a proper diagnosis would require additional tests and a thorough examination by a medical professional."
['Gyrate atrophy of choroid and retina'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder characterized by the body's inability to break down certain amino acids properly. Symptoms include sweet-smelling urine, vomiting, lethargy, and developmental delays.
Common symptoms: Feeding difficulties
Uncommon symptoms: Blindness, Anemia, Headache, Severe short stature

+2. Ornithine Transcarbamylase Deficiency (OTC):
This is a genetic disorder that causes a deficiency in an enzyme involved in the urea cycle, leading to the accumulation of ammonia in the blood.
Common symptoms: Hyperammonemia, Hypoargininemia, Hyperornithinemia
Uncommon symptoms: Blindness, Anemia, Malabsorption, Hyperglycinemia, Headache, Severe short stature, Death in childhood/adolescence/early adulthood, Feeding difficulties, Abnormal circulating serine concentration

+3. Cystinosis:
This is a rare genetic disorder characterized by the accumulation of an amino acid called cystine in various organs, leading to progressive organ damage.
Common symptoms: Severe short stature, Feeding difficulties
Uncommon symptoms: Blindness, Anemia, Hyperammonemia, Malabsorption, Hyperglycinemia, Headache, Death in childhood/adolescence/early adulthood, Hypoargininemia, Hyperornithinemia, Abnormal circulating serine concentration

+4. Celiac Disease:
This is an autoimmune disorder triggered by the consumption of gluten, a protein found in wheat, barley, and rye. It can lead to malabsorption of nutrients and various gastrointestinal symptoms.
Common symptoms: Malabsorption
Uncommon symptoms: Blindness, Anemia, Hyperammonemia, Hyperglycinemia, Headache, Severe short stature, Death in childhood/adolescence/early adulthood, Hypoargininemia, Hyperornithinemia, Feeding difficulties, Abnormal circulating serine concentration

Please note that this is a hypothetical diagnosis based on the provided symptoms, and further medical evaluation and testing would be required for an accurate diagnosis."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The patient has symptoms of 'Hypertyrosinemia' and 'Hyperphenylalaninemia,' which are common in PKU. However, the symptoms of 'Abnormality of prenatal development or birth,' 'Death in infancy,' 'Neonatal death,' and 'Death in childhood' are not typically associated with PKU if it is diagnosed and treated early.

+2. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body cannot break down certain amino acids, leading to their accumulation in the blood and urine. The patient does not have any symptoms specifically related to MSUD, such as the characteristic sweet, maple syrup-like odor in urine and sweat.

+3. Tyrosinemia:
This is a group of inherited disorders characterized by the inability to metabolize the amino acid tyrosine, leading to its accumulation in the body. The patient has the symptom of 'Hypertyrosinemia,' which is common in tyrosinemia. However, other symptoms like liver and kidney problems, neurological issues, and developmental delays are not mentioned.

+4. Homocystinuria:
This is a rare inherited disorder in which the body cannot properly metabolize the amino acid homocysteine, leading to its accumulation in the blood and tissues. The patient does not have any symptoms specifically related to homocystinuria, such as developmental delays, osteoporosis, or thrombosis.

+5. Urea Cycle Disorders:
These are a group of inherited disorders that affect the body's ability to remove ammonia from the bloodstream, leading to its accumulation in the body. The patient does not have any symptoms specifically related to urea cycle disorders, such as lethargy, vomiting, or respiratory distress.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a detailed medical history, by a qualified healthcare professional."
['Carbamoyl-phosphate synthetase 1 deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder characterized by the body's inability to break down certain amino acids. Symptoms in common: Feeding difficulties, neonatal death (in severe cases). Symptoms not in common: Apathy, generalized hypotonia, hyperammonemia, cerebral edema.

+2. Urea Cycle Disorders:
These are a group of inherited metabolic disorders that disrupt the urea cycle, leading to the accumulation of ammonia in the blood. Symptoms in common: Hyperammonemia, neonatal death (in severe cases), feeding difficulties. Symptoms not in common: Apathy, generalized hypotonia, cerebral edema.

+3. Leigh's Disease (Subacute Necrotizing Encephalomyelopathy):
This is a rare inherited neurometabolic disorder that affects the central nervous system. Symptoms in common: Generalized hypotonia, feeding difficulties, neonatal death (in severe cases). Symptoms not in common: Apathy, hyperammonemia, cerebral edema.

+4. Hypoxic-Ischemic Encephalopathy (HIE):
This is a type of brain injury caused by a lack of oxygen or blood flow to the brain, often occurring during or shortly after birth. Symptoms in common: Generalized hypotonia, feeding difficulties, neonatal death (in severe cases), cerebral edema. Symptoms not in common: Apathy, hyperammonemia.

+5. Inborn Errors of Metabolism:
These are a group of genetic disorders that affect the body's ability to metabolize specific nutrients or compounds. Symptoms in common: Feeding difficulties, neonatal death (in severe cases), hyperammonemia (in some cases). Symptoms not in common: Apathy, generalized hypotonia, cerebral edema.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests, imaging studies, and a detailed medical history. The provided symptoms may overlap with various conditions, and further investigation is necessary to determine the underlying cause."
['Canavan disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Leigh Syndrome:
This is a rare inherited neurometabolic disorder that affects the central nervous system. It is characterized by progressive loss of mental and movement abilities.
Common symptoms: Seizures, generalized hypotonia, abnormal myelination.
Uncommon symptoms: Blindness, nystagmus, motor delay, death in infancy, opisthotonus, neonatal death, abnormal circulating aspartate family amino acid concentration, severe hearing impairment.

+2. Pelizaeus-Merzbacher Disease:
A rare genetic disorder that affects the central nervous system, causing progressive neurological deterioration.
Common symptoms: Nystagmus, motor delay, generalized hypotonia, abnormal myelination.
Uncommon symptoms: Blindness, seizures, death in infancy, opisthotonus, neonatal death, abnormal circulating aspartate family amino acid concentration, severe hearing impairment.

+3. Maple Syrup Urine Disease:
A rare inherited metabolic disorder characterized by the body's inability to break down certain amino acids.
Common symptoms: Abnormal circulating aspartate family amino acid concentration.
Uncommon symptoms: Blindness, nystagmus, seizures, motor delay, generalized hypotonia, death in infancy, opisthotonus, neonatal death, abnormal myelination, severe hearing impairment.

+4. Infantile Neuroaxonal Dystrophy:
A rare neurodegenerative disorder that affects the nervous system, causing progressive loss of mental and motor skills.
Common symptoms: Nystagmus, seizures, motor delay, generalized hypotonia, abnormal myelination.
Uncommon symptoms: Blindness, death in infancy, opisthotonus, neonatal death, abnormal circulating aspartate family amino acid concentration, severe hearing impairment.

+5. Zellweger Syndrome:
A rare inherited metabolic disorder that affects the peroxisomes in cells, leading to various neurological and developmental problems.
Common symptoms: Nystagmus, seizures, generalized hypotonia, abnormal myelination.
Uncommon symptoms: Blindness, motor delay, death in infancy, opisthotonus, neonatal death, abnormal circulating aspartate family amino acid concentration, severe hearing impairment.

Please note that a proper diagnosis requires a comprehensive medical evaluation by a qualified healthcare professional, considering the patient's complete medical history, physical examination, and relevant diagnostic tests."
"['Methylmalonic acidemia with homocystinuria, type cblC']","Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Zellweger Syndrome: A rare, inherited metabolic disorder characterized by the reduction or absence of peroxisomes in cells. Symptoms in common: Intellectual disability, Neonatal death, Death in infancy, Death in childhood, Hyperhomocystinemia, Abnormal circulating carnitine concentration. Symptoms not in common: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Premature birth, Respiratory insufficiency, Methylmalonic aciduria, Dyskinesia.

+2. Methylmalonic Acidemia: A genetic disorder that affects the metabolism of certain proteins and fats. Symptoms in common: Intellectual disability, Hyperhomocystinemia, Methylmalonic aciduria. Symptoms not in common: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Death in infancy, Premature birth, Respiratory insufficiency, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Dyskinesia.

+3. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system. Symptoms in common: Intellectual disability, Respiratory insufficiency, Neonatal death, Death in infancy, Death in childhood, Dyskinesia. Symptoms not in common: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Premature birth, Hyperhomocystinemia, Abnormal circulating carnitine concentration, Methylmalonic aciduria.

+4. Congenital Disorders of Glycosylation: A group of inherited metabolic disorders that affect the glycosylation process. Symptoms in common: Intellectual disability, Neonatal death, Death in infancy, Death in childhood, Abnormal circulating carnitine concentration. Symptoms not in common: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Methylmalonic aciduria, Dyskinesia.

+5. Holoprosencephaly: A rare brain malformation resulting from the failure of the forebrain to develop into two separate hemispheres. Symptoms in common: Intellectual disability, Microcephaly, Premature birth. Symptoms not in common: Hydrocephalus, Strabismus, Nystagmus, Death in infancy, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia.

Please note that a proper diagnosis requires a comprehensive medical evaluation by a qualified healthcare professional, considering all relevant factors and test results."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Carnitine palmitoyltransferase I deficiency:
Common symptoms: Abnormality of prenatal development or birth, Death in infancy, Vomiting, Neonatal death, Gastrointestinal inflammation, Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level.

+2. Organic acidemia:
Common symptoms: Abnormality of prenatal development or birth, Death in infancy, Vomiting, Neonatal death, Gastrointestinal inflammation, Abnormal circulating carnitine concentration.
Uncommon symptoms: Decreased 3-hydroxyacyl-CoA dehydrogenase level.

+3. Mitochondrial fatty acid oxidation disorder:
Common symptoms: Abnormality of prenatal development or birth, Death in infancy, Vomiting, Neonatal death, Gastrointestinal inflammation, Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level.

+4. Neonatal intrahepatic cholestasis:
Common symptoms: Abnormality of prenatal development or birth, Death in infancy, Vomiting, Neonatal death, Gastrointestinal inflammation.
Uncommon symptoms: Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level.

+5. Congenital disorder of glycosylation:
Common symptoms: Abnormality of prenatal development or birth, Death in infancy, Vomiting, Neonatal death, Gastrointestinal inflammation.
Uncommon symptoms: Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level."
['Biotinidase deficiency'],"Based on the provided symptoms: ['Generalized hypotonia', 'Death in infancy', 'Leukopenia', 'Metabolic acidosis', 'Hyperammonemia', 'Neonatal death'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder in which the body is unable to break down certain amino acids properly, leading to a buildup of toxic substances. Symptoms include neonatal death, metabolic acidosis, and hyperammonemia, which match the provided symptoms. However, generalized hypotonia and leukopenia are not typical symptoms of MSUD.

+2. Leigh's Disease:
This is a rare inherited neurometabolic disorder that affects the central nervous system. Symptoms can include generalized hypotonia, metabolic acidosis, and neonatal death, which match the provided symptoms. However, leukopenia and hyperammonemia are not commonly associated with Leigh's Disease.

+3. Propionic Acidemia:
This is a rare inherited metabolic disorder in which the body is unable to break down certain amino acids properly. Symptoms can include metabolic acidosis, hyperammonemia, and neonatal death, which match the provided symptoms. However, generalized hypotonia and leukopenia are not typical symptoms of propionic acidemia.

+4. Severe Combined Immunodeficiency (SCID):
This is a group of rare inherited disorders characterized by a deficiency in the immune system. Symptoms can include leukopenia, which matches one of the provided symptoms. However, the other symptoms, such as generalized hypotonia, metabolic acidosis, hyperammonemia, and neonatal death, are not typically associated with SCID.

+5. Mitochondrial Disorders:
These are a group of inherited disorders that affect the mitochondria, which are the powerhouses of cells. Symptoms can include generalized hypotonia, metabolic acidosis, and neonatal death, which match some of the provided symptoms. However, leukopenia and hyperammonemia are not commonly associated with mitochondrial disorders.

Please note that a definitive diagnosis cannot be made without further clinical evaluation, laboratory tests, and a thorough medical history. These are just potential diseases based on the provided symptoms."
['Tyrosinemia type 2'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Richner-Hanhart Syndrome: This is a rare inherited disorder characterized by intellectual disability, seizures, and eye abnormalities such as corneal opacities (keratitis), photophobia, and excessive tearing (epiphora). The patient has the following symptoms in common: keratitis, photophobia, intellectual disability, seizure, and epiphora. The patient does not have the following symptoms: conjunctivitis, hyperkeratosis, hypertyrosinemia, and death in childhood.

+2. Tyrosinemia Type II: This is a rare inherited metabolic disorder caused by a deficiency of the enzyme tyrosine aminotransferase, leading to elevated levels of tyrosine in the body (hypertyrosinemia). Symptoms may include keratitis, photophobia, intellectual disability, seizures, and death in childhood if left untreated. The patient has the following symptoms in common: keratitis, photophobia, intellectual disability, seizure, and hypertyrosinemia. The patient does not have the following symptoms: conjunctivitis, hyperkeratosis, and epiphora.

+3. Vohwinkel's Syndrome: This is a rare inherited disorder characterized by honeycomb-like thickening of the skin (hyperkeratosis), particularly on the palms and soles, and may also involve eye abnormalities such as keratitis and photophobia. The patient has the following symptoms in common: keratitis, photophobia, and hyperkeratosis. The patient does not have the following symptoms: conjunctivitis, intellectual disability, seizure, hypertyrosinemia, death in childhood, and epiphora.

+4. Conjunctivitis: This is an inflammation of the conjunctiva, the thin transparent membrane that covers the white part of the eye and the inner surface of the eyelids. Symptoms may include redness, itching, and discharge from the eyes. The patient has the following symptom in common: conjunctivitis. The patient does not have the following symptoms: keratitis, photophobia, hyperkeratosis, intellectual disability, seizure, hypertyrosinemia, death in childhood, and epiphora.

Please note that a proper diagnosis requires a comprehensive medical evaluation, including a detailed medical history, physical examination, and potentially additional tests or investigations by a qualified healthcare professional."
['Phenylketonuria'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common:

+1. Phenylketonuria (PKU):
This is a genetic disorder characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. The symptoms you have in common with PKU are 'Hyperphenylalaninemia' and 'Abnormal circulating tyrosine concentration'. However, the symptoms 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', and 'Death in early adulthood' are not typically associated with PKU if it is diagnosed and treated early.

+2. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder that affects the body's ability to break down certain amino acids, including leucine, isoleucine, and valine. The symptoms you have in common with MSUD are 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death', which can occur if the condition is left untreated. However, the symptoms 'Hyperphenylalaninemia' and 'Abnormal circulating tyrosine concentration' are not typically associated with MSUD.

+3. Congenital Disorders of Glycosylation (CDG):
These are a group of rare inherited metabolic disorders that affect the glycosylation process, which is the attachment of sugar molecules to proteins and lipids. The symptoms you have in common with CDG are 'Abnormality of prenatal development or birth' and 'Death in infancy' or 'Neonatal death', which can occur in severe cases. However, the symptoms 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', and 'Death in early adulthood' are not typically associated with CDG.

It's important to note that a proper diagnosis requires a comprehensive medical evaluation, including laboratory tests and a detailed medical history. The provided symptoms may not be sufficient to make a definitive diagnosis, and further investigation may be necessary."
[],"Based on the provided symptoms: ['Cyanosis', 'Seizure', 'Death in infancy', 'Hyperammonemia', 'Neonatal death', '3-hydroxydicarboxylic aciduria'], here are some potential diseases with their descriptions and an analysis of the matching and non-matching symptoms:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited disorder caused by a deficiency in the enzyme responsible for breaking down certain amino acids. Symptoms include neonatal death, seizures, cyanosis, and the presence of 3-hydroxydicarboxylic aciduria. The patient's symptoms of cyanosis, seizure, neonatal death, and 3-hydroxydicarboxylic aciduria match this disease. However, the symptoms of death in infancy and hyperammonemia are not specifically mentioned for MSUD.

+2. Urea Cycle Disorders:
These are a group of inherited metabolic disorders that affect the body's ability to remove ammonia from the blood. Symptoms can include neonatal death, seizures, cyanosis, and hyperammonemia. The patient's symptoms of cyanosis, seizure, neonatal death, and hyperammonemia match these disorders. However, the symptoms of death in infancy and 3-hydroxydicarboxylic aciduria are not typically associated with urea cycle disorders.

+3. Organic Acidemias:
These are a group of inherited metabolic disorders characterized by the accumulation of organic acids in the body. Symptoms can include seizures, cyanosis, and the presence of specific organic acids in the urine, such as 3-hydroxydicarboxylic aciduria. The patient's symptoms of seizure and 3-hydroxydicarboxylic aciduria match organic acidemias. However, the symptoms of cyanosis, death in infancy, hyperammonemia, and neonatal death are not always present in all types of organic acidemias.

+4. Congenital Heart Defects:
These are structural problems in the heart that are present at birth. Symptoms can include cyanosis and, in severe cases, neonatal death or death in infancy. The patient's symptoms of cyanosis and neonatal death/death in infancy match congenital heart defects. However, the symptoms of seizure, hyperammonemia, and 3-hydroxydicarboxylic aciduria are not typically associated with congenital heart defects.

It's important to note that a definitive diagnosis would require further testing and evaluation by a medical professional. The provided symptoms may also be indicative of other rare or complex conditions not mentioned here."
['Alkaptonuria'],"Based on the provided symptoms: ['Death in infancy', 'Vomiting', 'Dark urine'], here are some potential diseases with their descriptions:

+1. Biliary Atresia: A rare disease of the liver and bile ducts that affects newborns. Symptoms in common: Dark urine. Symptoms not in common: Death in infancy, Vomiting.

+2. Galactosemia: A rare genetic metabolic disorder that affects an infant's ability to metabolize galactose, a sugar found in milk. Symptoms in common: Vomiting, Death in infancy (if untreated). Symptoms not in common: Dark urine.

+3. Crigler-Najjar Syndrome: A rare inherited disorder that impairs the ability to break down bilirubin, a byproduct of red blood cell breakdown. Symptoms in common: Dark urine. Symptoms not in common: Death in infancy, Vomiting.

+4. Hepatitis A: A viral liver disease that can cause mild to severe illness. Symptoms in common: Dark urine, Vomiting. Symptoms not in common: Death in infancy.

+5. Neonatal Hemochromatosis: A rare disorder that causes excessive iron accumulation in the liver and other organs of a newborn. Symptoms in common: Dark urine. Symptoms not in common: Death in infancy, Vomiting.

Please note that a proper diagnosis requires a comprehensive evaluation by a medical professional, considering the patient's medical history, physical examination, and additional tests if necessary."
['Maple syrup urine disease'],"Based on the provided symptoms, here are some potential diseases with their descriptions and an analysis of the symptoms the patient has or does not have in common with each disease:

+1. Maple Syrup Urine Disease (MSUD):
This is a rare inherited metabolic disorder characterized by the inability to break down certain amino acids (leucine, isoleucine, and valine). Symptoms the patient has in common: Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Feeding difficulties. Symptoms the patient does not have: Seizure, Death in infancy, Sleep abnormality, Severe hearing impairment, Elevated urinary carboxylic acid.

+2. Glutaric Aciduria Type 1:
This is a rare inherited metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to an accumulation of glutaric acid and other metabolites. Symptoms the patient has in common: Seizure, Lethargy, Growth delay, Metabolic acidosis, Drowsiness, Feeding difficulties, Elevated urinary carboxylic acid. Symptoms the patient does not have: Death in infancy, Hyperammonemia, Sleep abnormality, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Severe hearing impairment.

+3. Methylmalonic Acidemia:
This is a rare inherited metabolic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase, leading to an accumulation of methylmalonic acid and other metabolites. Symptoms the patient has in common: Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Feeding difficulties, Elevated urinary carboxylic acid. Symptoms the patient does not have: Seizure, Death in infancy, Sleep abnormality, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Severe hearing impairment.

+4. Propionic Acidemia:
This is a rare inherited metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to an accumulation of propionic acid and other metabolites. Symptoms the patient has in common: Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Feeding difficulties, Elevated urinary carboxylic acid. Symptoms the patient does not have: Seizure, Death in infancy, Sleep abnormality, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Severe hearing impairment.

+5. Biotinidase Deficiency:
This is a rare inherited metabolic disorder caused by a deficiency of the enzyme biotinidase, leading to a deficiency of the vitamin biotin. Symptoms the patient has in common: Seizure, Lethargy, Growth delay, Metabolic acidosis, Drowsiness, Feeding difficulties, Severe hearing impairment. Symptoms the patient does not have: Death in infancy, Hyperammonemia, Sleep abnormality, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Elevated urinary carboxylic acid.

Please note that a proper diagnosis would require additional tests and a thorough evaluation by a medical professional."
['Ornithine transcarbamylase deficiency'],"Based on the provided symptoms, here are some potential diseases with their descriptions:

+1. Urea Cycle Disorders: Characterized by hyperammonemia, vomiting, lethargy, coma, and other neurological symptoms due to the body's inability to remove ammonia from the bloodstream. Symptoms in common: Hyperammonemia, vomiting, coma, cerebral edema, neonatal death, death in childhood, death in adolescence.

+2. Propionic Acidemia: A rare inherited disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid and other metabolites. Symptoms in common: Vomiting, lethargy, hypotonia, developmental delay, seizures, abnormal circulating proline and arginine concentrations, hyperammonemia, gastrointestinal inflammation.

+3. Maple Syrup Urine Disease (MSUD): A rare inherited disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex, leading to the accumulation of branched-chain amino acids. Symptoms in common: Vomiting, lethargy, coma, athetosis, abnormal circulating amino acid concentrations, maple syrup odor in urine and sweat.

+4. Ornithine Transcarbamylase Deficiency (OTC): A urea cycle disorder caused by a deficiency of the enzyme ornithine transcarbamylase, leading to hyperammonemia and other metabolic disturbances. Symptoms in common: Hyperammonemia, vomiting, lethargy, coma, cerebral edema, neonatal death, death in childhood, death in adolescence.

+5. Leiner's Disease: A rare inherited disorder caused by a deficiency of the enzyme arginase, leading to the accumulation of arginine and other metabolites. Symptoms in common: Abnormal circulating arginine concentration, hyperammonemia, developmental delay, seizures, spasticity.

Please note that the provided symptoms may overlap with multiple disorders, and a definitive diagnosis would require further clinical evaluation and laboratory testing."
